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The posttranslationally modified antimicrobial peptide nisin belongs to the family 
of lantibiotics, which constitute a group of small peptides that contain a high proportion 
of unusual amino acids. These unusual residues confer unique properties that are essential 
for its biological activity. Nisin is produced by Lactococcus lactis, and has a broad 
spectrum of activity against gram-positive bacteria including food-spoilage bacteria and 
pathogens. 
The aim of this work was to express nisin from Bacillus subtilis 168 by 
transferring the nisin gene cluster from its natural host into the chromosome of B. subtilis 
168.This would allow the exploration of the use of genetic engineering techniques to 
create structural analogs of nisin and also enable a more facile study of the post-
translational modification machinery. A variety of strategies to achieve this transfer were 
explored. In one strategy, a λ genomic library of L. lactis 11454 was constructed. The  
clones containing the 16.5 kb nisin gene cluster and immediate neighboring genes was 
then subcloned into a cassette vector, pLPVcat, and transformed into B. subtilis 
erm∆sunA, which was then integrated into the B. subtilis chromosome by a double 
recombination. This recombinant was tested for its ability to express mature nisin into the 
culture supernatant by using mass spectrometry. However, no nisin or nisin like peptide 
could be detected when the culture supernatant was analyzed. Integration of a constitutive 
promoter in front of the nisin structural gene in an attempt to insure that the nisin gene 
was expressed did not solve the problem. There could be several explanations for this 
result. One possibility is that transcription of the nisin gene cluster was inadequate 
despite the presence of the integrated promoter. Another possibility is that transcription 
was adequate, but there was a lesion in the posttranslational processing pathway. RT-
PCR was employed to establish that all of the nis ABTCIPRK genes were 
transcriptionally active, but the possibility that the level of transcription was too low to 
give detectable levels of nisin could not be ruled out. It is noted that nisin biosynthesis is 
a complex process, and that one or more of the posttranslational events could be 
inefficient in the B. subtilis 168 host. 
An important achievement in this work was the construction of a B. subtilis 168 
strain that contains the entire nisin gene cluster integrated into the chromosome. This will 
greatly facilitate future work on expression of nisin in a heterologous strain that is more 
suitable for laboratory studies than is the natural producer strain.
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Bacteria are a very large group of single-cell microorganisms. Bacteria were first 
discovered with the advent of the microscope in the 17th century. However, it was not 
until Louis Pasteur studied them in the mid-19th century that it became clear that bacteria 
were responsible for many human diseases. 
The new era in modern medicine began with the discovery of the first antibiotic 
drug penicillin by Alexander Fleming in 1928 and it was first used to cure soldiers in 
World War II. Since then, many antibiotics have been developed and discovered. The 
advent of antibiotics has revolutionized the treatment of serious bacterial illness that has 
not been controlled by the immune system. These medications work either by killing 
bacteria directly, or else by stopping their growth in order that the immune system can 
more effectively eliminate them. Unfortunately, bacteria frequently develop resistance to 
the antibiotics, which once killed them. In effect, a war has begun between the scientists 
who keep developing new antibiotics, and the bacteria, which seem to develop resistance 
to those antibiotics at an ever-increasing rate. In the search for new antibiotics, scientist 
have discovered that bacteria as well as non-bacterial cells fight for niche and nutrients 
against other bacteria and as one of the many ways to combat this environmental take 
over, some have evolved the ability to secrete antimicrobial peptides. Today, we can 
broadly classify peptide antibiotics into two categories. One category consists of 
peptides, which are synthesized by multienzyme complexes, and another category 
consists of peptides, which are encoded by structural genes and synthesized ribosomally.  
 1
Peptide antibiotics that contain unusual amino acids are common, and most of 
them, such as valinomycin and Gramicidin S, are synthesized by a non-ribosomal 
mechanism. In contrast nisin, another antimicrobial peptide, is derived from 
posttranslational modifications of a ribosomally synthesized polypeptide. Nisin’s being 
gene encoded has the great advantage over the antibiotics that are biosynthesized by 
multistep enzymatic pathways in that their structure can be modified by mutagenesis of 
the gene. This allows us to construct antibiotics that may have much improved 
antimicrobial activities or to design new antibiotics that can be used to treat diseases to 
which no treatments are known. 
 
Part I.   The lantibiotics 
Gene-encoded antimicrobial peptides are widely distributed in nature, being 
produced by mammals, birds, fish, amphibia, insects, plants, fungi, and microorganisms 
(68;3;68). Lantibiotics are a subgroup of antimicrobial peptides that are produced by 
gram-positive bacteria of different genera: Staphylococcus, Lactococcus, Streptococcus, 
Bacillus and Streptomyces (29). The activity of nisin, the prototype of the lantibiotics, 
was first observed in 1928 (67). Subtilin, which is produced by Bacillus subtilis ATCC 
6633, is a natural analogue of nisin and was discovered in 1948 (29). They exhibit 60% 
identity in their amino acid residues.  
 Lantibiotics have high proportion of modified residues that are introduced by 
posttranslational modification machinery. For example, in both nisin and subtilin one 
third of the amino acids are modified, including three dehydro residues, two 
dehydroalanine (Dha) and one dehydrobutyrine (Dhb), and five lanthionine rings each 
 2
contain two modified residues. Initially, it was thought that nisin was synthesized by a 
non-ribosomal mechanism due to the presence of high proportion of unusual amino acids. 
However, Hurst’s observation that nisin biosynthesis was inhibited by protein synthesis 
inhibitors suggested that protein synthesis was required, which argued for a ribosomal 
mechanism (33). This was confirmed when the nisin gene was first cloned in the Hansen 
laboratory in1988 (8). 
Lantibiotics originate via enzymatic modification of ribosomally synthesized 
precursor molecules, the so-called prelantibiotics (Figure 2). These polypeptides consist 
of a leader peptide and the unmodified prolantibiotic. The name lantibiotic is derived 
from their content of the thioether amino acids lanthionine and 3-methyllanthionine (73) 
(Figure 1). These amino acids arise through a multistep process; first, β-hydroxy-α-
amino acids in the pro-peptide portion of the precursor are enzymatically dehydrated to 
their respective α,β-unsaturated equivalents and then the thiol group of a neighboring 
Cys residue is added to the double bond in an enzyme mediated reaction to generate the 
corresponding thioether.  
 
Part I-1.   Classification of lantibiotics 
Lantibiotics can be categorized according to their structural features (Figure 3). 
Type A lantibiotics, of which nisin is the most thoroughly characterized, are elongated, 
screw shaped, and amphiphilic and cationic; and they have a molecular weight in the 
range of 2,000-5,000. Examples of this class are nisin, subtilin, Pep5, epidermin, and 
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Figure 1.   Nisin and unusual amino acids present in nisin. 
) Structure of modified nisin. B) Formation of dehydro and lanthionine residues 


















































































































































Figure 2.   Scheme for posttranslational modification of prenisin into nisin. 
The serines and threonines (marked with asterisks) undergo sequence-specific 
dehydration reaction to create modified amino acids with electrophilic centers. 
Stereospecific addition of the sulfhydryl group of the cysteine to the dehydro residues 
result in the formation of thioether cross-linkages called lanthionine and β-
methyllanthionine. This scheme was originally proposed by Ingram (34). 











































Figure 3.   Structures of the representative Type A, B, and C lantibiotics 
Ala-S-Ala: Lanthionine, Ala-S-Aba: β-methyllanthionine, Dha: Dehydroalanine, Dhb: 





have molecular weights of about 2,000. Examples of this class are cinnamycin, 
duramycins, and ancovenin. The type A lantibiotics interact with the membrane of the 
susceptible cells and form transient voltage-dependent pores (55), whereas at least some 
type-B lantibiotics act by inhibiting the functioning of certain enzymes. Mersacidin and 
actagardine are categorized as type-C lantibiotics since they do not fit into either type-A 
and type-B category (27;29;61). Type-C lantibiotics interfere with the cell wall synthesis 
in gram-positive bacteria (70). 
 
Part I-2.   Genes involved in the biosynthesis of lantibiotics. 
Lantibiotics begin as ribosomally synthesized prepeptides (Lan A peptide) and 
undergo a complex series of events including posttranslational modification of the mature 
region, cleavage of the leader peptide, and secretion outside the cell. However, our 
current knowledge of these events, such as the order in which they occur or the location 
is incomplete. Besides the structural genes for the individual lantibiotic prepeptides (lanA 
genes), there are additional genes which code for a number of other functions that are 
clustered near the structural gene (Figure 4) in the host chromosome, or alternatively, on 
plasmids. Genes that are found as homologs in more than one type of lantibiotic gene 
cluster are denoted with prefix lan. These include: i) proteins with sequence similarity to 
the family of two-component regulatory proteins (proteins designated LanR and LanK); 
ii) proteins with sequence similarity to serine proteases (LanP proteins); iii) proteins with 
sequence similarity to translocators of the ATP-binding cassette transporter protein 
family (LanT proteins); iv) proteins without similarity to known proteins which were 
found to be involved in producer –self-protection (‘immunity’, LanI proteins); and v) two 
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nisA nisB nisT nisC nisI nisP nisR nisK
10 kb
nisin
nisF nisE nisG 
SpaAspaB spaT spaC spaI spaF spaR spaKspaG
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pepT pepI pepP pepB pepCpepA
cylA1 cylA2 cylM cylT cylP
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Figure 4.   Organization of the selected lantibiotic gene clusters. 
Genes with similar proposed function or substantial sequence similarity are given   
similar suffixes and are highlighted in the same manner. The arrowheads indicate the 
transcription of each lan gene. The functions of the genes are described in the text. 
LactocinS gene cluster contains several open reading frames with no counterparts in other 
gene cluster with known functions. The gene names used are standardized nomenclature 




proteins with no obvious sequence similarity to proteins in databases (LanB and LanC 
proteins). 
The lan genes are all these genes involved in the lantibiotic synthesis, and those 
of a particular lantibiotic have their specific names, such as the nis genes involved in 
nisin biosynthesis and the spa genes involved in subtilin biosynthesis. LanB and LanC 
proteins seem to be novel, as they have no homology to other known proteins in the 
databases. Thus it has been speculated that these genes may be responsible for the 
formation of the thioether rings which are characteristics of the lantibiotics (23);(37). The 
first experimental evidence showing that nisB is required for dehydration and nisC for 
correct lanthionine formation in nisin maturation was published recently (43). The lanB 
and lanC genes appear to be missing in the gene clusters responsible for the production of 
lacticin S, cytolysin and in some other lantibiotics. These clusters do however contain a 
gene encoding a LanM protein, which is much longer. The C-terminal domain shows 
25% sequence identity to the LanC proteins, arguing that they may perform both LanB 
and LanC functions (35). 
Many lantibiotic-producing strains have three genes in common considered as 
lanB, lanC, and lanT. With respect to the nisin biosynthesis, the nisT gene product shares 
strong homology with several ATP-dependent tranport proteins having two ATP-binding 
sites and a very hydrophobic region at the N terminus with six potential membrane-
spanning domains. 
It is also interesting to note that these modifications are only found in the 
lantibiotics and not any other proteins inside the bacteria. This suggests that the leader 
sequence, or region in the mature sequence, may contain some signals that may direct 
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them to the NisB and NisC proteins in producing the modified peptide. Identifying these 
specific signals might allow us to design novel biomolecules that would contain these 
modified amino acids, which would confer novel activities or chemical properties that 
cannot be attained by the common 20 amino acids. 
 
Part I-3.   Leader peptide. 
 The last step in the biosynthesis of a lantibiotic is the removal of the leader 
peptide from the lantibiotic precursor. In the gene clusters for the lantibiotics nisin, 
epidermin, Pep5, epilancin K7, lacticin S, cytolysin and epicidin 280 a lanP gene was 
found encoding a subtilisin-like protease. The location, at which processing of the leader 
peptide occurs, varies with the lantibiotic. NisP, responsible for cleavage of the nisin 
precursor is anchored to the cellular membrane at the outside of the host cell (80). In 
contrast to nisin, the spa gene cluster does not contain a gene encoding a peptidase, and it 
is assumed that processing of subtilin occurs by a general serine protease of the host 
Bacillus subtilis (76). 
 Leader peptides of type A lantibiotics are hydrophilic, highly charged, devoid of 
cysteine residues and do not show the characteristics of sec-dependent signal sequences 
(14;11;70). The leader peptides are not post-translationally modified as shown for nisin 
and Pep5 (10;81). The leader peptide part of precursor nisin, the synthetic leader peptide, 
and probably also the leader peptide in the primary translation product are predominantly 
random coil in aqueous solution (79;84). Thus, the conserved sequence Phe-Asn-Leu-Asp 
of the nisin leader peptide does not adopt a well-defined structure that could act as a rigid 
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recognition site. However, conformational adjustment is possible to binding sites of 
modifying enzyme(s), of proteins involved in the transport, or at a membrane. 
 Four possible functions have been proposed for type A lantibiotic leader peptides 
(16). First, the leader peptide may keep precursor molecules biologically inactive. Indeed, 
the final intermediate in biosynthesis of nisin is almost inactive. Second, assistance of the 
precursor peptide in transport across cytoplasmic membrane is possible. In this respect, it 
is noted that the leader peptide part of the precursor of nisin was observed to be in contact 
with, but not traversing, the membrane like surface of micelles. The biological relevance 
of this observation is not clear. Third, it may act as recognition or binding site for 
biosynthetic enzymes. Fourth, an interaction between the leader peptide part and the rest 
of the molecule may favor a conformation essential for correct modification, preventing 
nonspecific reactions. In precursor nisin, which is already modified, the leader peptide 
part and the nisin part do not interact, so that at this point in the maturation there are no 
indications for such a function.  
 
Part I-4.   Immunity of producer organisms 
 The nisI gene was identified in the middle of the nisin gene cluster and shown to 
be involved in the development of immunity. The deduced sequence of the 245-residue 
NisI protein suggests that it is a lipoprotein, probably anchored in the membrane with its 
C-terminus toward the outer side of the cell (45). The nisin and subtilin (165 residue) 
immunity proteins are similar in amino acid sequence and general properties, most likely 
as a reflection of the high degree of similarity of these lantibiotics; however there is no 
cross immunity between producing strains, demonstrating the specificity of the immunity 
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mechanisms (70). Cross immunity was only observed between strains producing natural 
variants such as nisin A and nisin Z (15). Nisin Z differs from nisin A by a single 
mutation (58). Overexpression of LanI proteins in cells that do not possess the lantibiotic 
biosynthetic machinery only yields very low protection levels (1-4%) against the 
corresponding lantibiotic (45). An in-frame disruption of nisI in Lactococcus lactis 
yielded a strain that could still produce nisin, albeit to levels five times lower than the 
wild-type (64), which suggests that the immunity level could be the first limiting factor in 
reaching high production levels. These results already indicate that additional factors are 
involved in the full self-protection. 
 In several lantibiotic gene clusters, three other proteins are encoded, named LanF, 
LanE, and LanG. The LanFEG proteins belong to the group of ABC transporters, where 
LanF contains the intracellular ATP-binding domain and LanEG the membrane spanning 
subunits. The genes lanFEG have been found in the gene clusters for nisin (74), subtilin 
(40). It is tempting to speculate that these proteins have a function in the removal of the 
corresponding lantibiotic at a certain stage of its membrane interaction. Expression of the 
LanFEG proteins, without LanI, yields a significant level of immunity although it 
remains below the wild type level. The synergistic function of all the immunity proteins 
could thus reside in the first recognition and binding or ‘immobilization’ of the lantibiotic 
in the membrane by NisI, followed by active removal, in which the LanFEG proteins are 
involved. It can not be excluded, however that also other proteins encoded in the 
lantibiotic gene clusters display a synergistic effect in the immunity mechanism, for 
instance by being involved in a multi-protein complex that spans the membrane. 
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Candidates to be involved in such a complex are LanBTC proteins, which have already 
been shown to form a membrane associated complex (75;38;59). 
 Interestingly, in some cases, e.g. nisin and subtilin production, the expression of 
the immunity genes is also regulated by the concentration of the lantibiotic in the 
medium, which means that by sensing low (subinhibitory) amounts of the antimicrobial 
peptide in the medium, cells can rapidly increase the immunity level, concominant with 
or even faster than the biosynthesis rate (12). 
 
Part I-5.   Regulation of biosynthesis 
Biosynthesis of lantibiotics appears to be under the control of two-component 
response regulatory proteins, a large family of proteins involved in regulation of a variety 
of physiologically important processes. Nisin also plays an important role in the 
regulation of its own biosynthesis. In fact, nisin can be regarded as a peptide pheromone, 
which is sensed by the histidine kinase NisK, which resides at the outer side of the 
membrane, probably by direct protein-peptide interaction. By analogy with other known 
two-component regulatory systems (39), NisK will autophosphorylate at a specific 
histidine residue when it senses a certain concentration of nisin in the medium and 
subsequently transfer the phosphate moiety to the response regulator NisR. The response 
regulator is assumed to get phosphorylated at a specific Asp residue, which is supposed 
to trigger its binding to two regulated promoters in the nisin gene cluster, i.e. the nisA and 
nisF promoter, thereby activating transcription of the structural gene nisA and the 
downstream genes nisBTCIP by limited read through from nisA, and the genes nisFEG 
located at the end of gene cluster (44;12;56). The regulatory genes nisRK themselves are 
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transcribed from their own promoter which is assumed to be not dependent on nisin 
induction (12). 
 The transcription from the nisA and nisF promoter in the nisin gene cluster is 
directly related to the concentration of nisin in the medium. This property is extremely 
useful for the development of a controlled gene expression system, since a linear dose-
response for the expression of target genes is highly desirable for industrially-relevant  
production organisms. In the case of subtilin production, the autoregulatory process has 
been shown to be very similar to the nisin case, because the spaB, spaI and spaS 
promoters could be activated by subtilin in the medium. Knockouts of spaRK and nisRK 
have been shown to be detrimental for lantibiotic production (30;54). 
 Both inducer and sensor engineering have been used to study the molecular 
interaction between these molecules. First, it was shown that variants and fragments of 
nisin were able to act as inducer with variable efficiencies and that their induction 
capacity was unrelated to their antimicrobial activity, demonstrating that the mechanisms 
for the induction and pore formation are different (20;42).  
 
Part I-6.   Bacteriocidal activity. 
Type A lantibiotics exert bacteriocidal activity toward a broad range of Gram-
positive bacterial strains, including Streptococci, Bacilli, Listeriae, Clostridia, and 
Staphylococci (32). The antibacterial effect is strong, with nM concentrations of a 
lantibiotic being sufficient to kill the bacterial cells. Fungal cells, yeast cells or human 
cells are very insensitive to lantibiotics, even when treated with mM concentrations of the 
peptides (82). In general, gram-negative bacteria are also insensitive to lantibiotics. It has 
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been shown that their outer membrane functions as a barrier for the lantibiotics. When the 
outer membrane of the gram-negative strains was weakened by treatment with EDTA or 
osmotic shock, the susceptibility of cells towards nisin (78) or Pep5 strongly increased. 
 Positive charge and amphipathicity are general features of antimicrobial peptides, 
which kill bacteria by permeabilization of their membranes. It has been shown that nisin 
most efficiently interacts with anionic membrane lipids (3;18), and that positive charges 
in the C-terminal domain of nisin are important for this interaction (4). The peptides 
appear to interfere with the membrane function of sensitive cells by increasing the 
permeability of the bilayer for small molecules and disrupting the membrane potential, 
resulting in cell death. Within several minutes, the lantibiotics induce the release of ions, 
small molecules and ATP from sensitive bacterial cells. The efflux of high-molecular-
weight compounds (>500 Da) was not observed (21), indicating that lantibiotics do not 
completely disrupt the barrier function of the membrane, as detergents do. Recent studies 
have also indicated that nisin binds specifically to Lipid II (6). The presence of Lipid II, a 
specific docking molecule, has increased the pore formation efficiency of nisin in the 
model membranes (5). Lipid II molecules provide the peptidoglycan precursors necessary 
for biosynthesis of extracellular cell wall. In contrast to recent reports on resistance or 
tolerance to vancomycin, no resistance to nisin has been reported, despite its use as a 
preservative for the last 50 years. Complete elucidation of events in nisin’s mechanism of 
action could be invaluable in terms of development of a new class of highly efficient 
antibiotics. 
 A second mode of action that several type-A lantibiotics possess is inhibition of 
spore outgrowth. There is some evidence supporting the fact that nisin and subtilin may 
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become covalently attached to nucleophilic membrane sulfhydryl groups on the surface 
of germinating spores by reacting with one or more electrophilic dehydro residues. It has 
been shown that Dha5Ala mutant of subtilin (51) and nisin (9) is unable to inhibit the 
outgrowth of spores but is fully active against vegetative cells. 
 
Part II.   Nisin. 
Nisin is the most extensively studied lantibiotic due to its being stable at high 
temperatures and at low pH, its non-toxic nature (LD50 5g/kg), and commercial 
availability. It is produced by food-grade strains of Lactococcus lactis. Nisin has been 
given the generally recognized as safe (GRAS) status for certain food applications in 
1988 and its currently being used as a food preservative worldwide. It has many other 
potential industrial applications. The genes involved in biosynthesis of lantibiotic nisin 
are located on a 70 kb conjugative transposon (65), which also contains the genetic 
information for sucrose metabolism. The first gene of the cluster is the structural gene 
nisA, which encodes for the precursor consisting of a 23-residue leader region and a 34-
residue structural region. The mature peptide has a molecular weight of 3353.4 Da and 
overall positive charge. The structural gene is followed by ten other genes i.e. nisB, nisT, 
nisC, nisI, nisP, nisR, nisK, nisF, nisE, nisG, encoding regulatory proteins, proteases, 
transport proteins and immunity proteins (14).  
In aqueous solution, nisin does not adopt a preferred conformation. In a lipophilic 
environment, it adopts an amphiphilic α-helix shape with two domains. The N-terminal 
domain that contains ring A-C is connected to the C-terminal domain (rings D and E) 
through a flexible hinge region. The exact role of thioether bridges is not clear but they 
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are likely to constrain the peptide into a conformation that is required for activity and/or 
confer protease resistance, possiblity to prevent degradation by proteases of competing 
bacteria. 
 
Part II-1.   Applications of nisin and other lantibiotics 
Nisin has a very broad spectrum of activity against many species that are 
important in dairy and food industry and has been approved for use in about 50 countries 
(17). Applications of nisin as a food preservative includes the use in processed cheese, 
canned foods, meat, milk, high moisture baked products, and fermented beverages such 
as beer and wine (28). It can also be used in cosmetics to increase the shelf life of certain 
products. The proteases of the human stomach and intestinal tract hydrolyze it completely 
and it does not damage the gram-negative bacteria of the intestinal flora. Nisin is a 
naturally occurring product in various fermented foods due to the fact that nisin 
producing L. lactis is commonly used as a starter culture in dairy industry. Thus, humans 
have consumed nisin safely for hundreds, or perhaps thousands of years. It is widely used 
in prevention of bovine mastitis and has potential for treatment of peptic ulcer caused by 
Helicobacter pylori (28). Another area of interest for nisin is dental applications, since it 
has been shown to be effective in killing S. mutans, the prime cause of dental cavities, 
and in prevention of oral plaque and gingivitis (28). 
Epidermin, another type-A lantibiotic, is used for treatment of skin infections 
(28). Ancovenin can inhibit the angiostatin-converting enzyme and thus has potential for 
use in treatment of high blood pressure (28). Cinnamycin, a type B lantibiotic has been 
shown to inhibit replication of Herpes simplex virus, HSV1 (28). 
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 In spite of nisin’s frequent use as a biopreservative for nearly 50 years, no 
bacterial strains, which have developed resistance to nisin, have been detected. This is in 
great contrast with the case of regular antibiotics. Perhaps the unusual residues present in 
the lantibiotics play a crucial role in their distinct mechanism of action. Elucidation of the 
ways that lantibiotics orchestrate the introduction of these unusual residues, 
determination of their mode of action against vegetative cells and spores, and the set of 
events that take place during the biosynthesis would be of great importance to the 
scientific and medical communities. It is likely that this knowledge could be applied to 
the development of novel antimicrobial agents to fight bacterial resistance and may be 
even targeted against infectious or other diseases that are currently incurable. 
 
Part II-2.   Heterologous expression of nisin and subtilin. 
 The ability to produce an antibiotic is a trait that can be easily transmitted 
between bacteria. Usually, the genes necessary for production of the antibiotic are 
clustered together within the chromosome or within some kind of genetic element such as 
plasmid or transposon. This facilitates the transfer of antibiotic production between 
bacterial species. Being gene encoded makes the lantibiotics particularly amenable to 
expression in other bacteria since they could adapt to different environments by the 
mechanism of mutation and selection that is available to all proteins. 
 We are particularly interested in expressing lantibiotics in hosts that are suitable 
for industrial production. This is because if these antbiotics can be produced 
inexpensively on a large scale, their use in a variety of new applications is more likely to 
be explored and thus widely used. Another goal is to identify all the genes involved in the 
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biosynthetic pathway of lantibiotics. To date, the genes were assigned to functions by 
comparison of their sequences with the protein database, however genetic and 
biochemical analysis should be done ultimately to confirm these functions. The details of 
the biosynthesis machinery also need to be explored. However not every lantibiotic 
producer can be easily manipulated by genetic engineering. 
 The genes responsible for subtilin production have been transferred from B. 
subtilis 6633 to B. subtilis 168 (50) in this laboratory. Derivatives of B. subtilis 168 have 
been widely exploited for industrial production of biological materials. There are 
extensive genetic information and methodologies available for B. subtilis 168. Being a 
gram-positive bacteria and not producing an endotoxin are other great advantages of this 
organism for lantibiotic gene transfer and expression. 
 The presence of nisin genes on a conjugative transposon, a mobile genetic 
element, argues the fact that nisin could be expressed in other bacteria. In fact, transfer of 
nisin production ability between species and strains of L. lactis has been achieved by 
several labarotories (27). Since nisin and subtilin are so closely related, it is presumed 
that information about one will provide useful insight about the other such as the 
specificity of leader peptides and/or the role of leader peptide in the introduction of 
unusual residues etc. 
 A primary goal of this project has been to transfer nisin producing ability into B. 
subtilis 168 so that all the genes involved in nisin biosynthesis could be characterized in 
this new host. This would create opportunities to engineer the nisin structure in order to 
study structure/function relationships and to design analogs with modified and novel 
biophysical, biochemical, and biological properties. 
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Materials and Methods 
Part I.   Material sources 
Part I-1.   Reagents and Chemicals 
Acetic Acid, Glacial    Baker Chemical, Phillipsburg, NJ 
Acetonitrile, HPLC grade   Fisher Scientific Co., Fairlawn, NJ 
Acrylamide     Bio-Rad Laboratories, Hercules, CA 
Agarose     BRL, Gaithersburg, MD 
Amino acids     Sigma Chemical Company, St. Louis, MO 
Ammonium acetate    Fisher Scientific Co., Fairlawn, NJ 
Ammonium bicarbonate   Sigma Chemical Company, St. Louis, MO 
Ammonium hydroxide (30%)   Baker Chemical, Phillipsburg, NJ 
Ammonium persulfate   U. S. Biochemicals, Cleveland, OH 
Ammonium phosphate, dibasic  Sigma Chemical Company, St. Louis, MO 
Ammonium sulfate    Baker Chemical, Phillipsburg, NJ 
[γ-32P]ATP     New England Nuclides, Boston, MA 
BCIP      Bio-Rad Laboratories, Hercules, CA 
BioGel Agarose    Bio 101, Vista, CA 
Bisacrylamide     Bio-Rad Laboratories, Hercules, CA 
Bovine serum albumin   Sigma Chemical Company, St. Louis, MO 
Bromophenol Blue    Sigma Chemical Company, St. Louis, MO 
Calcium Chloride    Fisher Scientific Co., Fairlawn, NJ 
Cesium chloride    Sigma Chemical Company, St. Louis, MO 
Chloroform     Baker Chemical, Phillipsburg, NJ 
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Cellulose, non ionic powder   Bio-Rad Laboratories, Hercules, CA 
Citric acid (anhydrous)   Fisher Scientific Co., Fairlawn, NJ 
dGTP, dATP, dTTP, dCTP   U. S. Biochemicals, Cleveland, OH 
DEPC      Sigma Chemical Company, St. Louis, MO 
Dimethylformamide    Fisher Scientific Co., Fairlawn, NJ 
Disodium EDTA dihydrate   Fisher Scientific Co., Fairlawn, NJ 
Ethanol     Fisher Scientific Co., Fairlawn, NJ 
Ethidium Bromide    Sigma Chemical Company, St. Louis, MO 
Ferric Chloride    Acros Organics, New Jersey, USA 
Formaldehyde     Sigma Chemical Company, St. Louis, MO 
Formamide     Baker Chemical, Phillipsburg, NJ 
Glycine     Baker Chemical, Phillipsburg, NJ 
Goat Anti-Rabbit IgG-AP Conjugate  BRL, Gaithersburg, MD 
Glycerol     Fisher Scientific Co., Fairlawn, NJ 
Herring sperm DNA    BRL, Gaithersburg, MD 
Hydrochloric acid (30%)   Baker Chemical, Phillipsburg, NJ 
IPTG      Sigma Chemical Company, St. Louis, MO 
Isopropanol     Baker Chemical, Phillipsburg, NJ 
Manganous chloride tetrahydrate  Baker Chemical, Phillipsburg, NJ 
Magnesium chloride hexahydrate  Fisher Scientific Co., Fairlawn, NJ 
Magnesium sulfate    Sigma Chemical Company, St. Louis, MO 
β-mercaptoethanol    Sigma Chemical Company, St. Louis, MO 
ΜΟPS      Sigma Chemical Company, St. Louis, MO 
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NBT/BCIP 1 Step™ Solution   Pierce Biotechnology Inc., Rockford, IL 
Paraffin oil     Baker Chemical, Phillipsburg, NJ 
Phenol      Fisher Scientific Co., Fairlawn, NJ 
Phosphoric acid    Fisher Scientific Co., Fairlawn, NJ 
Polyethylene glycol-8000   Fisher Scientific Co., Fairlawn, NJ 
Potassium chloride    Baker Chemical, Phillipsburg, NJ 
Potassium hydroxide    Fisher Scientific Co., Fairlawn, NJ 
Potassium phosphate, monobasic  Fisher Scientific Co., Fairlawn, NJ 
Potassium phosphate, dibasic   Fisher Scientific Co., Fairlawn, NJ 
Sinapinic acid     Sigma Chemical Company, St. Louis, MO 
Sodium acetate trihydrate   Baker Chemical, Phillipsburg, NJ 
Sodium chloride    Fisher Scientific Co., Fairlawn, NJ 
Sodium citrate, anhydrous   Fisher Scientific Co., Fairlawn, NJ 
Sodium dodecyl sulfate   Fisher Scientific Co., Fairlawn, NJ 
Sodium hydroxide    Fisher Scientific Co., Fairlawn, NJ 
Sodium phosphate, monobasic,monohydrate EM Science, Gibbstown, NJ 
Sodium phosphate, dibasic,12-hydrate Baker Chemical, Phillipsburg, NJ 
Sodium sulfate    Fisher Scientific Co., Fairlawn, NJ 
Sucrose     Fisher Scientific Co., Fairlawn, NJ 
TEMED     Sigma Chemical Company, St. Louis, MO 
Tricine      Sigma Chemical Company, St. Louis, MO 
Tris base     Fisher Scientific Co., Fairlawn, NJ 
tRNA      Sigma Chemical Company, St. Louis, MO 
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Tween-20     Sigma Chemical Company, St. Louis, MO 
X-Gal      Sigma Chemical Company, St. Louis, MO 
Xylene cyanol FF    Baker Chemical, Phillipsburg, NJ 
Zinc Chloride     Sigma Chemical Company, St. Louis, MO 
 
Part I-2.   Strains, Enzymes and kits 
Alkaline Phosphatase, calf intestinal  New England Biolabs, Boston, MA 
DyNAzymeTM EXT    MJ Research, Waltham, MA 
Eppendorf Perfectprep® Plasmid Mini kit Eppendorf, Westbury, NY 
GenecleanTM DNA purification  Bio 101, Vista, CA 
Klenow DNA polymerase   Fermentas Inc., Hanover, MD 
Lysozyme     Sigma Chemical Company, St. Louis, MO 
Μutanolysin     Sigma Chemical Company, St. Louis, MO 
One step RT-PCR kit    Qiagen Inc., Valencia, CA 
Proteinase K     Sigma Chemical Company, St. Louis, MO 
Restriction enzymes    New England Biolabs, Boston, MA 
Restriction enzymes    Promega Corporation, Madison, WI 
Restriction enzymes    Fermentas Inc., Hanover, MD 
Ribonuclease A    Sigma Chemical Company, St. Louis, MO 
RNase free DNase set    Qiagen Inc., Valencia, CA 
RNeasy® Mini Kit    Qiagen Inc., Valencia, CA 
T4 DNA ligase    Fermentas Inc., Hanover, MD 
T4 polynucleotide kinase   Fermentas Inc., Hanover, MD 
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TA Cloning® kit    Invitrogen, Carlsbad, CA 
Taq DNA polymerase    Fermentas Inc., Hanover, MD 
100 bp DNA ladder    Fermentas Inc., Hanover, MD 
 
Part I-3.   Media 
Bacto Agar     Difco, Detroit, MI 
Bacto casamino acids    Difco, Detroit, MI 
Bacto lactose     Difco, Detroit, MI 
Bacto tryptone     Difco, Detroit, MI 
Yeast extract     Becton Dickinson, Sparks, MD 
M17 media     Difco, Detroit, MI 
NZY Broth     Gibco Laboratories, Madison, WI 
SOC media     Invitrogen, Carlsbad, CA 
Penassay broth (PAB) antibiotic medium 3 Difco, Detroit, MI 
 
Part I-4.   Antibiotics, oligonucleotides 
Ampicillin     U. S. Biochemicals, Cleveland, OH 
Chloramphenicol    Sigma Chemical Company, St. Louis, MO 
Erythromycin     Sigma Chemical Company, St. Louis, MO 
Oligonucleotides    Sigma/Genosys, St. Louis, MO 
 
Part I-5.   Apparatus 
Aerosol spray unit    Sigma Chemical Company, St. Louis, MO 
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Air and water incubating shakers  New Brunswick Scientific, New Brunswick 
Chromatography columns   BIO-RAD Laboratories, Hercules, CA 
Centrifuge, Avanti J25-I   Beckman, Irvine, CA 
Centrifuge Bottles    VWR Scientific, Baltimore MD 
Corex glass centrifuge tubes, 30 ml  DuPont 
Dialysis tubing    VWR Scientific, Baltimore MD 
Digital photo documentation system  Eastman Kodak, Rochester, NY 
Electrophoretic transfer cell   BIO-RAD Laboratories, Hercules, CA 
Electroporation cuvette PlusTM, Model 610 BTX Inc, San Diego, CA 
Electroporation system, Model ECM 600 BTX Inc, San Diego, CA 
ESI-Mass Spectrometer (LCQ)  Finnigan, San Jose, CA 
HPLC column, Zorbax   Agilent Technologies, Palo Alto, CA 
HPLC column, Microsrob   Rainin Instrument Co., Inc, Woburn, MA 
HPLC      Hewlett-Packard, Avondale, PA 
ImmobilonTM-NC nitrocellulose membrane Millipore Inc, Bedford, MA 
Eppendorf Microcentrifuge   VWR Scientific, Baltimore MD 
Gel electrophoresis horizontal units  BRL, Gaithersburg, MD 
Gel electrophoresis horizontal units  Owl scientific 
Gel electrophoresis vertical units  BioRad Laboratories, Hercules, CA 
Gel electrophoresis vertical unit glass plates VWR Scientific, Baltimore, MD 
Hybridization bags    Kapak, St. Louis, MI 
Hybridization bag sealer (Kapak)  VWR Scientific, Baltimore, MD 
Klett-Somerson photoelectric colorimeter Klett Manufacturing, Inc., New York, NJ 
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MALDI-TOF MS    Bruker Instruments, Manning Park, MA 
MALDI-TOF MS sample stages  Bruker Instruments, Manning Park, MA 
Microscope     Nikon, Japan 
Molecular biology disposable supplies VWR Scientific, Baltimore, MD 
Nitrocellulose membranes   Millipore, Bedford, MA 
Nitrocellulose membranes   Schleicher and Schuell, Keene, NH 
NanoESI Capillaries, PicoTip™ Emitter,  
EconoTip™                New Objective, www.newobjective .com 
Orbital platform shaker   Hoefer Scientific, San Francisco, CA 
pH meter, Accumet AB15   VWR Scientific, Baltimore MD 
Phosphor Imager (Storm™)    Molecular Dynamics, Sunnyvale, CA 
Phosphor Imager intensifying screen  Molecular Dynamics, Sunnyvale, CA 
Pipetteman, P20, P200, P1000  Rainin Instruments company Inc. 
Power Supply, Model 494   ISCO, Lincoln, NE 
Power Supply, Model EC105   E-C Apparatus, St. Petersburg, FL 
SpeedVac     Savant Instruments, Farmingdale, NY 
Syringes, 10cc, 20cc, 60cc   VWR Scientific, Baltimore, MD 
Syringe Filters     VWR Scientific, Baltimore, MD 
Syringe needles 18G11/2, 20G1, 27G11/2 VWR Scientific, Baltimore, MD 
Toyopearl® Butyl 650M HIC resin  Tosohaas, Montgomeryville, PA 
Ultracentrifuge, Preparative, Model L3-50 Beckman, Irvine, CA 
UV transluminator    Fotodyne, Inc., New Berlin, WI 
UV-VIS Spectrophotometer   Hewlett-Packard, Avondale, PA 
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XAR-5 X-ray films    VWR Scientific, Baltimore, MD 
Water bath, constant temperature  Precision Scientific, Chicago IL 
Whatmann Filter Paper (1MM and 3MM) VWR Scientific, Baltimore, MD 
X-ray film developer    Konica, Newark, NJ 
 
Part II.   Methods 




Description Source of reference 
B. subtilis 
BE1010 
B. subtilis 168 that carries a deletion in 
chromosomal genes encoding subtilisin and 
neutral protease. 
(63) 
B. subtilis 168 
BR151 
Wild-type B. subtilis 168 (trpC2, metB10, 
lys-3) 
Bacillus Genetics Stock 
Center 
B. subtilis erm∆ 
sunA 
B. subtilis BR151 in which, sunA, sublancin 
structural has been replaced with erm gene. 




B.subtilis SYNcat in which the cat gene has 
been replaced with the erm gene and A2 




B.subtilis BR151 that was transformed with 
pSYcat. Integrated the sacR, transposase 





B. subtilis BR151 that was tansformed with 
pSY2cat. Integrated the nisin gene cluster 




B.subtilis BE1010 that was transformed 
with B. subtilis SYNEC chromosomal 





B. subtilis erm∆sunA in which the erm gene 
has been replaced wit the cat gene and nisin 




B. subtilis SYcat that was transformed with 
pSYNE. Integrated the erm gene and nisin 






Natural nisin-producing L. lactis strain. (7) 
E. coli JM101 Standard E. coli cloning strain. BRL 
E. coli INVαF′ An E. coli cloning strain included with the 
TA Cloning Kit. 
Invitrogen 
pTZ18R Standard cloning vector. USB 
pCR2.1 Cloning vector included with the TA 
cloning kit. 
Invitrogen 
pLPvcat sunA gene mutagenesis cassette vector. (62) 
pSYcat pTZ18R derivative, contains amyE, 
transposase, sacR homology regions (see 
Figure 5). 
This work 
pGh9:ISS1 Plasmid that can replicate in E. coli, B. 
subtilis, L. lactis. Contains a temperature 
sensitive origin of replication. 
(52) 
pGH9USR pGh9:ISS1 that contains the upstream sacR 
homology region (see Figure 7). 
This work 
pCR2.1nisin pCR2.1 vector that contains nisin gene 
cluster (see Figure 10). 
This work 
pSY2cat pCR2.1nisin that was fused with 
pEZamycat (see Figure 10). 
This work 
pEZamycat pEZcat that contains amyL homology 
region (see Figure 10). 
This work 
pEZcat Plasmid which contains mpc restriction 
sites at either end of cat gene. 
(36) 
pEZerm Plasmid which contains mpc restriction 
sites at either end of cat gene. 
(19) 
pSYNcat pLPvcat which contains nisin gene cluster 
(see Figure 15). 
This work 
pSYNE pCR2.1 that contains the erm gene and 
nisin gene cluster (see Figure 18). 
This work 
pSYA2NE pSYNcat in which the yolF gene has been 
replaced with A2 promoter and upstream 
nisA homology region (see Figure 24). 
This work 
pLPerm pLPvcat in which the cat gene has been 
replaced with the erm gene (see Figure 24). 
This work 
pA2trpA Plasmid containing the constitutive phage 
promoter which functions in B. subtilis 168 
(see Figure 24).  
Personal gift from Dr. 
George Spiegelman, at 
the University of 
British Columbia, in 
Vancouver. 
 
Table 1.   Bacterial Strains and plasmids. 
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Part II-2.   Frequently used stock solutions, buffers, enzymes and growth media. 
2-1.   Solutions 
 Ammonium acetate:   A 7.5 M stock of ammonium acetate was prepared by 
dissolving 57.8 g of NH4OAc in 70 ml ddH2O. The solution was adjusted to 100 ml with 
ddH2O. The solution was autoclaved 20 min at 120 °C and stored at room temperature.  
 Antibiotic stock solutions:   A stock solution of 100 mg/ml ampicillin was 
prepared by dissolving 100 mg of sodium ampicillin in 1 ml of sterile ddH2O and stored 
at –20 °C. A working concentration of 100 µg/ml was used. The solution was prepared 
fresh every month. A chloramphenicol stock solution (10 mg/ml) was prepared by 
dissolving 100 mg of chloramphenicol in 10 ml of 95% ethanol and stored at –20 °C. A 
working concentration of 10 µg/ml was used for B. subtilis strains and 5 µg/ml used for 
E. coli strains. A 10 mg/ml stock of erythromycin was prepared by dissolving 100 mg of 
erythromycin in 10 ml of 95% ethanol. The solution was stored in a lightproof bottle at –
20 °C. A working concentration of 10 µg/ml was used for B. subtilis strains and 500 
µg/ml used for E. coli strains. 
Calcium chloride:   A 1 M stock solution of calcium chloride was prepared by 
dissolving 18.4 g of CaCl2.2H2O in 125 ml ddH2O. 50 mM CaCl2 was prepared by 
dissolving 7.35 g of CaCl2.2H2O in 1 liter of ddH2O and used for E. coli transformations. 
The solutions were autoclaved for 20 min at 120 °C and stored at 4 °C. 
Denhardt’s solution:   A 100x stock of Denhardt’s solution was prepared by 
dissolving 20 g of Ficoll type 400, 20 g of polyvinylpyrolidone, 20 g of bovine serum 
albumin fraction V in 800 ml ddH2O. The final volume was adjusted to 1 L. The stock 
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was aliquoted into 50 ml polypropylene tubes, and stored at –20 °C. A single aliquot was 
kept at 4 °C for use in hybridizations. 
EDTA:   0.5 M EDTA was prepared by adding 93.05 g of Na2EDTA2H2O to 300 
ml ddH2O. The pH was adjusted to 8.0 with 1 N NaOH (EDTA will not go into the 
solution until pH is around 7.0). The volume was then adjusted to 500 ml with ddH2O. 
The solution was autoclaved for 20 min at 121 °C and stored at room temperature. 
 Ethidium Bromide:   A 10 mg/ml solution was prepared by dissolving 0.1 g of 
ethidium bromide in 10 ml ddH2O. The solution was stored in a lightproof bottle at room 
temperature.  
 Herring sperm DNA:   A 2 mg/ml stock was prepared by dissolving Herring 
sperm DNA in 50 mM Tris-HCl, pH 7.6, and 0.4 M NaCl. The DNA was sheared by 
using a French press at 20,000 psi. The DNA was then extracted twice with 1 volume of 
1:1 phenol-chloroform and once with 1 volume of chloroform. The DNA was 
precipitated by using 2 volumes of 95% ethanol and then resuspended in TE to a final 
concentration of 2 mg/ml. The stock was stored at –20 °C. 
 IPTG:   A 0.1 M stock solution was made by dissolving 250 mg of isopropyl β-
thiogalactoside (IPTG) in 10.5 ml ddH2O. The solution was sterilized by filtering through 
0.2 µm filter and stored in 0.5 ml aliquots at –20 °C. A volume of 20 µl was used per 
plate. 
 Nisin:   A 10 mg/ml stock solution was prepared by dissolving 10 mg of nisin in 1 
ml of 0.05 % TFA. 
 Phenol, buffer saturated:   A buffer saturated phenol was used in all experiments 
and was prepared by adding the following reagents to a bottle containing 500 g of Fisher-
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loose crystals phenol (A92-500): 110 ml of 2 M Tris-HCL, pH 7.6, 143 ml of deionized, 
distilled water, 27.5 ml m-cresol, 1.1 ml 2-mercaptoethanol, and 550 mg 8-
hydroxyquinoline. The reagents were combined in the phenol bottle and placed in a 37 °C 
water bath. The bottle was swirled occasionally until the two phases were liquid. The 
phases were mixed thoroughly overnight. The phases were then allowed to separate over 
several hours. The saturated phenol was stored in brown phenol bottle and was stable for 
up to one year at room temperature. 
 Sodium acetate (NaOAc):   A 1 M NaOAc pH 4.0 solution, used for HIC column 
purification, was prepared by adding 57.2 ml glacial acetic acid to 400 ml ddH2O. The 
pH was adjusted to 4.0 with 10 N NaOH. The volume was then adjusted to 500 ml with 
ddH2O. 
 3M NaOAc was prepared by dissolving 204 g sodium acetate trihydrate in 300 ml 
ddH2O. The pH was adjusted to 6.0 with glacial acetic acid, and the volume brought up to 
0.5 L with ddH2O. The solution was autoclaved for 20 min at 120 °C and stored at room 
temperature. 
 Sodium chloride:   A 5 M stock of sodium chloride, used for HIC column 
purification, was prepared by dissolving 146.1 g into ∼480 ml of ddH2O. The volume was 
then adjusted to 500 ml with ddH2O. 
 Sodium dodecyl sulfate (SDS):   20% (w/v) SDS was prepared by adding 400 ml 
ddH2O into the SDS bottle containing 100 g of SDS while slowly stirring. Moderate heat 
was applied to dissolve SDS if it was necessary. The volume was then adjusted to 500 ml 
and the solution was stored at room temperature.  
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 Sodium Hydroxide:   10 N NaOH was prepared by dissolving 40.0 g NaOH in a 
final volume of 100 ml ddH2O. 
Standard saline citrate (SSC):   A 20x SSC stock (3 M NaCl, 0.3 M sodium 
citrate) was prepared by dissolving 175.3 g of NaCl and 88.2 g sodium citrate in 800 ml 
ddH2O. The volume was adjusted to 1 L with ddH2O and stored at room temperature. 
Tracking dye (6X):   0.25% Xylene cyanol FF, 0.25% bromophenol blue, and 
30% glycerol. 0.25g of xylene cyanol FF and bromophenol blue were dissolved in 50 ml 
ddH2O. 30 ml of glycerol was added to the mixture and the volume was adjusted to 100 
ml. The solution was kept at 4 °C. 
Tris-HCl:   2 M stocks of Tris-HCl were prepared by dissolving 121.11 g of Tris 
Base in 300 ml ddH2O and adjusting the desired pH with concentrated HCl. The volume 
was then adjusted to 0.5 liter with ddH2O. Solutions were then autoclaved 20 min at 120 
°C and stored at room temperature.  
Yeast t-RNA:   A 10 mg/ml stock soltion was prepared by dissolving 10 mg in 1 
ml sterile distilled H2O. 
X-Gal:   A 40 mg/ml stock was prepared by dissolving 200 mg of 5-bromo-4-
chloro-3-indolyl galactoside (X-Gal) in 5 ml dimethylformamide. The 0.5 ml aliquots of 
solution were stored in the dark at –20 °C. Any solutions that turned yellow or orange-red 
over time were discarded. 
2-2.   Buffers 
 TE Buffer:   10 mM Tris-HCl, pH 8.0, 1 mM EDTA was prepared from stocks of 
2 M Tris-HCl, pH 8.0 and 500 mM EDTA, pH 8.0.  
 32
Phage Buffer:   Phage buffer was prepared from the following components in 
ddH2O to the indicated final concentration: 20 mM Tris-HCl pH 7.4, 100 mM NaCl, 10 
mM MgSO4. The solution was autoclaved for 20 min at 120 °C and stored at room 
temperature.  
 SM buffer:   SM buffer was prepared from the following components in ddH2O to 
the indicated final concentration: 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 8 mM 
MgSO4, 0.01% gelatin. The solution was autoclaved for 20 min at 120 °C and stored at 
room temperature.  
Tris Acetate-EDTA (TAE):   A 50x TAE electrophoresis buffer was prepared 
from the following components: 2 M Tris-OAc, 0.01 M EDTA. The stock was prepared 
by adding 242 g Tris base, 57.1 ml glacial acetic acid, 18.6 g Na2EDTA.2H2O to 800 ml 
ddH2O and pH was adjusted to 7.2. The volume was adjusted to 1 liter.  
2-3.   Solutions for peptide purification 
 Hydrophobic interaction column (HIC) equilibration/wash buffer:    50 mM 
NaOAc pH 4.0, 1 M NaCl. The solution was prepared by adding 50 ml of 1M NaOAc pH 
4.0 and 200 ml of 5 M NaCl to 750 ml of ddH2O.  
 Hydrophobic interaction column (HIC) elution buffer:    60% Acetonitrile was 
prepared by adding 60 ml acetonitrile to 40 ml ddH2O. 
 Non-ionic cellulose (NIC) column equilibration/wash buffer:   100 mM NaPi at 
pH 7.8 was prepared by dissolving 13.8 g of monobasic sodium phosphate in 900 ml of 
ddH2O. The pH was adjusted to 7.8 by 10 M NaOH and the final volume was brought up 
to 1 liter.  
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Non-ionic cellulose (NIC) column elution buffer:   5.4 M HOAc was prepared by 
adding 155 ml of glacial acetic acid into 345 ml of ddH2O.  
2-4.   Solutions for RNA work. 
 Formaldehyde loading dye:   10x formaldehyde loading dye was prepared from 
the following components in DEPC-ddH2O to the indicated final concentration: 50% 
glycerol, 1mM EDTA, 0.25 % bromophenol blue, 0.25% xylene cyanol. 
 MOPS buffer:   10X stock was prepared by mixing 41.8 g MOPS, 16.6 ml of 3M 
NaAc (pH 7.0) and 20 ml of 0.5M EDTA (pH 8.0) in 800 ml of DEPC-ddH2O. The 
volume was adjusted to 1 liter. The solution was then filter sterilized and stored in dark 
(or wrapped with aluminum foil). 
 Pre-mix:   Pre-mix was prepared by mixing 50 µl of 10X MOPS and 87 µl of 37% 
formaldehyde (buffered) and 250 µl of deionized formamide. Pre-mix was added to RNA 
in such a way that the amount if premix added is 2x volume of RNA. 
2-5.   Solutions for SDS-PAGE electrophoresis. 
Acrylamide/bisacrylamide:   A 49.5 % acrylamide, 3% bisacrylamide stock 
solution was prepared by dissolving 48 g of acrylamide and 1.5 g of bisacrylamide in 75 
ml ddH2O. The volume was then adjusted to 100 ml with ddH2O. The solution was filter 
sterilized with 0.45-µm filter and stored at room temperature in a light proof bottle. 
Ammonium persulfate:   A 10% stock solution was prepared by dissolving 0.5 g 
in 5 ml ddH2O. The solution was stored at 4 °C. 
Anode buffer:   A 5X stock of anode buffer (1 M TrisHCl, pH 8.9) was prepared 
by dissolving 121.11 g of tris base in in 750 ml of ddH2O. The pH was adjusted to 8.9 
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with HCl. The volume of the solution was brought up to 1 liter with ddH2O. The solution 
was stored at room temperature. 
Cathode buffer:   A 5X stock of cathode buffer (0.5 M Tris HCl, pH 8.25, 0.5M 
tricine, 0.5% SDS) was prepared by dissolving 60.55 g tris base, 89.6 g of tricine and 5 g 
of sodium dodecyl sulfate in 750 ml of ddH2O. The volume was then adjusted to 1 liter. 
The solution was stored at room temperature. The pH does not need to be adjusted. 
Gel buffer:   A 5X gel buffer (3 M Tris, pH 8.45, 0.3% SDS) was prepared by 
dissolving 36.33 g of tris base and 0.3 g of sodium dodecyl sulfate in 70 ml of ddH2O. 
The pH was adjusted to 8.45 with HCl and then volume was brought up to 100 ml with 
ddH2O. 
SDS-PAGE gel loading buffer:   A 2X loading buffer was prepared by adding 4 g 
of SDS, 12 g of anhydrous glycerol, 5 ml of 1 M TrisHCl pH 6.8, 10 g of bromophenol 
blue, and 4 ml of β-mercaptoethanol to 25 ml of ddH2O. The volume was then adjusted to 
50 ml. The solution was stored at room temperature. 
2-6.   Solutions for western blotting 
Transfer buffer:   25 mM Tris, 192 mM glycine, and 20 % methanol. The solution 
was prepared by dissolving 12.11 g of tris base and 57.65 g of glycine in 2 liter of 
ddH2O. 800 ml of methanol was added and then the volume was adjusted to 4 liters with 
ddH2O. The buffer was stored at room temperature. 
TBST:   50 mM TrisHCl pH 7.4, 150 mM NaCl, 0.05 % Tween-20. The solution 
was prepared by dissolving 6.05 g of tris base and 8.77 g of NaCl in 800 ml of ddH2O. 
500 µl of Tween-20 was added and stirred thoroughly. The pH was adjusted to 7.4 with 
HCl and then the volume was brought up to 1 liter. 
 35
Blocking buffer:   1 % BSA in TBST was prepared by dissolving 0.5 g of BSA in 
50 ml of TBST. 
2-7.   Enzymes 
DNAase I:   A 1 mg/ml stock solution was prepared by dissolving the DNAase I 
in 50 mM Tris-HCl pH 7.6, and 50% glycerol and stored at –20 °C. 
 Lysozyme:   A 10 mg/ml stock solution was prepared by dissolving 10 mg of 
lysozyme in 1 ml of sterile ddH2O and stored at –20 °C. 
 Proteinase K:   A 10 mg/ml stock solution was prepared by dissolving 10 mg of 
proteinase K in 1 ml of sterile ddH2O and stored at –20 °C. 
 Ribonuclease A (RNAase):   A 10 mg/ml was prepared by dissolving 10 mg of 
RNAase in 1 ml of 20 mM sodium acetate, pH 6.0. The solution was boiled for 15 min in 
a water bath and slowly cooled to room temperature. 0.5 ml aliquots were stored at –20 
°C. A working concentration of 10 µg/ml was used unless otherwise was indicated. 
 Mutanolysin:   A 10 units/µl stock of mutanolysin was prepared by dissolving 
1,000 units of mutanolysin in 100 µl of ddH2O and stored at –20 °C. 
2-8.   Growth Media 
Culture media were sterilized by autoclaving for 20 min at 120 °C and stored at 
room temperature unless otherwise indicated. To make plates, 15 g of Bacto-agar was 
added per liter of media before autoclaving. The appropriate antibiotic was added to the 
media only after it had cooled to 50 °C. 
 Luria-Bertani (LB) Medium:   10 g of Bacto tryptone, 5 g of yeast extract, and 5 g 
of NaCl were dissolved in the final volume of 1 liter ddH2O. 
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 Penassay Broth (PAB):    The media was prepared by dissolving 17.5 g of 
antibiotic medium No. 3 in final volume of 1 liter ddH2O. 
 M17 media:   M17 media was prepared by dissolving 37.25 g of dehydrated M17 
broth into 800 ml ddH2O. The volume was then adjusted to 950 ml with ddH2O, and 
autoclaved. This media was stored at 4 °C. 50 ml of the sterile 10% glucose was added to 
the 950 ml of M17 just before inoculation with the bacteria. 10% (w/v) glucose solution 
was made by dissolving 10 g of glucose in the final volume of 100 ml ddH2O. The 
solution was then sterilized by filtering through 0.2 µm filter, and stored at 4 °C.  
 Medium A:   This medium was originally designed for the production of subtilin 
in B. subtilis 6633 (25). It was later modified for production of subtilin and sublancin in 
168 derivatives (60). 0.5 liter of this medium was prepared just before inoculation with 
the B. subtilis strain by mixing 390 ml of solution I, 100 ml of solution II and 5 ml of 
solution III and IV at room temperature. Solutions I and II were autoclaved and stored at 
4 °C. Solutions III and IV were both sterilized by filtering through 0.2 µm filter and 
stored at 4 °C.  
Solution I consists of 2% sucrose and 0.2% PAB and was prepared by dissolving 
10 g of sucrose and 1 g of PAB in a final volume of 390 ml of ddH2O in a 2 L baffled 
flask. Solution I was always prepared fresh the day before inoculation. 
Solution II was prepared as a 5X stock by dissolving 35.1 g of citric acid 
(anhydrous), 12.6 g (NH4)2HPO4, 12 g of Na2SO4, and 15 g of yeast extract into 500 ml 
ddH2O. The pH was adjusted to 6.9 with concentrated ammonium hydroxide followed by 
adjustment of the volume to 600 ml with ddH2O.  
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Solution III was prepared as a 100x stock by dissolving 7.62 g KCl, 4.18 g 
MgCl2•6H2O, 0.543 g MnCl2.4H20, and 0.11 g ZnCl2 in 100 ml ddH20.  
Solution IV was prepared as a 100x stock by dissolving 0.25 g of FeCl3 
(anhydrous) in 100 ml ddH2O.  
NZCYM Medium:   21 mg of NZY broth (composed of 10 g of enzymatic casein 
hydrolysate, 5 g of NaCl, 5 g of bacto-yeast extract, 0.94 g of MgSO4) and 1 g of 
casamino acids were dissolved in 950 ml of ddH2O. The pH was adjusted to 7.0 with 
NaOH. Then the volume was brought up to 1 L by adding ddH2O. The solution was 
autoclaved 20 min at 120 °C.  
SOC Medium:    20 g of bacto-tryptone, 5 g of bacto-yeast extract and 0.5 g of 
NaCl was dissolved in 950 ml of ddH2O. Then 10 ml of a 250 mM KCl solution was 
added. The volume was adjusted to 1 l and autoclaved 20 min at 120 °C. Just before use, 
5 ml sterile solution of 2 M Mg2Cl and 20 ml of a sterile1 M solution of glucose were 
added. 
 Top agarose:    1.0 g of Bacto-tryptone, 0.8 g NaCl and 0.6 g agarose were mixed 
in 100 ml ddH2O. The solution was autoclaved 20 min at 120 °C and stored at room 
temperature.  
 
Part II-3.   Maintenance and growth conditions. 
 Strains of E. coli were stored on LB plates at 4 °C for up to 2 months. Appropriate 
antibiotic was added to the plate if the strain had been transformed with a plasmid 
carrying an antibiotic selection gene. Cultures were grown in LB media at 37 °C with 
shaking at 250 rpm. 
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Strains of Bacillus subtilis were kept on PAB plates with no or appropriate 
antibiotic added at room temperature and a parafilm wrapped around the plates. Cultures 
were grown in PAB media at 37 °C with shaking at 250-300 rpm. 
 Strains of Lactococcus lactis were maintained on M17 plates with no or 
appropriate antibiotic added at 4 °C for up to one month. Cells were cultured 
anaerobically at 32 °C in M17 media. 
 For long-term storage, each bacterial strain was stored at –80 °C in 15-20% 
glycerol mixed with the medium. To prepare a glycerol stock, a single colony was 
streaked heavily onto a fresh plate, with the appropriate antibiotic added if necessary, and 
incubated overnight. 1 ml of sterile 50% glycerol solution in ddH2O was added to 2 ml of 
the appropriate liquid media. No antibiotic was added to this mixture. This solution was 
poured onto the plate with the freshly grown cells, which were then gently resuspended 
by pipeting. A 1 ml aliquot was then transferred to a labeled 1.5 ml cryotube, and frozen 
in a dry ice/ethanol bath. The tubes were immediately placed at –80 °C in a labelled 
archive box. All information concerning the particular strain including location of the 
archived sample was entered into the archive books. 
 
Part II-4.   Plasmid DNA isolation. 
 Depending on the subsequent analysis steps, plasmids were isolated from strains 
of E. coli by using either one of two protocols. Eppendorf Perfectprep® kit was used for 
rapid isolation of plasmid DNA for restriction endonuclease screening enzyme analysis 
of the clones or transformation into B. subtilis host strain. The DNA isolated this way 
was obtained quickly and in a highly pure form. Plasmid DNA was isolated by the rapid 
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alkaline extraction method when large amounts of DNA were necessary for the 
subsequent analysis steps. These methods are described below. 
4-1.   Purification of plasmid DNA using the rapid alkaline extraction method. 
The procedure followed was modified from the method initially described by 
Brinboim and Doly (1979). A single colony of the E. coli strain from a LB plate, 
containing the appropriate antibiotic, was inoculated into 3-5 ml of LB media containing 
the appropriate antibiotic and incubated at 37 °C overnight in an orbital shaker. 1.5 ml 
aliquot of the culture was then transferred to a 1.7 ml microfuge tube, and centrifuged at 
14,000 rpm for 1 min in a microfuge. The media was aspirated and the cell pellet was 
resuspended in 200 µl of solution I (50 mM glucose, 25 mM TrisHCl pH 8.0, 10 mM 
EDTA), with vigorous vortexing. The suspension was incubated for 5 min at room 
temperature. Then 400 µl of freshly prepared solution II (0.2 N NaOH, 1% SDS) was 
added and mixed by gently inverting several times. The solution had become transparent 
which was an indication of cell lysis. The lysate was incubated on ice for 5 min. Then 
300 ml of solution III (7.5 M ammonium acetate, pH 7.2) was added and mixed by 
inverting several times. The sample was incubated on ice for 10 min and then centrifuged 
at 14,000 rpm, for 5 min to pellet the cell debris. The supernatant was then transferred to 
a new microfuge tube. At this point the sample could be treated with RNAase if desired. 
RNA might sometimes interefere with the restriction digests by decreasing the visibility 
of low moleculer weight DNA bands. In this case, 5 µL of 10 mg/ml Rnase I was added 
to the sample and incubated at 37 °C for 30 min. 
A series of phenol/chloroform and chloroform extractions were then performed. 
First an equal volume of (1:1) phenol:chloroform was added (For 900 µl of sample, 450 
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µl phenol and 450 µl of chloroform was added) followed by vortexing, and centrifuging 
at 14,000 rpm for 2 min. The top aqueous layer was transferred to a new tube and 
extracted twice with equal volume of chloroform. The plasmid DNA was then 
precipitated by adding 0.6 volumes of isopropanol followed by mixing and incubating for 
10 min on ice. Precipitated DNA was then recovered by centrifugation at 14,000 rpm, 10 
min. The liquid was decanted and the DNA pellet was washed by the addition of 1 ml 
ice-cold 70% ethanol. Then the sample was centrifuged at 14,000 rpm, 2 min and the 
wash was aspirated. The DNA was dried in the speed vacuum for 5-10 min. The pellet 
was then resuspended in 20-50 µl of TE pH 8.0, with vortexing. The purified plasmid 
DNA was stored at –20 °C.  
This procedure could be adapted to isolate a stock supply of plasmid DNA by 
scaling up the volumes appropriately. For the medium scale plasmid isolation, 50 ml 
culture was grown overnight. The cells were harvested by centrifugation at 4,000 rpm for 
5 min in a SS-33 rotor at room temperature. Solution volumes were increased to 3 ml for 
solution I, 6 ml for solution II, and 4.5 ml for solution III. The same temperature and 
incubation times were used. The centrifugation to pellet the cell debris was then carried 
away in 30 ml corex tubes for 10 min at 10,000 rpm in a SS-34 rotor. The volumes of 
extraction agents were also scaled up accordingly. After the final wash, the tube was air-
dried for 1-2 hr. Then the DNA was resuspended 100-300 µl of TE.  
4-2.   Purification of plasmid DNA using the Eppendorf Perfectprep® Plasmid 
Mini kit. 
The manufacturer’s method was exactly followed for purification of plasmid 
DNA. A single colony of the E. coli strain from an LB plate was used to inoculate 3-5 ml 
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of LB medium with the appropriate antibiotic and incubated in an orbital shaker at 37 °C 
for overnight or 8-10 hr. 1.5 ml of the culture was then transferred to a 1.7 ml microfuge 
tube, and centrifuged at 14,000 rpm for 1 min. The supernatant was aspirated and the 
pellet was resuspended in 100 µl of solution I by vortexing, followed with the addition of 
100 µl solution II and sample was mixed with gentle inversions. Finally, 100 µl of 
solution III was added and mixed thoroughly by vigourous inversions of the tube. The 
tube was centrifuged at 14,000 rpm for 1 min. The supernatant was transferred to a 
PERFECTprep spin column in a collection tube followed by the addition of 450 µl of 
DNA binding matrix. The solution was mixed well and briefly centrifuged. The DNA 
bound matrix was washed by 400 µl of diluted purification solution. The tube was briefly 
centrifuged and spin column was transferred to a new tube and centrifuged again. Finally 
the DNA was eluted from the matrix by addition of 50 µl of elution buffer. The purified 
DNA was stored at a –20 °C. 
 
Part II-5.   Isolation of chrosomal DNA from bacteria. 
5-1.   Isolation of chrosomal DNA from B. subtilis strains. 
 
 A single colony of B. subtilis was used to inoculate 50 ml PAB with no or 
appropriate antibiotic added.  This was grown for overnight at 37 °C with shaking. The 
cells were precipitated by centrifuging at 4,000 rpm for 5 min. The supernatant was 
decanted. The cell pellet was resuspended in 10 ml of Solution I (10 mg lysozyme, 25 
mM Tris-HCl, pH 8.0, 50 mM glucose and 10 mM EDTA) by vortexing. The cell 
suspension was incubated at 37 °C for 20 min without shaking followed by addition of 
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0.25 ml 20% SDS and 0.25 ml of 10 mg/ml proteinase K. The solution was mixed by 
gentle inversions and incubated at 37 °C for 15 min or overnight without shaking. 
Overnight incubation slightly increases the yield of DNA. Proteins were extracted by 
adding 1:1 ratio of phenol/chloroform (5 ml phenol and 5 ml chloroform), which was 
mixed by gently rocking for 10 min followed by centrifugation for 10 min at 10,000 rpm 
at 4 °C in corex tubes. Aqueous (upper) layer was transferred to a new 50 ml 
polypropylene tube and the phenol/chloroform extraction was repeated once more. The 
aqueous upper layer was again transferred to a new tube and extracted twice with equal 
volume of chloroform. A pasteur pipette with a broken tip was used to collect the 
aqueous phase in order not to disturb white protein precipitate at the interface of the 
organic and aqueous layers. The mixture was centrifuged at 10,000 rpm for 10 min at 4 
°C. To precipitate the DNA 0.1 volumes of 3 M NaOAc, pH 6.0 and 2 volumes of ice-
cold 95% ethanol were added to the aqueous phase, gently mixed and the tube was put at 
–80 °C for 10 min. The sample was centrifuged at 10,000 rpm for 10 min at 4 °C to pellet 
the DNA. The ethanol was decanted and wash step was repeated with 2 ml of 80% 
ethanol. The DNA pellet was air-dried. The DNA was then resuspended in 250-500 µL of 
TE and stored at –20 °C. At this point the sample could be treated with RNAase if a 
cleaner sample was required and the RNAase could then be removed by a series of 
phenol/chloroform and chloroform extractions. Amount of DNA was estimated by 
running a 2-3 µl aliquot on a 0.8 % gel or by UV spectrophotometry.  
5-2.   Isolation of chromosomal DNA from L. lactis 11454. 
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A single colony of L. lactis 11454 was used to inoculate a 50 ml of M-17 medium 
in a 50 ml polypropylene tube. The culture was incubated overnight without shaking at 
28 °C to get the OD600 between 0.6-1.0. The following morning, the OD was checked and 
DL-threonine was added to a final concentration of 20 mM to weaken the cell walls and 
incubated at 32 °C for an additional 1-2 hr. The cells were then pelleted by spinning 
down at 4,000 rpm for 10 min at room temperature. The supernatant was decanted and 
the pellet was washed with 50 ml TE-wash three times by resuspending and centrifuging. 
TE-wash buffer consisted of 20 mM Tris-Hcl, pH 8.0 and 50 mM Na2EDTA, pH 8.0. 
After the last wash, the cells were resuspended in 4 ml of the TE-wash and lysozyme (10 
mg/ml) to a final concentration of 2 mg/ml followed by the addition of equal volume of 
24% PEG. Then mutanolysin (10 units/µl) was added to a final concentration of 0.5 
units/µl and sample was incubated at 37 °C for 2 hr. The protoplasts were collected by 
centrifuging at 4,000 rpm for 5min and the pellet was resuspended in 1 ml of 12% PEG 
buffered with TE (0.5 ml TE and 0.5 ml 24% PEG). The protoplasts were then lysed with 
the addition of 10 ml TE buffered 1% SDS. The mixture was rocked gently for 5 min (or 
until the solution had cleared). Proteinase K (20 mg/ml) was added to a final 
concentration of 20 µg/ml and incubated at 50 °C for 2 hr. The lysate was extracted with 
equal volume of chloroform, then equal volume of phenol:chloroform (1:1) and finally 
again with an equal volume of chloroform. Then the DNA was precipitated by adding 0.1 
volume of 3 M sodium acetate and 95% ethanol to the aqueous phase. The DNA was 
incubated at –80 °C for 7 min and the DNA was spun down at 10,000 rpm, 4 °C, for 10 
min the ethanol was decanted and the DNA pellet was air-dried. Finally, the DNA was 
resuspended in 500 µl of TE. 
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Part II-6.   Restriction enzyme digestion of nucleic acids. 
Restriction enzyme digestions are often performed to prepare compatible ends of 
the plasmid DNA and the fragment of interest for subcloning. After the fragment was 
cloned, 6-10 colonies were screened by diagnostic restriction enzyme digest(s) for the 
presence of the fragment or a unique restriction site introduced by the insert. The number 
of colonies to be analyzed was decided by looking at the efficiency of transformation. If 
the fragment had contained new restriction sites that were going to be used in the 
subsequent cloning steps, functioning of these sites were tested at each subcloning step. 
For a typical restriction digest, 0.5-1 µg of plasmid DNA (usually 3-5 µl of 
purified plasmid DNA by PERFECTprep kit) or chromosomal DNA, 4 µl of the 
suggested 10x digestion buffer (supplied with the enzyme), 0.5 µl of enzyme (5-10 units), 
were used in a reaction volume of 40 µl in microfuge tube. The digestions were 
performed at 37 °C for an hour unless otherwise indicated by the supplier. To visualize 
the digests, 8 µl of 6X tracking dye was added and the photograph of the gel was taken 
on an UV illuminator. If further manipulations were required, the band of interest was 
excised from the gel and cleaned by GenecleanTM kit (Part II-8). More DNA could also 
be digested in a single tube by increasing the reaction volume and the amount of enzyme.   
 
Part II-7.   Agarose gel electrophoresis. 
 Agarose gels of various concentrations were often used to resolve different sizes 
of DNA fragments and then specific fragments could be further purified if necessary. A 
100 bp DNA ladder (Fermentas) or λ DNA digested with Eco RI and Hind III was often 
run along with the sample as a size standard. 1% (w/v) agarose gels in 1X TAE were used 
 45
to resolve restriction digests of DNA between 0.4-10 kb. For fragments bigger than 10 kb 
or chromosomal DNA, 0.8% (w/v) agarose gels were used and finally to resolve 
fragments smaller than 0.4 kb 3% (w/v) BioGel agarose was used. 
Agarose gels were prepared according to procedures described by Maniatis et al 
(71). To make the 1% gel, 1 g of agarose was mixed with 2 ml of 50X TAE and 98 ml of 
ddH2O in a 250 ml Erlenmeyer flask (Proper amounts of agarose were used for different 
concentrations). Agarose was dissolved by microvawing the flask until the solution had 
boiled. The solution was swirled or stirred to dissolve any undissolved agarose and 
allowed to cool to 50 °C. 3 µL of Ethidium Bromide (10 mg/ml) was then added to the 
flask and mixed by swirling. The agarose solution was then poured onto the mini (7 cm) 
or midi (13 cm) gel casts that had been taped at the open ends. A comb was inserted to 
create wells and the gel was allowed to solidify at room temperature. 1x TAE was used to 
run the gels at a constant voltage of 100 mV. Samples were run until the appropriate 
resolution of DNA bands was obtained and then visualized by an UV transilluminator. 
Gels were photographed by Kodak Digital Science DC120 Zoom Digital camera. 
 
Part II-8.   GenecleanTM purification of DNA. 
This method was used for either isolation of DNA from agarose gels or from 
solutions containing unwanted materials such as enzymes and other chemical reagents. 
The protocol supplied by the manufacturer was followed and used for DNA fragments 
ranging from 0.2-10 kb. For purification of DNA fragments from agarose, the bands were 
excised from the gel and placed in a microfuge tube. Then 3 volumes of the 6 M sodium 
iodide buffer was added and incubated at 55 °C until the gel had melted (∼5 min). For 
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DNA in solution, the incubation step was omitted and directly went on to the next step, 
which was the addition of 5 µl of Glass Milk for up to 5 µg of DNA. The suspension was 
mixed by vortexing and incubated on ice for 5 min with vortexing every 1-2 min. The 
sample was centrifuged at 14, 000 rpm for 5 sec. The supernatant was decanted and the 
pellet was washed twice with 500 µl of cold NEW TM solution. The pellet was dried in the 
speed vacuum for 3-4 min and then resuspended in 15 µl of 1X TE or ddH2O followed by 
incubation at 55 °C for 5 min. The mixture was centrifuged for 1 min at 14,000 rpm. The 
10 µl of supernatant containing the DNA was transferred to a new tube. To increase the 
yield of DNA the pellet was again resuspended in 10 µl of 1X TAE or ddH2O and 
incubated and centrifuged the same way described above. The amount of DNA was 
estimated by running 3-4 µl on an agarose gel. 
 
Part II-9.   Subcloning. 
 Subcloning fragments of DNA from one type of vector to another is one of the 
most frequently used procedure in molecular cloning.  Subcloning is a simple matter 
when the restriction sites at the termini of the target fragment are identical to, or 
compatible with, those of the new vector. However, this was not the case in many of the 
cloning experiments. The procedures used during the course of this work to create DNA 
with compatible ends were listed in this section.  
9-1.   Preparation of linkers by annealing of two synthetic single-stranded 
oligonucleotides. 
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 A problem often faced during designing cloning strategies is the lack of 
appropriate restriction sites. This problem can be overcomed by cloning short (usually 
20-30 bp) DNA pieces that were designed to contain appropriate restriction site(s). The 
oligonucleotides were designed to have complementary central region (16-20 bases) and 
protruding bases at the 5’ ends, representing the digested version of the restriction site(s) 
to which the linker is going to be cloned. The oligonucleotides were chemically 
synthesized by Sigma-Genosys. Each oligonucleotide was resuspended in ddH2O to a 
final concentration of 1 µg/ml. To anneal the two DNA strands to each other; 1 µg of 
each strand was added to a microfuge tube along with 2 µl of 10X NEBuffer 2 (50 mM 
NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT, pH 7.9) or 4 µl of 5X annealing 
buffer (50mM Tris pH 7.8, 20 mM MgCl2), and ddH2O to a final volume of 20 µl. The 
tube was vortexed and incubated in a boiling water bath for 10 min on a hot plate to 
denature the oligonucleotides. The heat was turned off and the tube was allowed to cool 
down to room temperature in the water bath. After this, DNA was purified by 
precipitating with 0.4 volume of 7.5 M ammonium acetate and ethanol and then the DNA 
pellet was air-dried. The DNA was then resuspended in 20 µl of ddH2O and was ready to 
be used in the ligation reaction. If the oligonucleotides have tendency to make secondary 
interactions or dimers, then the volume of annealing mixture could be increased to 250 µl 
since the bigger volumes will enhance the proper complementary annealing of two 
strands by decreasing the chance of self-interaction. 
9-2.   Klenow filling-in reaction  
 Another way to overcome the lack of appropriate restriction site in subcloning is 
to blunt a restriction site with Klenow Polymerase to make the vector and insert ends 
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compatible. After digesting the DNA with a restriction endonuclease that generated a 5′ 
overhang, the DNA sample was treated with a Klenow Polymerase that fills in the 
flanking fragments with the complementary nucleotides. If both sites were going to be 
blunted, the insert could be ligated to the vector in two ways. In this case, diagnostic 
restriction enzyme digestions might need to be done to determine the orientation of the 
insert after cloning. The reaction is carried out according to protocol provided by the 
manufacturer of the Klenow Fragment (DNA Polymerase I large fragment). To prepare 
the reaction mixture the following were added in a microfuge tube; 2 µl of 10x reaction 
buffer (500 mM Tris-HCl pH 8.0, 50 mM MgCl2, 10 mM DTT), 0.1-4 µg of DNA, 0.5 µl 
of 2 mM 4dNTP mix (to the final concentration of 0.05 mM), 1-5 units of Klenow 
fragment, and ddH2O to the final volume of 20 µl. The mixture was incubated at 37 °C 
for 10 min. The DNA was purified by using GenecleanTM DNA purification kit (Part II-
8). 
 
Part II-10.   PCR of DNA fragments. 
The PCR technique was often used during the course of this work to amplify 
fragments ranging from 500 bp to 14 kb from the appropriate templates. Software called 
“Primer3” (69) was used to pick PCR primers and hybridization probes that were used in 
this work (http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi). This 
product includes software developed by the Whitehead Institute for Biomedical Research. 
The oligonucleotides chemically synthesized by Sigma-Genosys. The manufacturer 
provided the parameters such as molecular weight, Tm, OD and nmoles of nucleotides 
for each sample. 250 µM stock of each primer was prepared by resuspending in ddH2O 
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unless otherwise indicated and stored at –20 °C. To prepare the working stock of 2.5 µM, 
oligonucleotides were diluted 100 times with ddH2O. During the sample preparation, 
sterilized solutions and equipments were used to prevent any contamination and gloves 
were worn at all times. Prior to the preparation of samples, the dNTP mix was allowed to 
thaw on ice. The tube was briefly vortexed, then several 20 µl aliquots were prepared in 
microfuge tubes and stored at –20 °C for future use. Preparing aliquots saved time as the 
thawing time shortened and prevented the degradation of dNTPs in the stock due to 
repeated freezing and thawing cycles. dNTPs were always kept on ice and placed at –20 
°C immediately after usage. The thermocycler was turned on for about half an hour to 
allow the machine warm up. 
10-1.   PCR of fragments shorter than 10 kb. 
The samples were prepared on ice in 0.5 ml thermowellTM tubes and the reaction 
components were added in the following order. First, sterile ddH2O was pipetted into the 
tubes to brought up the final volume to 100 µl then 10 µl of 10X Taq PCR buffer, 10 µl 
of the 25 mM MgCl2 (to a final concentration of 2.5 mM), 10 µl of the forward (2.5 µM) 
and the reverse primer (2.5 µM) to a final concentration of 0.25 µM, 2 µl of template 
DNA (15 ng/µl), 1 µl of 100 mM dNTP mix (25 mM of each dNTP) to a final 
concentration of 1 mM and finally 0.25 µl of Taq polymerase (5 unit/µl) were added. 
Tube was vortexed briefly and spun down for 3-5 sec. 50 µl of paraffin oil was then 
carefully pippetted onto the samples to prevent evaporation and recondensation during 
the reactions. The cycles were started and when the temperature in the wells reached to 
94 °C, tubes were placed into the PCR thermocycler. 
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Three cycles/profiles were generally used to amplify the target sequence from the 
template. The first step involved the initial denaturation of template DNA and primers by 
keeping the mixtures at 94 °C for 2 min. Then the cycler advanced to the second profile. 
In this step samples were denatured at 94 °C for 30 seconds and then the temperature 
ramped down to 50 °C and was kept there for 1.5 min to allow annealing of primers to the 
template DNA followed by ramping up to 72 °C for 3 min for the extension of the 
sequence from the primers. The second step repeated 30 times and then the cycler 
switched to the last profile in which the tubes were kept at 72 °C for 10 min for the final 
extension and then ramped down to 4 °C indefinitely. The ramp rate was set up to the 
machine’s maximum during all the cycles. The samples were pipetted into a clean tube to 
get rid of the paraffin oil and 5 µl aliquots were run on a 1 % agarose gel along with a 
size standard. Then a ligation reaction was step up for immediate ligation with the pCR 
2.1 vector (Part II-11, 11-2). Taq polymerase was used for the amplification because of 
its ability to add 3’-adenine overhangs at the ends of the nascent polynucleotide strands.  
10-2.   PCR of fragments longer than 10 kb. 
 Long range PCR was used to amplify 14 kb nisin gene cluster from L. lactis 
11454. DyNAzymeTM EXT (MJ Research) was used as an enzyme since it was optimized 
for long range PCR, has proofreading activity, more thermostable than Taq and has non-
template dependent 3’ adenine addition activity for TA cloning. 
Two reaction master mixes were prepared on ice. To prepare the first master mix, 14.2 µl 
of ddH2O, 4 µl of 10 µM forward and the reverse primer (to a final concentration of 0.8 
µM each), 1 µl (100 ng) of the L. lactis 11454 genomic DNA and 1.44 µl of the 12.5 mM 
dNTP mix (to a final concentration of 360 µM) were added into one tube. To prepare the 
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second master mix, 17.3 µl of ddH2O, 5 µl of the 10X Mg2+-free DyNAzyme EXT 
buffer, 1.7 µl of 50 mM MgCl2 and 1 µl of the DyNAzymeTM EXT (1 unit/µl) were 
mixed in another tube. The tubes were vortexed, briefly centrifuged and then combined in 
a 0.5 ml ThermowellTM tube. 50 µl of paraffin oil was pipetted and then placed into the 
thermocycle when the temperature reached to 94 °C. 
In the first cycle, the tubes were denatured at 94 °C for 2 min. The second cycle 
composed of 3 stages. First stage was 30 seconds denaturation at 94 °C, then 30 seconds 
annealing at 62 °C, followed by 11.5 min extension at 70 °C. The second cycle was set to 
repeat 10 times. Then the machine advanced to third cycle. The first stage of the third 
cycle was 30 seconds denaturation at 94 °C, then 15 seconds annealing at 62 °C, followed 
by 12 min extension at 70 °C. The third cycle was set to repeat 16 times. In the fourth and 
the final stage, the extension continued for 10 more minutes at 70 °C and the temperature 
ramped down to 4 °C indefinitely. 
The sample was pipetted into a clean tube to get rid of the paraffin oil. 5 µl 
aliquot of the sample was run on a 0.8 % agarose gel along with a size standard and then 
immediately ligated to pCR 2.1 vector (Part II-12, 12-2). 
 
Part II-11.   5-prime dephosphorylation of vector DNA. 
 5-prime dephosphorylation of linearized vector significantly decreases the number 
of background colonies during the subcloning steps. Backgroung colonies formed when 
the vector circularizes by ligating to itself instead of ligating to insert. Since the ligases 
cannot ligate the DNA pieces without 5′ phosporyl termini, calf instestinal alkaline 
phosphatase (CIAP) was used to prevent the re-circularization of the vector. The protocol 
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suggested by the vendor was followed. For the reaction, DNA was suspended in 1x 
NEBuffer 3 (10 mM NaCl, 5 mM Tris-HCl, 1 mM MgCl2, 0.1 mM DTT, pH 7.9) to a 
concentration of 0.5 µg/10 µl. 0.5 units of enzyme was added per µg of DNA and 
incubated at 37 °C for exactly 60 min. Excess amounts of enzyme on the pipette tip was 
wiped with a Kimwipe since too much enzyme might result in the removal of nucleotides 
from the ends. After the reaction was over, the DNA was purified immediately by 
GenecleanTM DNA purification kit.  
 
Part II-12.   Ligation of insert and vector DNA. 
12-1.   Sticky and blunt end ligations 
After the vector and the plasmid containing the insert were digested with the 
appropriate restriction enzyme(s) they were run on an agarose gel. The fragments that 
were going to be ligated to each other were excised from the gel and purified by 
GenecleanTM kit (Part II-8). To estimate the amount of purified DNA, 3-4 µl aliquot of 
each sample were run on a gel and ethidium bromide-DNA complexes were visualized. 
Best ligation efficiencies were obtained with freshly cut samples since the DNA 
overhangs might be degraded over time, especially in unbuffered environments.  
Ligation efficiencies were also increased when the insert was used in excess of the vector 
(usually vector:insert ratios of 1:3, 1:4 gave optimal results). Several reactions in varying 
amounts of vector:insert ratio were set up. For a typical reaction, vector to insert ratios of 
1:3, 1:1 and 3:1 were used. The amount of vector used was usually about 100 ng and the 
amount of insert was adjusted acordingly. Linear vector by itself and linear vector in the 
presence of ligase were also set up as control reactions. If the vector had been 
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dephosphorylated, ligase treated vector was expected to yield no transformants since the 
linear vector was not suppose to recircularize. 
The reaction was set up according to the vendor’s protocol. For a typical ligation 
reaction, following components were added to a microfuge tube placed on ice: 
appropriate volumes of insert and vector DNA, 2 µL of 10x ligase buffer (containing 10 
mM ATP), 0.5 µl (2 units for sticky ends) or 1µl (4 units for blunt ends) of T4 DNA 
ligase (Fermentas), and ddH2O to the final reaction volume of 20 µL. The solutions were 
thoroughly mixed and incubated at room temperature for 1 hr or overnight. Better results 
were achieved when the incubation was carried out overnight at room temperature 
especially with blunt end ligations. 2 µl of 50% (w/v) PEG 4000 solution was also added 
to the reaction mixture for only blunt end ligations. 
12-2.   Ligation of PCR amplified fragments into pCR2.1 vector. 
For cloning of PCR products amplified by Taq polymerase, the TA Cloning® kit 
(Invitrogen) was used. In this kit, a linearized vector (pCR2.1) with single 3′ 
deoxythymidine (T) overhangs was provided. Since Taq polymerase has a non-template 
dependent activity that adds a single deoxyadenosine (A) residue to the 3′ ends of PCR 
product, any fragment amplified by Taq polymerase can be ligated to this vector. The 
advantage of this vector is that it does not require designing long PCR primers with 
restriction sites, which can sometimes complicate PCR reactions. For the ligation 
reactions, the protocol provided by the manufacturer was followed. To set up 10 µl of the 
reaction, 1 µl of 10X ligation buffer, 2 µl of linearized pCR2.1 vector (25 ng/µl), 1µl of 
T4 DNA ligase (4.0 units/µl), 1.5 µl of the fresh PCR product and 4.5 µl of sterile ddH2O 
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was mixed in a microfuge tube. The reaction mixture was incubated at 14 °C overnight. 
The next morning 2 µl of this mixture was transformed into E. coli INVαF′ or JM101 
cells.  
 
Part II-13.   Preparation of competent cells and transformation. 
13-1.   Transformation into competent E. coli JM101, JM109 strains. 
 E. coli JM101 and JM109 competent cells are prepared and transformed as 
described by Maniatis et al (71). E. coli cells were streaked out onto a LB plate from the 
archieve and incubated overnight at 37 °C. The plates older than several days were not 
used for competent cell preparation since the efficiency of the transformantions dropped 
significantly when the cells stored at 4 °C for prolonged times. However, once the 
competent cells were prepared, glycerol stocks of them can be stored at –80 °C and could 
be used up to 6 month without any significant drop in the competency.  
A single colony of E. coli was used to inoculate 3-5 ml of LB in a 15 ml sterile 
polypropylene culture tube. The tube was shaken at 250 rpm, 37 °C overnight in an 
orbital shaker. The following day, 1 ml of the overnight culture was used to inoculate 50 
ml of LB in a sterile 250 ml Erlenmeyer flask. The culture was grown at 37 °C with 
shaking for 1.5 hr or until the OD600 was 0.5-0.8. After the inoculation 30 ml of 50 mM 
CaCl2 was transferred into a sterile 50 ml tube with printed graduations and chilled on ice 
while the culture was growing. Cells were then harvested by transferring the culture to a 
sterile 50 ml polypropylene tube and centrifuged at 4000 rpm for 5 min at room 
temperature. The supernatant were discarded and cells were resuspended in 25 ml of 
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sterile, chilled 50 mM CaCl2 by gentle up-and-down pipetting using a motorized 
Pipetman. During the pipetting the tube was kept on ice as much as possible. The tube 
was incubated on ice for 1 hr after which the cells were pelleted by centrifugation at 4000 
rpm for 5 min. The supernatant was discarded and the tube was placed on ice. The cells 
were resuspended in 5 ml of sterile, chilled 50 mM CaCl2 very gently the same way 
described above. At this point the cells are competent and were usually used within 30 
min. For long-term storage, sterile 50% glycerol added to a final concentration of 15% 
and cells were quickly frozen in dry ice ethanol bath in 1 ml aliquots at -80°C. Once 
thawed, the cells were used immediately  
Transformation of the ligation mixtures and controls were done as follows. 200 
µL of the competent cell preparation was added into the chilled ligation mixtures, which 
was mixed by very gentle pipetting. For transformation controls, one microfuge tube was 
set up with only competent cells to test the ampicillin plates, another tube was set up with 
a known concentration of an uncut plasmid and competent cells to check the efficiency of 
cells. The tubes were incubated on ice for 30 min. The samples were then heat shocked in 
a 42 °C water bath for exactly 2 min and placed back on ice. 0.8 ml LB was added to the 
each microfuge tube and incubated at 37 °C water bath for 2 hr. A 100 µL aliquot of the 
transformed cells were spreaded on an LB plate usually containing 100 µg of ampicillin 
(or appropriate antibiotic). The tubes were centrifuged at 14,000 rpm for approximately 1 
min to pellet the remaining cells. 750 µl of media was discarded and the cells were 
resuspended in the remaining media by vortexing. The cells were spreaded on another 
plate. Plates incubated at 37 °C overnight. If the colonies were going to be screened for 
Lac Z α-complementation, 20 µl of 40mg/ml X-Gal and 40 µl of 0.1 M IPTG were mixed 
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with the cells and spreaded onto plates. Transformant colonies were screened for the 
presence of recombinant DNA constructs by restriction enzyme analysis and Southern 
blots or colony lifts/hybridization techniques. 
13-2.   Transformation into competent E. coli INVαF′ cells. 
E. coli INVαF′ cells were provided as frozen 50 µl aliquots with the TA Cloning® 
kit. They were made competent chemically and had high transformation efficiency. The 
protocol for the transformation was provided by the vendor. The required number of 
tubes was thawed on ice. 2 µl of the ligation mixture as described in Part II-12, 12-2 was 
gently pipetted into the thawed competent cells and mixed gently by moving around the 
pipette tip in the suspension of cells. The tubes were incubated on ice for 30 min and then 
heat shocked for exactly 30 seconds in 42 °C water bath without shaking and the placed 
on ice for 2 min. SOC medium provided with the kit was prewarmed to room 
temperature. 250 µl of prewarmed SOC medium was added onto each sample after the 
heat shock. The samples were incubated at 37 °C shaking horizontally at 225 rpm for 1 
hr. 50 µl of each sample was spreaded onto a prewarmed LB/amp plate with 40 µl of X-
Gal from the 40mg/ml stock. No IPTG was added, since this strain does not express the 
Lac repressor. The remaining culture was centrifuged at 14,000 rpm in a microfuge for 1 
min and supernatant was decanted. Pelleted cells were resuspended in 100 µl of the SOC 
and plated onto LB/amp plates the same way. After 15 minutes, the plates were inverted 
and incubated at 37°C for at least 16 hours. The following day, the plates were placed in 
the refigerator for 2 hours for color development.  
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13-3.   Transformation into competent Bacillus subtilis strains. 
In contrast to E. coli strains, Bacillus subtilis 168 becomes competent naturally 
during the late stationary phase when grown in appropriate media. To prepare competent 
B. subtilis 168 strains the following solutions were prepared in advance. Bott and Wilson 
(BW) salts solution, Bott and Wilson (BW) amino acids solution, a stock of 0.1M 
MgSO4, a stock of 20% (w/v) glucose, a stock of 2% (w/v) yeast extract, a stock of 1 M 
MgCl2, a stock of 1M CaCl2 and 4X PAB. These solutions were sterilized by autoclaving 
at 120 °C for 20 min except the glucose and BW amino acids solution, which were 
sterilized by filtering through 0.2 µm nitrocellulose filters. 4X Bott and Wilson (BW) 
salts solution were prepared by adding 4.96% (w/v) K2HPO4, 3.04% (w/v) KH2PO4, 
0.4%(w/v) sodium citrate, and 2.4% (w/v) (NH4)2SO4, pH 7.0. The pH of this solution 
was then adjusted to 7.0 with 1N KOH if necessary. A 100 ml of Bott and Wilson (BW) 
amino acids solution was prepared by dissolving 500 mg of each of the following amino 
acids in ddH2O: valine, lysine, threonine, glycine, aspartic acid, methionine, histidine, 
tryptophan, and arginine. Calcium chloride, yeast extract, BW amino acids (wrapped with 
aluminium foil), glucose were stored at 4 °C. All the solutions were prepared in ddH2O. 
On the day of inoculation GM1 media was prepared fresh in a sterile 100 ml 
graduated cylinder by adding 12.5 ml BW salts, 1.25 ml 20% glucose, 2.5 ml BW amino 
acids, 0.5 ml of 0.1M MgSO4, and 2.5 ml 2% yeast extract and sterile ddH2O to a final 
volume of 50 ml. 20 ml of GM1 was transferred to an autoclaved Klett flask and 
inoculated by a single colony of B. subtilis 168. 10 ml of GM1 was transferred to a sterile 
250 ml Erlenmeyer flask and stored at 4 °C to prepare GM2 media the next day. 
Remaining 20 ml was used as a blank to calibrate the Klett-Somerson photoelectric 
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colorimeter. The inoculated GM1 was kept at room temperature overnight without 
shaking. The following day a slight turbidity was observed in the media. The culture was 
then placed in a gyrotory water bath shaker and shaken at level 7. The turbidity was 
measured every 15-min using a Klett-Summerson colorimeter to monitor the growth. A 
growth curve was made by plotting turbidity (Klett units) vs. time (min) on semi-log 
graph paper. Usually after 2 hours, cells had reached the stationary phase, which was 
marked by constant turbidity readings. After the beginning of stationary phase, cells were 
incubated 90 more minutes. In order to determine the beginning of stationary phase 
experimentally, a best line was drawn both on the log phase and the stationary phase 
readings on the growth curve. The intersection of these lines was taken as the beginning 
of stationary phase. At the end of 90 minutes, 1 ml of the culture was transferred into 10 
ml of prewarmed (to 37 °C) GM2, which was prepared by adding 5 µl of 1 M CaCl2 and 
25 µl of 1 M MgCl2 to the 10 ml of GM1 prepared the day before. This culture was 
shaken at 37 °C for 1 hr at the end of which the cells became competent.  
To transform the DNA, 0.5 ml of GM2 culture was transferred to a 15 ml sterile 
polypropylene tube and 0.5-5 µg of uncut or linear plasmid DNA or chromosomal DNA 
was added. There was an increase in the recombination as the amount of DNA was 
increased up to a certain limit. If extraordinarily complex recombination events were 
expected to happen such as big pieces of DNA was targeted to be transferred into the 
chromosome of the host by using small homology regions, the chances of recombination 
were increased by adding DNA up to 50 µg. The tubes were shaken in an orbital shaker 
at 37 °C for 30 min and then 1 ml of 4X PAB was added to each tube. Incubation 
continued for an additional 90 min. The selection was usually done on choloramphenicol 
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or erythromycin both of which inhibits protein synthesis. In order to induce the 
expression of the antibiotic, the cells were incubated with small amount (to a final 
concentration of 0.5µg/ml) of the appropriate antibiotic for an additional 30 min. A 100 
µL aliquot of the transformed cells was spread on a PAB/Cm plate. The remaining 
culture was centrifuged briefly and the pellet was resuspended in 150 µl of PAB and 
spreaded on a PAB/Cm plate. Plates were inverted and incubated at 37 °C until colonies 
appeared which took 24-72 hr. 
13-4.   Transformation into electrocompetent E. coli JM101 strain. 
A single colony of the E. coli strain from a freshly streaked LB plate was 
inoculated into 3 ml of LB media and incubated at 37 °C overnight in an orbital shaker. 
Next morning, a 1 ml aliquot of this culture was transferred to a 500 ml flask containing 
200 ml of LB medium and incubated at 37 °C in an orbital shaker until the OD600 had 
reached 0.6 (about 2.5-3 hr). These mid-log phase cells were chilled on ice for 15 min 
and then aseptically transfered to a sterile, ice-cold centrifuge tube. Always well-chilled 
cells, rotors and containers were used in the subsequent steps of the process. The cells 
were precipitated by centrifuging at 5000 rpm for 20 min at 4 °C. The supernatant was 
decanted and the cells were resuspended in 200 ml of ice cold, sterile ddH2O by 
vortexing. The cells were recovered by centrifuging at 5000 rpm for 20 min at 4 °C and 
this wash step was repeated one more time. After centrifugation the pellet was 
resuspended in 40 ml of ice cold, sterile 10 % glycerol and pelleted at the same speed and 
temperature for 10 min. Finally, the volume of the pellet was estimated and the cells were 
resuspended in an equal volume of 10 % ice cold, sterile glycerol. 50 µl aliquots in 
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microfuge tubes were snap frozen in dry ice ethanol bath and stored at –80 °C for up to a 
year with a little loss in electrocompetence or immediately used.  
For electroporation, 1 µl of the ligation mixture or uncut DNA was mixed with 50 
µl of electrocompetent cells and transferred to a prechilled sterile BTX disposable 
electroporation cuvette (1 mm gap). The cuvette was chilled on ice 10 more minutes and 
placed in the chamber in BTX ECM 600 electroporation system. High voltage mode 
(field strengths >2.5 kV/cm) was chosen, the capacitance was fixed at 50 µF and the 
resistor number was set to 5 (129 ohms) to generate a 5 msec pulse when 1. 70 kV 
charging voltage was applied. 1 ml of the ice-cold SOC medium was added immediately 
after the pulse was over and placed on ice. The mixture was then transferred to a sterile 
microfuge tube and incubated at 37 °C water bath for 2 hr. The cells were spreaded on 
LB-amp plates and incubated overnight at 37 °C. The transformation was more efficient 
when the cells were pulsed only once instead of twice. 
13-5.   Transformation into electrocompetent L. lactis 11454 strain. 
In contrast to E. coli, the best transformation efficiency was obtained when the 
stationary phase L. lactis cells were used for electroporation (53). A single colony of the 
L. lactis 11454 from a freshly streaked M-17 plate was inoculated into 50 ml of M-17 
media in a sterile 50 ml polypropylene tube and incubated at 32 °C without agitation until 
the OD600 reached 1.2. These stationary phase cells were chilled on ice for 15-30 min and 
then aseptically transfered to a sterile, ice-cold centrifuge tubes. Cells were pelleted by 
centrifuging at 5,500 g at 4 °C for 10 min. Supernatant was discarded and pellet was 
resuspended in 10 ml ice cold, sterile ddH2O. The cell suspension was centrifuged at 
12,000 g at 4 °C for 10 min. This wash step was repeated one more time. This time cells 
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were spun at 12,000 g at 4 °C for 15 min. The wash was repeated the third time by 
resuspending the sample in 1 ml ice cold, sterile ddH2O instead of 10 ml. The cells were 
pelleted 12,000 g at 4 °C for 3 min. These washes were necessary since contaminating 
ions from the media could decrease the transformation efficiency by altering the ionic 
strength of the cell suspension. Finally, the cell pellet was resuspended in 1.25 ml of ice 
cold, sterile ddH2O and was now ready for electroporation.  
Electrocompetent L. lactis cells were always prepared fresh for electroporation. 
70 µl of the elecrocompetent cells were mixed with 3 µl of the plasmid DNA, chilled on 
ice for 10 min and exposed to either one or two high-voltage (1.70 kV) electric pulses, 
which lasted about 5 msec. The same settings described for the electroporation system in 
the above section (13-4) were also used for L. lactis cells. Immediately after the pulse(s) 
1 ml of M-17 media was added and the cuvette was placed on ice. The sample was then 
transferred to a microfuge tube and incubated in a 37 °C water bath for 2 hr. Then the 
cells were spreaded on M-17 plates containing the appropriate antibiotic and incubated at 
37 °C until the colonies were observed (24-72 hr). 
 
Part II-14.   Construction of λ library of Lactoccocus lactis 11454. 
 A genomic DNA library of L. lactis 11454 was constructed in order to be able to 
isolate the piece of DNA that contains the whole nisin gene cluster. The protocols for the 
Lambda GEM®-11 BamH I arms plus packagene system kit were provided by the 
manufacturer. 
14-1.   Digestion of L. lactis 11454 DNA with Bgl II. 
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Analysis of restriction enzyme map of the ~18 Kb region including nisin gene 
cluster of L. lactis 11454 genomic DNA revealed the presence of Bgl II sites that will 
release a 16561 bp fragment upon digestion. This fragment would contain the whole nisin 
gene cluster and part of the upstream and downstream sequences.  
The digestion mixture was set up as follows. 3 µg of genomic DNA (0.3 µg/µl), 
25 µl of NEBuffer 3, 3 µl of Bgl II (10 units/µl) were mixed in a microfuge tube and the 
volume was brought up to 250 µl with ddH2O. The mixture was incubated at 37 °C, 
overnight. The following morning the DNA was extracted by adding equal volume of 1:1 
ratio of phenol:chloroform and extraction repeated once more with an equal volume of 
chloroform. 0.5 volume of 7.5 M ammonium acetate and 2 volumes of 95 % ethanol were 
added to the aqueous phase to precipitate the DNA. The sample was incubated at –80 °C 
until the solution had thickened and then centrifuged at 10,000 rpm for 15 min at 4 °C. 
The pellet was washed with 70% ethanol once and DNA was lyophilized in speedVac. 
The dried DNA pellet was then resuspended in 50 µl of TE. 10 µl aliquot was run on a 
0.8 % agarose gel along with the uncut DNA to be able to visualize the efficiency of 
digestion. λ DNA that had been digested with EcoR I was also included as a size 
standard. 
14-2.   Ligation of L. lactis 11454 Bgl II digest with Lambda GEM®-11 BamH I 
arms. 
The flanking ends produced with Bgl II genomic DNA digest are compatible with 
BamH I ends of the λ DNA provided with the Lambda GEM®-11 BamH I arms plus 
packagene system. And the λ BamH I arms were already dephosphorylated to prevent the 
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self-ligation. The ligation reactions were set up as follows. Reaction mixtures were 
incubated at room temperature for 3 hr. 
Reaction I Reaction II Reaction III 
Component     (-) control (+) control  L. lactis digest 
Lambda vector BamH I arms (0.5 µg/µL)     2 µl             2 µl    2 µl  
Positive control insert (0.5 µg/µL)*       ⎯        2 µl      ⎯ 
Bgl II L. lactis digest (~0.5 µg/µl)       ⎯         ⎯      2 µl 
10x ligase buffer        1 µl        1 µl     1 µl 
ddH2O          6.5 µl       4.5 µl     4.5 µl 
T4 DNA Ligase (5 units/µL)       0.5 µl       0.5µL     0.5 µl 
Total reaction volume        10 µL       10 µl              10 µl 
* Test insert was provided with the kit. 
14-3.   Packaging of ligated DNA and titration of the recombinant phage 
The ligated λ DNA was packaged into bacteriophage particles using the 
packaging extract supplied by Promega in the Lambda GEM®-11 BamH I arms plus 
Packagene system. Three tubes containing the Packagene® Extract (50 µl/ tube) was 
thawed on ice. Then 5 µl of the ligation reaction was pipeted into tube containing the 
extract and mixed by gently tapping the bottom of the tube. The DNA/extract mixes were 
incubated at 22 °C (room temperature) for 3 hr. Then 445 µl of phage buffer and 25 µl of 
chloroform was added to each tube and mixed by gentle inversions. At this point, the 
packaged phage could be stored at 4 °C for a week without a significant drop in the titer. 
The packaging reactions were diluted 1:1,000 and 1:10,000 fold with phage buffer for 
tittering. 100 µl of the diluted phage was added to the 100 µl of log phase (OD600 0.6-0.8) 
E. coli LE392 cells in a 5 ml sterile tubes and incubated at 37 °C for 30 min to allow 
adsorbtion of phage particles onto bacteria. Then 3 ml of molten (45 °C) LB top agar was 
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poured onto the mixture, mixed by quick inversions and immediately poured onto pre-
warmed LB plates. The plates were inverted and incubated overnight at 37 °C after the 
top agar had hardened. To prepare log phase cells, a single colony from a freshly streaked 
plate was inoculated into a 3 ml of LB medium supplemented with 0.2% maltose and 10 
mM MgSO4. The culture was shaken at 37 °C until the OD600 was between 0.6-0.8 
(~5hr).  
14-4.   Screening of the λ library for the presence of nisin gene cluster. 
Lambda clones containing the nisin gene cluster were identified by hybridizing a 
number of plaques with a probe against the nisin structural gene, nisA, (see table 3). 10 
plates were prepared to yield ~200 plaques/plate for screening with hybridization as 
follows. 100 µl of the log phase E. coli LE392 cells (see Part II-14-3) were mixed with 2 
µl of the undiluted phage in 5 ml sterile tubes and incubated at 37 °C for 30 min. Then 3 
ml molten LB top agar was poured onto the mixture, mixed by quick inversions and 
immediately poured onto pre-warmed LB plates. The plates were inverted and incubated 
overnight at 37 °C and then stored at 4 °C for at least 1 hr prior to the hybridization.  
The nitrocellulose filters were labeled with a pen. Then the filter was gently 
placed at one edge of the plate and more of the filter was progressively laid down as it 
wetted. Formation of any air bubble between the filter and the top agar and repositioning 
of the filter was avoided. The filters were left on the plates for an hour at room 
temperature. To record the orientation of the filter to the plate, a 20-gauge needle was 
stabbed through the filter at 12, 3, 6, 9 o’clock postions. The filters were slowly removed 
with the help of a forceps, placed on a paper towel plaque side up and dried for 30 min at 
room temperature. The dry filters (plaque side up) were placed on a piece of Whatman 3 
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MM paper saturated with 0.2 M NaOH, 1.5 M NaCl for 2 min and then transferred onto 
another Whatman paper saturated with 0.4 M Tris-HCL (pH 7.6), 2X SSC for 2 min. 
Finally, the filters were placed on a piece of Whatman paper saturated with 2X SSC for 2 
min and dried on a clean paper towel (plaque side up). The filters were then baked at 80 
°C for 2 hr to immobilize the DNA. The filters were hybridized with end labeled nis A 
probe (see part II-16, 16-1) as described in part II-17.  
Two of the plaques hybridizing with the nis A probe were chosen for large-scale 
preparation of recombinant bacteriophage λ. Plaques were scraped of from the top 
agarose with a pipette tip and put in a microfuge tube containing 100 µl of the phage 
buffer and placed at 4 °C overnight. The phage plug eluate was assumed to contain 1010 
pfu/ml. The recombinant λ DNA from the chosen clones were amplified at low 
multiplicity and isolated according the protocol of Sambrook et. al. (71). 100 ml of 
NZCYM media prepared in a 500 ml flask was inoculated with a single colony of E. coli 
LE392 and incubated at 37 °C, shaking at 300 rpm, overnight (~12 hr). The following 
morning, OD600 of the culture was measured and recorded (OD600= 1.02). 1 OD600 
assumed to have 8x 108 cells. 2 aliquots containing 1010  (12.5 ml) cells were withdrawn 
and centrifuged at 4000 rpm for 10 min at room temperature seperately. Pellets were 
resuspended in 3 ml of SM buffer. ~5 x 107 pfu was pipetted onto bacterial cell 
suspensions, mixed and incubated at 37 °C for 20 min with intermittent shaking. Each 
infected aliquot was added onto the 500 ml of prewarmed (37 °C) NZCYM medium in a 
2 L flask. The culture was observed for cell lysis after 4 hr. The white thread like cell 
debris was observable at this point. The cultures were incubated for a total of 11 hr, after 
which, 10 ml of chloroform was added to each culture. The flasks were shaken at 300 
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rpm for 10 more minutes at 37 °C. Recombinat bacteriophage λ was purified from the 
culture as described in part II-14, 14-5.  
14-5.   Purification of the recombinant bacteriophage λ. 
The lysed cultures were cooled down to room temperature and pancreatic DNAse 
I and RNAse were added to the final concentration of 1 µg/ml and incubated at room 
temperature for 30 min. Then solid NaCl was added to the final concentration of 1 M to 
promote dissociation of bacteriophage particles from bacterial debris and precipitate the 
particles efficiently from polyethyleneglycol (PEG). After the NaCl had dissolved, the 
culture was left at 4 °C overnight (or at least for an hour on ice). The following morning, 
debris was removed by centrifuging at 11,000 g for 10 min at 4 °C. The supernatants 
were pooled into a clean flask and PEG 8000 was added to a final concentration of 10% 
w/v and dissolved with slow stirring at room temperature. The solution was incubated on 
ice for at least an hour to allow phage particles to form a precipitate. The precipitated 
phage particles were recovered by centrifuging at 11,000 g for 10 min at 4°C. The 
supernatant was discarded and any remaining fluid was drained by keeping the bottles in 
a tilted position. Phage particles were then resuspended in 8 ml of SM buffer and the 
walls of the bottles were carefully washed to remove any stuck phages. The PEG and the 
cell debris were extracted from the bacteriophage suspension by adding an equal amount 
of chloroform and vortexing for 15 sec. The organic and the aqueous phase were 
separated by centrifugation at 3,000g for 15 min at 4 °C. Then 0.5 g of solid CsCl was 
added per milliliter of aqueous phase containing the phage suspension and mixed gently 
to dissolve. When the CsCl had dissolved, bacteriophage suspension was carefully 
layered onto CsCl step gradients that were preformed in a centrifuge tubes and the top of 
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the tubes were sealed. Solutions of CsCl with different densities (1.45 g/ml, 1.50 g/ml, 
1.70 g/ml) were prepared in SM buffer. The step gradients were prepared by carefully 
layering the solutions of decreasing density on top of one another. A mark was made on 
the outside of the tube opposite to the position of the interface between the densities of 
1.50 g/ml and 1.45 g/ml. The tubes were centrifuged for 4 hr 30 min at 70,000 rpm in a 
VTi80 rotor in a Beckman preparative ultracentrifuge. A band of phage particles was 
observable as a blue band when a light was shined from the side of the tube at the 
interface between the 1.50 g/ml layer and 1.45 g/ml layer. The top of the tube was cut off 
and a 20 gauge needle was stabbed underneath the blue band and collected into a tube. 
The phage suspension was dialyzed against 1000-fold volume of 10 mM NaCl, 50 mM 
Tris pH 8.0, 10 mM MgCl2 solution for an hour twice. The buffer was changed and 
dialyzed the third time overnight at 4 °C.  
The next morning, the dialyzed solution was transferred into a 50 ml 
polypropylene tube and EDTA was added to the final concentration of 20 mM followed 
by the addition of proteinase K and SDS to a final concentration of 50 µg/ml and 0.5% 
w/v, respectively. The solution was incubated at 56 °C for an hour. The sample was then 
extracted with an equal amount of phenol: chloroform mixture at 1:1 ratio and 
centrifuged at 3000 g for 5 min at room temperature and then extracted again with an 
equal volume of chloroform. The DNA was precipitated by adding 3 M sodium acetate to 
a final concentration of 0.3 M and 2 volumes of 95% ethanol. The mixture was incubated 
at – 20 °C for 30 min and centrifuged at 11,000g for 10 min at 4 °C to pellet the DNA.  
The DNA was washed with 1 ml of 70% ethanol and centrifuged again at 11,000g for 10 
min at 4 °C. The ethanol was discarded and the DNA was air-dried. The dry DNA was 
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resuspended in 200 µl of TE. The recombinant phage DNA was analyzed with restriction 
enzyme analysis (Part II-6) and Southern blot analysis and hybridization (Part II-15, 15-2 
& 17) for the presence of nisin gene cluster. 
 
Part II-15.   Immobilization of DNA on nitrocellulose membranes. 
15-1.   Screening of recombinant plasmid clones by colony lift. 
The colony lift/hybridization technique was used when it was necessary to screen 
large numbers of ampicillin resistant E. coli transformants. Usually 100 or more colonies 
could be screened with relative ease with this technique. Also the modified form of the 
protocol was used to screen the plaques obtained from the λ library of L. lactis 11454 
chromosome (Part 14, 14-4).  
The ampicillin resistant E. coli transformants were grided onto duplicate 
LB/ampicillin plates with a sterile toothpick. The orientantion of the plate was marked at 
12 and 3 o’clock positions with a marker. The plates were incubated overnight at 37 °C. 
Next morning, one of the plates was stored at 4 °C to be used as a source of viable 
positive clones and the replica plate was used for colony lift/hybridization analysis. The 
replica plate was also cooled to 4 °C for at least 30 min. A nitrocellulose filter with a 
diameter of 82 mm and a pore size of 0.45 µm was labeled with a water insoluble marker 
and placed on the surface of the each replica plate. After 5 minutes, filters were marked at 
the same positions by making holes on the filter and gently removed from the surface of 
the plate by a tweezer. Filters were dried at room temperature for 30 min colony side 
facing up on a dry paper towel. Nitrocellulose filters were always handled with gloves or 
with a tweezer in order to prevent contamination from the skin. A piece of Whatman 3 
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MM filter paper was placed on a glass plate and wetted with 0.5 N NaOH. The filter was 
placed on the saturated Whatman paper colony side up for 10 min to lyse the cells and 
denature the DNA. The filters were then transferred to Whatman paper soaked in 1.0 M 
TrisCl pH 7.6 neutralizing solution and allowed to stand for 10 min. Finally, filters were 
placed on a Whatman paper saturated with 1.0 M TrisHCl pH 7.6, 1.5 M NaCl for 20 
min. The filters were then removed and air-dried on a piece of dry paper towel for 30 
min. The DNA was immobilized on the membrane by baking at 80 °C in a vacuum oven 
for 2 hr. The membranes were then ready for prehybridization. The filters could be stored 
between the paper towels until the preparations of the hybridization experiment were 
done. 
15-2.   Screening of recombinant DNA’s with a Southern blot. 
Recombinant chromosomal DNA from B. subtilis cells or plasmid DNA from E. 
coli cells were digested with appropriate restriction enzymes including positive and 
negative controls such as DNA from the wild type strain that did not contain the cloned 
sequence and a source of DNA that did contain the insert. These were run on an agarose 
gel with an appropriate DNA ladder. The upper right corner of the gel was cut of with a 
razor blade to keep track of the orientation. The gel was placed on a UV transilluminator 
and a ruler was placed next to the gel and its picture was taken. This way bands on the X-
ray film could be compared to the actual bands on the gel later on. The DNA was soaked 
in 500 ml of denaturization solution (0.5 M NaOH, 1.5 M NaCl) for 1 hr in a plastic dish 
with gentle agitation. The gel was rinsed several times with ddH2O and then placed in 
500 ml of neutralization solution (1 M Tris-HCl, pH 7.6, 0.6 M NaCl) for 1 hr with gentle 
agitation. 
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To prepare the transfer set up, a pyrex dish was filled with 500 ml of 20X SSC 
and a glass plate was placed across the top of the dish. 3 MM Whatman paper was cut in 
a size so that two ends could be dipped in 20X SSC when placed across the top of glass 
plate and would serve as a wick. This Whatman paper with a width slightly bigger than 
the gel was briefly wetted in 20X SSC and placed on the glass plate. A 10 ml glass 
pipette was used to roll over the layers to eliminate any air bubbles. This step was 
repeated every time until the last whatman paper was layered on top of the nitrocellulose 
filter. It is important to smooth out the layers because trapped air bubles could interfere 
with the transfer of DNA. After neutralization the inverted gel was placed on the wick. A 
nitrocellulose paper was cut to the size of the gel and dropped flat to a dish filled with 
ddH2O. The filter was left in water for about 5 min. It is important not to submerge the 
filter into the water since it will not get wet if water touches the both surface at the same 
time. The nitrocellulose filter was then placed on top of the inverted gel. 3 MM Whatman 
paper cut in slightly bigger size than the gel was also wetted briefly in ddH2O and placed 
on top of the filter. Air bubbles were eliminated one last time. Saran wrap was placed on 
all sides of the gel to prevent any contact between the wick and the stack of paper towels 
placed on top of the gel making the transfer more efficient. A stack of dry paper towels 
that were about 8 cm was placed onto the last layer of Whatman paper, followed by a 
small glass plate and weight such as a bottle filled with 0.5 liter of water. The transfer of 
DNA onto the filter was achieved by the capillary action that took place between the SSC 
solution that was sucked by the paper towels. Next morning the assembly was 
dismantled. The places of the wells were marked on the nitrocellulose filter with a pen 
and then the filter was air-dried for 30 min on a dry paper towel. The DNA was 
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immobilized by baking at 80 °C in a vacuum oven for 2 hr. The membrane was then 
ready for prehybridization and could be stored at room temperature. 
 
Part II-16.   Radioactive labeling of DNA 
16-1.   5’ end labeling of oligonucletide probes. 
 Synthetic oligonucleotides that were end labeled with a radioactive 32P-phosphate 
were used to screen recombinant plasmid DNA’s in the hybridization of immobilized 
DNA from either colony lift or Southern blot experiments for the presence of fragment of 
interest. Unlike restriction fragments, synthetic oligonucleotides have 5’-hydroxyl ends 
that are required by the enzyme polynucleotide kinase. The oligonucleotides were usually 
designed to have 20 complementary base pairs.  
The following components were mixed in a microcentrifuge tube for the kinase 
reaction. 1µl of the 0.5 µg/µl oligonucleotide, 2.5 µl of 10x kinase buffer, 10 µl of 
ddH2O, 10 µl of [γ-32P]ATP (100µCi) (behind the plexiglass shield) and 1.5 µl of 10 
unit/µl T4 polynucleotide kinase. The sample was incubated at 37 °C for 30 to 45 min. 
The reaction was stopped by adding 5 µl of 0.5 M EDTA. Labeled oligonucleotide was 
precipitated by adding 2 µl of 10 µg/µl tRNA, 10.7 µl of 7.5 M NH4OAc, 120 µl of 95% 
ethanol. The mixture was vortexed and incubated on dry ice for 10 min followed by 
centrifugation at 14,000 rpm for 10 min. The radioactive supernatant was properly 
discarded into the radioactive waste container. The DNA pellet was allowed to air-dry 
and then resuspended in 600 µl of TE pH 8.0. The end labeled probe was stored in a lead 
container at –20 °C and were usable within 2 months. 
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16-2.   Labeling of DNA by HexaLabel PlusTM DNA labeling kit. 
 Uniform radioactive label was incorporated into longer pieces of DNA by priming 
the polymerase reaction on the template DNA with random hexanucleotide primers in the 
presence of labeled deoxyribonucleoside triphosphates. These probes were used in 
hybridization with the immobilized chromosomal DNA fragments. 
 The protocol provided by the vendor was followed. The reaction was set up in a 
microfuge tube by adding the following components. 10 µl of DNA template (100 ng), 10 
µl of 5X hexanucleotide reaction buffer and ddH2O up to 40 µl. The mixture was briefly 
vortexed and spun down in a microfuge for 3-5 seconds. The tube was incubated in a 
boiling water bath for 5-10 min and then cooled on ice. The tube was spun down briefly. 
The following components were also added to the same tube. 3 µl of Mix C, 6 µl of [α-
32P]CTP (50 µCi) and 1 µl of Klenow fragment exo- (5 units). The tube was vortexed and 
centrifuged for 3-5 seconds followed by incubation at 37 °C for 10 min. 4µl of dNTP mix 
added and incubated for 5 more min at 37 °C. The reaction was stopped with the addition 
of 1 µl 0.5 M EDTA, pH 8.0. The labeled DNA was used directly in hybridization or 
stored in a lead container at –20 °C. The reaction could also be carried out by using two 
α-32P labeled deoxynucleoside triphosphates. 
 
Part II-17.   Hybridization 
 The nitrocellulose filters from either the colony lift or Southern blot experiments 
were placed in a covered plastic container composed of 100 ml of prehybridization 
solution (6X SSC and 4X Denhardt’s, 1% SDS) and incubated in a 65 °C water bath for 2 
 73
hr. After which the membranes were placed on a dry paper towel to absorb excess 
solution and then transferred to a heat sealable plastic bag. 
 The hybridization solution was prepared in the mean time by adding the 
components in the following order into a 15 ml polypropylene tube behind a plexiglass 
shield. 250 µl of 2 µg/µl Herring sperm DNA, 200 µl of the end labeled probe (or 20 µl 
of probe labeled with HexaLabel PlusTM DNA labeling kit). The DNA was denatured by 
addition of 200 µl of 1 N NaOH and vortexed. This was followed by neutralization with 
50 µl of 2 M Tris pH 7.6, 200 µl of 1 N HCl, and 5.65 ml (or 5.83 ml if added 20µl of the 
probe) of ddH2O. The solution was vortexed and then pH was checked with a pH stick to 
make sure it was neutral. The pH was adjusted to pH 7-8, if necessary and then 3.0 ml of 
20x SSC, 400 µl of 100x Denhardt’s solution, and 50 µl of 20% SDS were added. This 
mixture was poured into a plastic bag containing the membranes and sealed with a bag 
sealer with a heating element, which was prewarmed by plugging in to an electrical 
outlet. The bag was then immersed in a 50 °C water bath upright, and taped to keep the 
position. Incubation continued overnight. Different bags were used for hybridizing with 
different probes. 
The next day, the hybridization bag was cut open and the liquid was properly 
discarded into the radioactive liquid waste container. Filters were gently removed with a 
tweezers and placed into a plastic container. 100 ml of post hybridization wash solution 
(2x SSC and 0.5 % SDS) was prepared by adding 10 ml of 20X SSC, 2.5 ml of 20% SDS 
and ddH2O up to 100 ml was poured onto the filters. SDS was added last while preparing 
the solutions in order to prevent the formation of white precipittate. The container was 
then placed in a gently rotating orbital shaker for 5 min. Then the solution was discarded 
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into liquid radioactive waste container. The filters were then incubated in 250 ml of the 
wash solution (2x SSC and 0.5 % SDS) at 55 °C water bath for 45 min followed by the 
disposal of the solution same way described above. The last wash step was repeated once 
more and then the filters were placed on a paper towel to remove excess liquid and 
analyzed by autoradiography (Part II-18). 
 
Part II-18.   Autoradiography 
 The wet filters were placed colony-side-up on an old piece of Kodak X-ray film. 
If there were more than one filter, they were placed assymetricaly on the support for 
easier identification of the filter later on the developed X-ray film. The filter were 
covered with Saran wrap and placed in a cassette with intensifying screen. A piece of 
unexposed Kodak X-Omat XAR-5 film was placed into the cassette containing the filters 
in the dark room. The cassette was closed tightly and the film was exposed to the filters at 
–80 °C for at least 2 hours. Exposure times were adjusted depending on the freshness of 
the labeled probe and/or the intensity of the signal on the filters after the washes. The 
films were developed using an automatic developer machine. 
 
Part II-19.   Integration of DNA into B. subtilis by single (Campbell integration) and 
double crossover.  
 Recombination is the exchange of homologous segments between the two DNA 
molecules. Foreign DNA that is introduced into a host cell could integrate itself into the 
host chromosome with a single or a double crossover depending on the form of DNA 
(linear or circular) and/or the number of homology regions. Single crossover (Campbell 
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integration) takes place if the recombination happens between a single homology region 
between the two DNA molecules and this results in the integration of the entire foreign 
genetic material into the recipient chromosome. The DNA should be in the circular form 
in order for this to happen since the integration of a linear DNA with a single crossover 
would result in the breakage of the host chromosome and the recombinant clone will not 
be viable. On the other hand, a double crossover occurs if the recombination takes place 
between two homology regions between the host and the foreign DNA. Unlike the single 
crossover, a double crossover results in the exchange of genetic material between the 
homology regions. It has been noted that for a double crossover event to occur most 
efficiently, 400 or more nucleotides of homology on either side of the gene of interest are 
necessary (24). 
 It was possible to differentiate the type of recombination with antibiotic selection 
when using vectors derived from pLPcat cassette vector (62). These vectors contain the 
cat gene in between homology regions and the target site in B. subtilis chromosome 
contains the erm gene in between the homology regions. Therefore, a B. subtilis cell that 
integrates the transformed plasmid by a single crossover results in the integration of the 
entire plasmid with no displacement of the erm gene from the chromosome and the 
resulting strain becomes both chloramphenicol and erythromycin resistant. However, if 
the double recombination occurs, the resulting strain becomes chloramphenicol resistant 
and erythromycin sensitive since the erm gene was displaced with the cat gene and the 
piece of DNA that was intended to be placed into the host chromosome. 
 The B. subtilis cells transformed with either of these plasmids were spread on 
chloramphenicol plates. Then the chloramphenicol resistant transformants were grided 
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first onto chloramphenicol (10 µg/ml) containing plate with the help of a sterile toothpick 
and then onto erythromycin (10 µg/ml) containing plate at the identical positions. The 
plates were inverted and incubated up to 48 hr at 37 °C to observe the colony formation. 
Both single and double crossover colonies were analyzed with halo assay to see if the 
biological activity was different between any of them. The clones that produced bigger 
halos and were chloramphenicol resistant and erythromycin sensitive were selected for 
further manipulations since they had integrated the desired piece of DNA through double 
crossover. The presence of a plasmid sequence in the chromosome is not desirable 
because it might interfere with further genetic manipulations if one has such plans. 
 
Part II-20.   Expression of peptides in B. subtilis strains.  
 B. subtilis strains containing the nisin gene cluster were selected as described in 
part II-15 and grown in Medium A which is used for the production of  sublancin and 
subtilin from the B. subtilis 168 strains. A single colony of the transformant from an 
overnight plate was inoculated into 5 ml of PAB with appropriate antibiotic in a sterile 15 
ml polypropylene tube. The culture was grown overnight with shaking at 250 rpm at 37 
°C. Next morning, this 5 ml culture was used to inoculate a flask of prewarmed Medium 
A (2% sucrose, 0.2% PAB) medium to determine if the transformant strain was 
producing nisin. The solutions for Medium A (Part II-2, 2-5) were prepared in advance 
and 500 ml of the media was prepared fresh by mixing the four solutions just before the 
inoculation as described previously. The 2 L baffled flask containing the culture was 
plugged with a foam stopper and shaken at 300 rpm in an orbital shaker at 37 °C for 26-
28 hr. The color change of the culture to a dark maroon and a drop in the pH to 5.8-6.2 
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was usually the indications of a good lantibiotic production in strains of B. subtilis 168. 
The production of nisin was also expected to produce the same effects. At the end of the 
incubation, the cultures were acidified to pH ~2.5 with phosphoric acid (85%). Then the 
cells were pelleted in a 250 ml centrifuge bottles by spinning at 10,000 rpm in a Beckman 
JLA-16.250 rotor for 10 min at room temperature. The supernatants were then transferred 
to another flask. At this point the supernatant was ready for the isolation of the peptide of 
interest or could be stored at –20 °C for later manipulation. For the initial purification of 
nisin, two different column chromatography approaches were used. The culture 
supernatants were either applied to a hydrophobic interaction column (HIC) as described 
in part II-21 or to a non-ionic cellulose (NIC) column as described in part II-23. 
 
Part II-21.   Purification of peptides with a hydrophobic interaction column (HIC). 
 The culture supernatant described in Part II-17 was prepared for the HIC 
purification by adding 1 M NaOAc, pH 4.0 and 5 M NaCl (Part-II-2, 2-2) to a final 
concentration of 50 mM and 1 M, respectively. A Bio-Rad econo column (11 cm in 
height, 1.5 cm in diameter, and 20 ml in volume) was prepared by packing with 
Toyopearl® Butyl 650M hydrophobic interaction resin. The resin was then equilibrated 
by passing 100 ml of wash buffer (50 mM NaOAc pH 4.0 and 1 M NaCl, see Part II-2, 2-
3) through the column using a peristaltic pump. The equilibrated culture supernatant was 
placed on ice and applied to the equilibrated hydrophobic interaction column by 
peristaltic pump at a flow rate of 1.5-2 ml/min. After all of the supernatant had flowed 
through, the column was washed by 100 ml of equilibration/wash buffer. Bound proteins 
were then eluted from the column with passing the elution buffer, 60 % acetonitrile, (see 
Part II-2, 2-3) through the column. About 30 ml of eluate was collected into a 300 ml 
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lyophilizer jar. The collection started after the front of eluting materials had reached to 
the bottom of the column (in other words after approximately 1 bed volume of buffer had 
passed through the column), this can be usually observed as a dark brown band. The jar 
was then frozen in a dry ice-ethanol bath and the contents were lyophilized overnight. 
The next morning, the dried eluate was dissolved in 2 ml of 100 mM HOAc. The solution 
was filtered through a 0.22 µm syringe filter and purified further by reversed phase 
HPLC as described in Part II-22.  
 
Part II-22.   Reversed phase high performance liquid chromatography (RP-HPLC). 
 Reversed phase high performance liquid chromatography (RP-HPLC) was used 
for further purification of peptides. RP-HPLC was performed on a Hewlett-Packard 
Series 1050 equipped with a photodiode array detector. A 250 mm x 4.6 mm 
MICROSORB 300 Å C-18 reversed phase column with 5 µm pore size was used to 
resolve the peptides. For the mobile phase, buffer A was composed of 0.5 % acetonitrile, 
0.1 % acetic acid and 0.01 % trifluoroacetic acid, in ddH2O and buffer B was composed 
of 0.5 % ddH2O, 0.1 % acetic acid 0.01% trifluoroacetic acid in acetonitrile. Linear 
gradient at a flow rate of 1.2 ml/min was applied. The elution profiles were monitored 
using absorbencies at 254 nm for dehydro residues and 214 nm for peptide bonds and 280 
nm for aromatic residues. Before sample injection, the column was washed twice or until 
completely cleaned with an acetonitrile gradient (0-100%) over 2 min, holding at 100% 
for 3 min, reversing the gradient over an additional 2 min and holding at 0% several 2 
min to equilibrate. Samples were then loaded into the loop and injected onto the column. 
After injection the mobile phase was maintained at 100% buffer A for 4 min to allow for 
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binding of peptides to the column and flow-through of any nonbinding material. The 
gradient was initiated by ramping the mobile phase from 0% to 100% buffer B over the 
next 21 min to gradually eluate the bound materials with respect to their hydrophobicity. 
The gradient was held at 100% buffer B for 3 min and and then reversed back to 0% over 
the next 2 min. Fractions were collected at one-min increments into clean 1.5 ml 
microfuge tubes and tested for biological activity using halo assay (see Part II-20). Active 
fractions were further analyzed with mass spectroscopy for the presence of lantibiotics. 
Collected fractions were frozen at -80 °C and then lyophilized in a vacuum centrifuge. 
The dried fractions were then resuspended in 100 µL of 100 mM HOAc and stored at –20 
°C. If the peptide yield was low, the halo assay was performed after concentrating the 
fractions with lyophilization. 
 
Part II-23.   Cellulose column purification of peptides produced by Lactococcus lactis 
11454 and recombinant B. subtilis strains. 
 The ability of nisin to bind to the non-ionic cellulose was characterized by a 
former group member Amer Villaruz (83). In order to isolate pure recombinant nisin 
species from the cultures of appropriate B. subtilis strains a non-ionic cellulose column 
was used. 50 g of non-ionic cellulose powder was resuspended in ddH2O and allowed to 
settle. The fine particles that remained in the liquid phase were gently decanted. This was 
repeated couple of times to get ride of the cellulose fine particles as much as possible. 
The cellulose was then resuspended in 100 ml ddH2O and was now ready for use. The 
suspension was poured into the column until about 20 ml resin was packed in while the 
water was running through the column. This allowed homogeneous packing. The column 
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was equilibrated with about 100 ml of 0.1 M NaPi pH 7.8. Culture supernatants were also 
equilibrated to pH 7.8 by titrating with NaOH. When working with cellulose column 
extra care was taken not to let the column to go dry. If the column had dried out, the resin 
was taken out and resuspended in a beaker and packed again. 
 Lactococcus lactis 11454 (natural host of nisin) culture was prepared by 
inoculating a single colony from an M17 agar plate to a 50 ml of sterile polypropylene 
tube filled to top with M17 media and incubated at 32 °C overnight. The next day, if the 
high turbidity of L. lactis cells was observed, the entire 50 ml of this culture was then 
transferred to 950 ml of sterile M17 media in a 1 L flask, which was sealed with parafilm 
and incubated at 32 °C overnight. The following morning  pH of this culture was adjusted 
to pH 2.5 with 85% phosphoric acid, and centrifuged at 10,000 rpm for 10 min at room 
temperature to pellet the cells. The supernatant was then collected, and the pH was 
adjusted to 7.8 with 10 N NaOH.  
The recombinant B. subtilis strains were cultured in Medium A as described in 
Part II-20. After the cells had pelleted the pH was adjusted to 7.8 as described for L. 
lactis cells. After the equilibration of the supernatant the same protocol was followed for 
both cell types. 
 The equilibrated supernatants were pumped into the cellulose column at a flow 
rate of 1.5-2 ml/min at room temperature. Then the column was washed with ~100 ml of 
100 mM NaPi pH 7.8. The bound materials were then eluted by applying 5.4 M HOAc to 
the column. The eluate was collected into a lyophilizer jar and frozen using a dry ice-
ethanol bath, and lyophilized. The dried residue was resuspended in 2 ml of 100 mM 
HOAc.  
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The cellulose column eluate was then further purified on RP-HPLC using a linear 
water-TFA-acetonitrile gradient described in Materials and Methods, Part II-22. The 
fractions were collected at one-min intervals, frozen at –80 °C, lyophilized in a Speedvac, 
and resuspended in 100 µL of 100 mM HOAc. A 10 µL aliquot of each fraction was 
tested for biological activity as described in Materials and Methods, Part II-24. The 
fractions were tested for the presence of nisin with MALDI- MS and analyzed by 
nanoESI MS as described in Materials and Methods, Part II-25, 25-2.  
 
Part II-24.   Testing the biological activity with spore outgrowth inhibition assay (Halo 
Assay). 
 After the HPLC purification, native or recombinant proteins were tested for 
biological activity by a halo assay (inhibition zone assay). The active HPLC fractions 
were determined by their ability to inhibit spore outgrowth. 10 µl of the HPLC fractions 
were pipetted onto a prewarmed PAB plate and allowed to air-dry for 10-15 min at room 
temperature. A thin layer of spores was sprayed onto the plate in a ventilated hood and 
allowed to sit at room temperature for 10-15 min. Plates were then inverted and incubated 
at 37 °C until the halos develop (~ 5 hr) or overnight. Plates were placed in a sealable 
plastic bag during incubation to avoid contamination. The plates were then photographed. 
 After the transformation of a construct into the B. subtilis cells, recombinant 
clones were also screened with halo assay to quickly detect if there was any change in the 
in the size of halos around the recombinant and wild type strains. The recombinant clones 
with bigger and clearer zones of inhibition were chosen for further investigation. Usually 
8 of the clones were grided per plate with a sterile toothpick and incubated overnight at 
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37 °C. The following day the plates were sprayed with a thin layer of B. cereus T spores 
and allowed to sit at room temperature for 10 min. Plates were placed in a sealable plastic 
bag, inverted and incubated at 37 °C. The halos were usually visible in 5 hr. The pictures 
of the plates were taken. 
B. cereus T spores was prepared by suspending 250 mg of dried spores in 20 ml 
of ddH2O. The spores were dispersed using a ground-glass homogenizer and then placed 
in a 50 ml polypropylene tube. The spore suspension was heat shocked at 65 °C for two 
hr. The spores were centrifuged at 6,000 rpm for 5 min. The spore pellet was resuspended 
in 40 ml of 10% ethanol. The spore suspension was then transferred to an aerosol spray 
bottle and stored at room temperature. 
 
Part II-25.   MALDI-TOF and nanoESI Mass Spectrometry. 
 Matrix assisted laser desorption/ionization-time of flight mass spectrometry 
(MALDI-TOF MS) and nanoelectrospray ionization mass spectrometry (nanoESI MS) 
techniques were used for quick identification and/or analysis of lantibiotic species from 
the cultures of bacteria.  
25-1.   MALDI-TOF MS. 
 Samples to be analyzed were crystallized on sinapinic acid (SA) matrix by the 
‘sandwich method’ as described by Kussman et al (49). A small metal disc, which was 
about 2 cm in diameter, was used as a sample stage.10 etched circles located on the disk 
allowed to analyze 10 separate samples at a time. To prepare the samples, 0.5 µl of the 
SA matrix was deposited onto desired number of circles and allowed to dry in a fume 
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hood. Then about 0.5 µl of the sample were pipetted onto the matrix and dried in a fume 
hood. Finally, 0.5 µl of the SA matrix was deposited onto each sample and dried the same 
way as described above. The samples were always dissolved in low pH solutions such as 
100 mM HOAc or 0.05% TFA to facilitate ionization. External standards (such as nisin) 
were used to calibrate the instrument. Samples were analyzed on a Bruker Proflex 
MALDI-TOF mass spectrometer which was interfaced to a Sun Solaris workstation. The 
measurements were averaged over the multiple laser shots and displayed on the screen as 
mass/charge ratio. The SA matrix solution (20 mg/ml) was prepared by dissolving 20 mg 
of 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid) in 1 ml of a 70% 0.1% TFA, 
30% CH3CN. Undissolved matrix was spun down. The solution was stored at 4°C. 
25-2.   NanoESI MS. 
The peptides purified from the culture supernatant with the described methods 
(Part II.20-23) were further analyzed by nanoESI mass spectrometry to be able to identify 
the mass peaks that might belong to nisin or nisin variants. The lyophilized RP-HPLC 
fractions were resuspended in 100 µl of 0.1 M HOAc. 2 µl aliquot of the sample was 
loaded on a nanospray capillary (New Objective) by a Hamilton syringe (10 µl). Voltage 
(1.00-1.5 keV) was applied to the nanospray capillary to charge the spraying droplets. 
The capillary inlet inside the machine was heated to 200 °C to facilitate the evaporation. 
The measurements were done on a Finnigan LCQ quadrapole ion trap mass spectrometer 
connected to a Windows 2000 workstation. The LCQ TunePlus software package was 
used to analyze the ions in the range of 150-2000 amu. The positive ion mode was used 
to analyze all the samples. Since the peaks were displayed as m/z values on the spectrum, 
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the charged state of a particular molecular ion had to be determined in order to calculate 
the molecular weight of that ion. Zoom scan mode was used to determine the charged 
state of a particular ion. In this mode, one peak within a 1 amu unit indicates a singly 
charged peptide ion whereas two peaks indicate a doubly charged peptide ion. Scans were 
collected for 3-10 min and saved into a file. Later on, a mass spectrum was obtained by 
averaging this collected data. 
 
Part II-26.   Isolation of total RNA and RT-PCR of nisin genes. 
 Proper microbiological, aseptic technique was always used when working with 
RNA. Gloves were worn at all times to prevent RNase contamination from the skin. In 
order to create and maintain an RNase free environment, the following precautions were 
taken while working with RNA. All tips and microfuge tubes were sterilized by 
autoclaving for 20 min at 120 °C. All glassware was filled up with 0.1% DEPC (in 
ddH2O) and stirred overnight at room temperature. DEPC treated glassware was then 
autoclaved for 20 min at 120 °C to remove any residual DEPC. The electrophoresis tank, 
cuvettes and non-disposable plasticware were treated with 0.3 N NaOH and then rinsed 
with DEPC-H2O. Solutions that were used in RNA work were either prepared with DEPC 
treated H2O and glassware or treated with 0.1% DEPC afterwards. When preparing Tris 
buffers, the water was treated first with DEPC and then used to make the appropriate Tris 
buffer because DEPC is highly unstable in the presence of Tris buffers.  
26-1.   Isolation of total RNA. 
 Total RNA was isolated from strains of B. subtilis 168 and L. lactis 11454 by 
using RNeasy® Mini Kit in accordance with the manufacturer protocol (Qiagen). The on 
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column Dnase digestion was performed by using the RNase free DNase set which was 
manufactured by Qiagen to be used with RNeasy kits. 
 The bacterial cultures were grown overnight at 37 °C with shaking except the L. 
lactis culture, which was grown overnight 28 °C without shaking. 500 µl of the bacterial 
cell culture was added onto 1 ml of RNA Protect™ Bacteria Reagent in order to stabilize 
the RNA in the cells. For the lysis of the L. lactis culture, DL threonine was added to a 
final concentration of 20 mM when the OD600 was between 0.6-1.0 and the incubated at 
30 °C for 1-2 hr to weaken the cell wall. In addition to the lysozyme (to a final 
concentration of 3 mg/ml) that was used to lyze B. subtilis cells, mutanolysin (10 
units/µl) was also added to a final concentration of 0.5 units/µl to the L. lactis 11454 
cells. 
 RNA was visualized on 1.2% formaldehyde agarose gels by staining with EtBr 
(Materials and Methods Part II-26, 26-2). The concentration and purity of the samples 
were determined taking readings at OD260 and OD280 with the UV-visible 
spectrophotometer. 
26-2.   Analysis of RNA on formaldehyde containing gels. 
 The following RNase free solutions were prepared in advance; 0.1 M Tris pH 7.9, 
0.5 M EDTA pH 8.0, 3 M NaOAc pH7.0, 10X MOPS buffer. 
 1.2 % agarose gels were prepared by melting 1.2 g agarose in 57 ml DEPC-
ddH2O in a microwave oven (10-15 seconds were counted after the solution had boiled). 
After the solution had cooled down to 50-55 °C, 10 ml 10X MOPS buffer (200 mM 
MOPS, 50 mM NaOAc, pH 7.0 and 10 mM EDTA, pH 8.0) and 30 ml 37% 
Formaldehyde (buffered) was added and mixed by swirling. The solution was then 
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poured onto midi (13 cm) gel casting stand that had been taped at the open ends. A comb 
was inserted to create wells and the gel was allowed to solidify at room temperature 
 To run the samples, appropriate volumes of RNA that contained 0.5-2.0 µg of 
RNA were prepared. If it was necessary, the SpeedVac was used to concentrate the 
samples. To each sample, a 2X volume of the pre-mix was added and mixed by 
vortexing. The tubes was briefly centrifuged to bring down all the solution and then 
incubated at 65 °C for 5 min. 2-5 µl of the 10X formaldehyde loading dye (50% Glycerol, 
1mM EDTA, 0.25 % bromophenol blue, 0.25% xylene cyanol) was added prior to 
loading the samples on the gel. A 100 bp DNA ladder was used as a size marker. The gel 
was run at 45V at constant current (50 mA) in 1X MOPS buffer (10X MOPS buffer was 
diluted with DEPC-ddH2O) until bromophenol blue migrated to the halfway of the gel. 
This took about 3-6 hrs. 
 The gel was rinsed with DEPC-ddH2O several times and then stained in DEPC-
ddH20 which was containing 0.5 µg/ml EtBr. Staining was continued for at least 30 min 
(or overnight) on a shaker. Then it was washed with DEPC-ddH2O overnight on a shaker 
to remove the excess EtBr. The next day, UV transilluminator was used to visualize the 
RNA bands. 
26-3.   RT-PCR of nisin genes. 
 The RT-PCR experiments were performed by using the Qiagen one step 
RT-PCR kit. The presence of a special enzyme combination in this kit allows the efficient 
and sensitive reverse transcription of any RNA quantity from 1 pg to 2µg. The enzyme 
mix also contains the HotStarTaq DNA polymerase which was activated by heating to 95 
°C for 15 min after the reverse transcription is complete. This step also inactivates the 
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reverse transcriptases and eliminates extension from nonspecifically annealed primers 
and primer dimers in the first cycle.  
A 240 µM stock of each primer was prepared by resuspending in RNAse free 
ddH2O and stored at –20 °C. To prepare the working stock of 2.4 µM, oligonucleotides 
were diluted 100 times with ddH2O. During the sample preparation, sterilized solutions 
and equipments were used to prevent any contamination and gloves were worn at all 
times. Prior to the preparation of samples, template RNA, primer solutions, dNTP mix, 
5x Qiagen OneStep RT-PCR buffer, and RNase free water was thawed and placed on ice. 
The samples were also prepared on ice in 0.5 ml RNase free thermowellTM tubes 
and the reaction components were added in the following order. First, RNase-free ddH2O 
was pipetted into the tubes to brought up the final volume to 50 µl then 10 µl of 5X RT-
PCR buffer, 12.5 µl of the forward (2.4 µM) and the reverse primer (2.4 µM) to a final 
concentration of 0.6 µM, 2 µl of dNTP mix (10 mM of each dNTP) to a final 
concentration of 400µM, 2 µl of Qiagen OneStep RT-PCR enzyme mix and finally 2 µl 
of template RNA (≤2 µg/reaction) were added. Tubes were vortexed briefly and spun 
down for 3-5 sec. 50 µl of paraffin oil was then carefully pipetted onto the samples to 
prevent evaporation and recondensation during the reactions. The cycles were started and 
when the temperature in the wells reached 50 °C, tubes were placed into the PCR 
thermocycler directly from ice.  
Four cycles/profiles were used to amplify cDNA of the target sequence from the 
RNA template. The first profile involved the reverse transcription from the template 
RNA by incubating the tubes at 50 °C for 30 min. Then the cycler advanced to second 
profile, which was initial PCR activation step. In this step, tubes were kept at 95 °C for 15 
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min in order to activate HotStarTaq DNA polymerase and inactivate reverse 
transcriptases. The cDNA template was also denatured. In the next profile, the cDNA was 
amplified through 30 repetitive denaturation, annealing and extension cycles. First, the 
denaturation was done at 94 °C for 30 seconds then the temperature ramped down to 51 
°C and kept there for 30 seconds to allow annealing of primers to the template cDNA 
followed by ramping up to 72 °C for 1 min for the extension of the sequence from the 
primers. Finally, the cycler switched to the last profile in which the tubes were kept at 72 
°C for 10 min for the final extension and then ramped down to 4 °C indefinitely. The 
ramp rate was set up to the machine’s maximum during all the cycles. A negative control 
was included in each experiment that did not contain any template RNA to detect 
possible contamination of the reaction components. Also a control reaction was set up to 
detect any DNA contamination by setting up the reaction and placing it on the 
thermocycler only after it had reached 95 °C for the HotStarTaq DNA polymerase 
activation step. This high-temperature step inactivates the reverse transcriptases and in 
the absence of the reverse transcription, the only DNA template for PCR is contaminating 
DNA. Therefore, formation of PCR products in these reactions indicates the presence of 
DNA contamination. 
After the cycles had completed, the samples were pipetted into clean tubes to get 
rid of the paraffin oil and 5 µl aliquots were run on a 1 % agarose gel along with a size 
standard to visually determine if the amplification was successful.  
Part II-27.   SDS Polyacrylamide gel electrophoresis 
All analyses were done by using the tricine SDS-PAGE that was initially 
described by Schagger and Jagow (72). 16.5 % separating gel was prepared by mixing 10 
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ml of 49.5 % acrylamide, 3 % bisacrylamide stock solution, 10 ml of gel buffer (3.0 M 
TrisHCl, pH 8.45, 0.3 % SDS), 6.4 ml of 50 % glycerol. The volume was brought up to 
30 ml. 100 µl of APS and 10 µl TEMED was added just before pouring the gel. 
14 cm x 16 cm gel plates were assembled with spacers of 1 mm thickness using 
clamps. The edges and the bottom were sealed with 1 % molten agarose. The assembly 
was filled with the separating gel by using a 60 ml syringe and then a comb was placed 
immediately at the top. The gel was allowed to polymerize for 45-60 min. After the gel 
had solidified, the comb and the clamps were removed and the gel was placed into the 
electrophoretic apparatus. 400 ml of the 1X cathode buffer was poured into the upper 
reservoir and 400 ml of the 1X anode buffer was poured into the lower reservoir. The 
samples were prepared by adding equal amount of the 2X gel-loading buffer and 
incubated in a boiling water bath for 2-5 min. The samples were then loaded onto the 
wells, which have been flushed with the 1X cathode buffer. The gel was electrophoresed 
at 100 mV for about 60 min and then at 15 mV overnight. The next morning, the gel was 
electroblotted onto a nitrocellulose membrane for western blot analysis. 
 
Part II-28.   Western blot analysis. 
 The peptides from the purified culture supernatants were analyzed for presence of 
nisin or nisin related peptides by doing a western blot analysis. The peptides separated on 
a SDS-PAGE gel were soaked into the transfer buffer for 30 min. The nitrocellulose 
membrane, two sheets of 3MM Whatman paper, and the two filter pads were also 
equilibrated in the transfer buffer for about 10 min. The transfer block was opened up and 
the layers were assembled on the clear side (that will be closest to the positive electrode). 
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The layering was done in the following order: a transfer filter pad, a 3MM Whatman 
paper, the nitrocellulose membrane, the polyacyrlamide gel, another 3MM Whatman 
paper, and finally the other transfer filter pad. The black side of the plate was placed on 
top and the assembly was clamped shut. The transfer cell was filled with 3 liters of the 
transfer buffer and the assembly was placed in it with clear side facing the positive 
electrode. The cell was electrophoresed at a constant current 250 mA for 3-4 hr. The 
nitrocellulose membrane was then immediately probed with polyclonal nisin antibodies 
or wrapped in plastic wrap and stored at 4 °C. 
 
Part II-29.   Immunodetection. 
The membrane-immobilized peptides were probed by using rabbit anti-nisin IgG. 
The nitrocellulose filter was incubated with 50 ml of the blocking buffer (1 % BSA in 
TBST) for 1 hr, while rocking gently. The filter was then immersed in 25 ml of TBST 
containing the 50 µl of the primary antibody (1:500 dilution) and gently agitated at room 
temperature for 45 min. The membrane was then washed twice in 50 ml of TBST for 5 
min with agitation. The membrane was immersed in 25 ml of TBST containing 5 µl 
(1:5,000 dilution) from the 1 mg/ml secondary antibody (goat anti-rabbit IgG conjugated 
with alkaline phosphatase) solution. The membrane was incubated for 45 min in this 
solution with gentle agitation. The membrane was then washed twice in 50 ml of TBST 
for 5 min with agitation to get rid of the unbound secondary antibody. 30 ml of the 1 
Step™ NBT/BCIP (Pierce) was poured on the membrane and incubated until the bands 
reached the desired color intensity. The reaction was stopped by rinsing the membrane 
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with water twice for 5 min and air dried on a clean paper towel. The developed 
membrane was photographed and stored in dark. 
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Results 
Part I. Transfer of nisin genes into Bacillus subtilis BR151. 
Rationale: 
 Nisin is an antimicrobial peptide that is very effective in killing food-spoilage 
bacteria and its non-toxic nature has led to its application as a food preservative in 
various food products in over 50 countries. Nisin is notable in containing a high 
proportion of unusual amino acids that are introduced by post-translational processing. 
These unusual residues confer highly unusual and useful properties to nisin. Novel 
dehydro residues (dehydroalanine and dehydrobutyrine) convert it into an electrophilic 
agent, and lanthionine residues confer remarkable chemical stability and protease 
resistance. In order to explore the potential of utilizing genetic engineering techniques to 
make structural analogs of nisin, and to explore the mechanism of posttranslational 
modification, it is useful to transfer the nisin biosynthetic machinery from its natural host 
(Lactococcus lactis) to a well characterized bacterial strain that is amenable to genetic 
manipulation. Bacillus subtilis 168 is an ideal host strain for the following reasons: The 
entire genome has been sequenced; it is already in use for industrial production of 
bioengineered materials; it is naturally competent and readily amenable to introduction 
and expression of foreign genes; it is a natural producer of a lantibiotic (sublancin) and is 
therefore compatible with lantibiotic processing proteins.  
In the long run, understanding the mechanism of formation of these unusual 
residues might also allow us to introduce them into different peptides to create novel 
antimicrobial agents directed towards many diseases. Genetic engineering techniques 
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could also be used to increase the efficiency of production. This would greatly facilitate 
the use for for its industrial and pharmaceutical applications. 
The goal of this work was to express nisin out of B. subtilis 168 through transfer 
of the nisin gene cluster from natural host into B. subtilis 168 chromosome. In pursuing 
this project, a major problem was to devise a suitable selection strategy. Different 
approaches were undertaken to transfer the 11 genes that are involved with the nisin 
biosynthetic machinery. In the following sections these experimental strategies for 
transfer and selection of nisin gene cluster are presented and evaluated. 
 
Part I-1.   Construction of pSYcat to provide recombination target sites from L. lactis. 
The plasmid pSYcat was constructed to introduce the flanking regions of the nisin 
gene cluster from Lactococcus lactis into the amyE locus of Bacillus subtilis 168. The 
amyE gene was chosen as the target site to transfer nisin genes because it is a non-
essential gene and is widely used as a target for integration of cloned genes into the 
Bacillus subtilis 168 chromosome.  
The pSYcat construct contained a 527 nucleotide segment from the left end of the 
amyE gene (amyL), then a 612 nucleotide segment from the transposase gene, followed 
by chloroamphenicol resistance gene, 640 nucleotides from the sacR gene and a 606 
nucleotide segment from the right end of the amyE gene (amyR). The cloning steps that 
were performed for the construction of the pSYcat are outlined in Figure 5. The 
construction involved making four PCR products as described in Materials and Methods 
Part II-10, 10-1. Table 2 shows the sequences of oligos used to make these products. The 
first step involved the cloning of each PCR fragment into the pCR2.1 vector by making 
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use of AT cloning. Then these fragments were sequentially subcloned into the 
multipurpose cloning site (mcs) of pTZ18R that contains an origin of replication that 
works in E. coli, which is non-functional in B. subtilis. The construct was completed by 
inserting the cat (chloramphenicol acetyl transferase) gene to generate 6.2 kb pSYcat. 
Each cloning step was subjected to extensive restriction enzyme analysis to confirm the 
presence of cloned fragments and also colony lifts and/or Southern blot hybridization 
experiments.  
The plasmid pSYcat was then linearized and transformed into competent cells of 
B. subtilis erm∆sunA (Figure 6). The cells were screened for chloramphenicol resistance. 
Since the vector did not have a B. subtilis origin of replication, the only way that the 
transformed cells could become cm resistant was through the integration of pSYcat into 
the chromosome. The vector was linearized prior to the transformation in order to 
integrate the homology regions through a double recombination. A linear plasmid cannot 
integrate into the host chromosome through a Campbell type of integration because this 
will break the chromosome. The resulting strain was called B. subtilis SYcat.  
 
Part I-2.   Transformation of L. lactis 11454 genomic DNA and selection on nisin. 
In the next step, L. lactis 11454 genomic DNA was transformed into B. subtilis 
SYcat (figure 6). The double recombination that would take place through transposase 
and sacR homology regions could integrate the nisin gene cluster into the host 
chromosome by replacing the cat gene. A known selection marker was not introduced to 
the flanking regions of nisin gene cluster because nisin gene cluster contains nisin 
immunity genes, which confer nisin resistance to the host cell. If these genes work in B. 
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subtilis BR151, transformants could easily be selected on nisin without need to design 
more elaborate selection strategies. The minimum inhibitory concentration (MIC) of nisin 
for wt-B. subtilis was determined by culturing the wt-B. subtilis  cells with increasing 
concentrations of nisin. MIC was found to be ~30 µg/ml. Then the amount of nisin to 
inhibit the growth of wt-B. subtilis BR151 on plate was also determined. When 200 µg of 
nisin was spread on a plate, it effectively inhibited the growth of wt-B. subtilis BR151. 
Competent B. subtilis SYcat cells were prepared and L. lactis DNA was transformed as 
described in materials and methods Part II-13, 13-3. The selection was tried on nisin 
spread plates several times, but no transformants were observed. Double recombination is 
a rare event and it happens fewer than 1 per 105 cells. One of the possibility of not 
observing a transformant was that recombination was not efficient enough to transfer ~14 
kb nisin gene cluster and its flanking regions into the B. subtilis BR151. It was also 
possible that the nisin immunity genes did not function properly in B. subtilis BR151. In 
order to circumvent these possibilities, a selection marker that is known to work in B. 
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Figure 5.   Construction of pSYcat. 
The homology regions were amplified by PCR using Taq polymerase, which has the 
ability to add single 3’ A residues at the end of DNA in a non-template dependant way. 
Lactococcus lactis 11454 genomic DNA was used as a template to amplify regions from 
transposase and sacR and B. subtilis BR151 genomic DNA was used to amplify amyL 
and amyR. PCR products were ligated to pre-linearized pCR2.1 vector with T overhangs 
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Figure 5.   (Continued) 
Each of these fragments was subcloned into the multi purpose-cloning site of pTZ18R 
sequentially. pCR2.1-AL was digested with EcoRI and the amyL fragment was ligated 
into EcoRI site of pTZ18R resulting in pTZ-AL. pCR2.1-T5 and pTZ-AL were digested 
with XhoI/HindIII  and the transposase fragment from pCR2.1-T5 ligated with the vector 
pTZ-AL to create pTZ-AT. PstI/Hind III sacR fragment from pCR2.1-S4 was put into the 
same restriction sites in pTZ-AT, making pTZ-ATS. The plasmid pTZ-ATSA was made 
by opening up pTZ-ATS with KasI/HindIII and ligating the amyR fragment from 
pCR2.1-AR, which was also digested with KasI/HindIII. Finally cat gene from pEZcat, 
which was contructed by Gonzalo Izaguirre, was digested with PstI to release cat gene 
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Figure 6.   Cloning strategy to transfer nisin genes. 
irst part of the scheme illustrates the recombination event that took place between 
SYcat and B. subtilis BR151 chromosome. About 0.5 µg of HindIII linearized pSYcat 
as transformed into the host, integrating the homologous sequences. The new strain was 
alled B. subtilis SYcat. The second recombination event was expected to happen when 
bout 2 µg of L. lactis 11454 chromosomal DNA was transformed into B. subtilis SYcat 
eplacing the cat gene with nisin gene cluster. 
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Table 2.   Oligonucleotides used in Results Part I-1.  
igonucleotides SYALf and SYALr were used in the construction of pCR2.1AL, SYTf 
d SYTr were used in the construction of pCR2.1T5, SYSf and SYSr were used in the 
nstruction of pCR2.1S4, SYARf and SYARr were used in the construction of 
R2.1AR and SYALh, SYTh, SYSh, SYARh were used as hybridization probes. 
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Part II.   Selection strategy using the thermosensitive plasmid pGh9:ISS1. 
 In this strategy, transformants that had integrated the nisin gene cluster were 
selected by using an erm gene that is known to function in B. subtilis (Figure 7). The 
plasmid pGh9:ISS1, which contains the thermosensitive replicon pG+host (52), was used 
to integrate the erm selection marker into downstream of nisin gene cluster in the L. lactis 
11454 chromosome. This plasmid can replicate at 28 °C in L. lactis, E. coli and B. subtilis 
but cannot replicate if the temperature is raised above 37 °C. A detailed description of the 
strategy was illustrated in Figure 7. 
 
Part II-1.   Construction of pGh9USR and electroporation into L. lactis 11454. 
 The 630 bp homology region from the upstream sacR gene was amplified by PCR 
as described in Material and Methods Part II, II-10 and cloned into pCR2.1 vector by AT 
cloning. The primers used for this reaction were listed in Table 4. The clone containing 
the upstream sacR homology region (pCR2.1USR) was subcloned into pGh9:ISS1. The 
transformants were analyzed with restriction enzyme digestions. The clone containing the 
homology region was selected and named pGh9USR. Electrocompetent L. lactis 11454 
cells were prepared and the pGh9USR was electroporated into the cells as described in 
Materials and Methods Part II-13, 13-4 in order to integrate the erm gene to the 
downstream region of nisin gene cluster. The cells seemed coagulated after the addition 
of M-17 medium even though a single pulse at the regular strength was applied as 
recommended. This did not happen with the E. coli control electroporation. The cells 
were incubated at 28 °C for 1.5 hr then 30 more minutes in the presence of 0.5 µg/ml erm 
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Figure 7.   Construction of the recombinant strain B. subtilis SYerm. 










. subtilis SYerm.The plasmid, pCR2.1USR was digested with HindIII to release the 
pstream sacR fragment which was isolated and ligated into HindIII linearized, 
GH9:ISS1. The construct pGh9USR was then electroporated into L. lactis 11454 
Materials and Methods Part II-13, 13-5). The DNA was isolated from the recombinant 
train, L. lactis 11454erm (Materials and Methods Part II-5, 5-2) and transformed into B. 
ubtilis SYcat (Materials and Methods Part II-13, 13-3). The last step shows the double 
ecombination that could take place between the L. lactis 11454erm and B. subtilis SYcat 
orming the recombinant strain B. subtilis SYerm. 
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for prolonged times, no colonies were observed on the plates. The electroporation was 
repeated with several different parameters to optimize the electroporation conditions. For 
example, an osmotic stabilizer such as sucrose and/or glycerol was included in the cell 
suspension. Below is a list of conditions tried. 
 
Tube #   Cells ( 70 µl)       Voltage        Resistance          Pulse length   Amount of DNA  
#1        10% glycerol     1.70 kV       129 ohms (R5)      4.15 msec  1.5 µl  
#2        10% glycerol     1.30 kV       129 ohms (R5)      4.58 msec  1.5 µl 
#3        10% glycerol     1.50 kV       129 ohms (R5)      4.25 msec  3 µl 
#4        10% glycerol     1.70 kV       72 ohms (R4)       2.84 msec  3 µl 
#5        10% glycerol +   1.70 kV       129 ohms (R5)       4.33 msec  2 µl 
            0.5 M sucrose  
 
#6       10% glycerol +    1.20 kV       129 ohms (R5)      4.93 msec  2 µl 
            0.5 M sucrose  
#7       10% glycerol     1.70 kV      129 ohms (R5)       4.04 msec    − 
 
 The cells in tube #7 was plated on M-17 plate without any antibiotic to make sure 
that cells were still viable after the applied electric field. A lawn of cells were observed 
on the plate after an overnight incubation at 37 °C. This confirms that many cells were 
still viable after the electroporation. Cells from the other tubes were plated on M-17 erm 
(3 µg/ml) plates and incubated at 28 °C. After 72 hr colonies were observed on some of 
the plates, and they had mixed phenotypes. Some of the colonies were whiter in color 
than the wt-L. lactis colonies and some of them were not round as the wt-L. lactis cells. 
Nine of the colonies that looked like L. lactis 11454 were streaked onto M-17 plates with 
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a higher concentration of erm (5 µg/ml) and incubated overnight at 28 °C. Also, a master 
plate was prepared by griding the cells onto M-17 erm (3 µg/ml) to keep track of the 
colonies. All of the clones grew on these plates but some of the colonies were varied 
considerably in size, some of them larger than average, and some of them smaller than 
average. 
 
Part II-2.   Testing the integration of pGh9USR into the chromosome of L. lactis 11454. 
 One of the clones was chosen to test whether integration of pGh9USR into the 
chromosome of L. lactis 11454 had occured. With a sterile loop, some of the cells were 
scooped out from the master plate and resuspended in 300 µl of M-17 medium. The cells 
were incubated at 30 °C for an hour. Then 50 µl of the undiluted and 1/10 diluted cells 
were spread onto two M-17 erm (5 µg/ml) plates. One plate with diluted and one plate 
with undiluted cells was incubated at 37 °C and the other two plates with diluted and the 
undiluted cells were incubated at 28 °C overnight. The cells that had integrated the 
plasmid pGh9USR into its chromosome should survive at 37 °C and thus be resistant to 
erm. However, the ones that have the plasmid in the cytoplasm will not be viable because 
the plasmid has no active origin of replication. The following morning, the density of the 
growth on the surface of the plates was compared. It was not possible to compare the 
plates to which the undiluted cells were spread since the colonies were too dense. 
However, less growth was observed with the 1/10 diluted plate that was incubated at 37 
°C when compared with the one incubated at 28 °C. This was the expected result since 
the chance of integration of the plasmid into the chromosome is less than the plasmid just 
transforming into the cytoplasm of the cell. To further confirm the integration of 
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pGh9USR into the chromosome of L. lactis 11454, chromosomal DNA from the two of 
the recombinant colonies were isolated (Materials and Methods Part II-5, 5-2) and 
digested with 4 different restriction enzymes (Xho I, Hind III, Kas I, Sac I). The 
digestions were run on a 0.8 % agarose gel and then blotted onto a nitrocellulose paper 
(Materials and Methods Part II-15, 15-2). This Southern blot was then hybridized with a 
32P end labeled probe (Table 3) against upstream sacR region to see if there was any shift 
in the appearance of the band containing the upstream sacR region due to the 
incorporation of the plasmid into the chromosome. A slight shift was observed in the SacI 
restriction pattern of the 2 of the recombinant DNA tested. This recombinant strain was 
called L. lactis 11454erm. 
 
Part II-3.   Transformation of L. lactis 11454erm into B. subtilis SYcat and testing the 
expression of peptides. 
Chromosomal DNA from L. lactis 11454erm was isolated and transformed into 
competent B. subtilis SYcat cells as described in Materials and Methods Part II-13, 13-3. 
The transformants were selected on PAB erm (5 µg/ml) plates. 15 colonies were 
observed after incubating the plates at 37 °C for 24-48 hr. The transformants were 
gridded onto a PAB erm (5 µg/ml) plate with the help of a sterile toothpick (to keep as a 
master plate) and then onto PAB-Cm (10 µg/ml) plate at an identical position to select for 
the disappearence of the cat gene as a result of the recombination. Six of the transformant 
strains were sensitive to choloramphenicol (Materials and Methods Part II-19). The Cm 
sensitive recombinant strain was called B. subtilis SYerm. These transformants were 
grided onto a PAB plate along with B. subtilis SYcat to do a halo assay as described in 
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Materials and Methods Part II-24. There was not any difference between the halos 
formed around the original and the transformant strains. This was just a preliminary test 
and the conditions on the plate might not represent how the bacteria behave in the culture 
medium. Thus, the recombinant strain was tested for the expression of peptides as 
described in Materials and Methods Part II-20. The B. subtilis SYerm was cultured in 
Medium A for 28 hr. The hydrophobic peptides from the culture supernant were purified 
on a HIC column (Materials and Methods Part II-21) and then the eluate was resolved on 
RP-HPLC (Materials and Methods Part II-22). The fractions were analyzed with a spore 
outgrowth inhibition assay (Figure 8) and then all the fractions were analyzed with 
MALDI-TOF MS to detect the molecular weight of the peptides present in these 
fractions. As confirmed from the mass spectra of the fractions, the activity observed in 
the halo assay was due to the production of sublancin. Sublancin was another lantibiotic 
naturally produced by B. subtilis 168. The characteristics of nisin halo, which leaves all 
clear zones, were also different from the ones observed in figure 8. No other mass peaks 
were identified that might be belong to nisin or nisin variants. Since neither nisin nor the 
nisin variants were detected with the halo assay and MALDI-TOF MS analysis, a 
Southern blot was performed on five of the Cm sensitive recombinant clones obtained as 
a result of transformation of L. lactis 11454erm into B. subtilis SYcat. The chromosomal 
DNA was isolated from these clones (Materials and Methods Part II-5, 5-1) and three sets 
of DNA were digested with Hind III. The digestions were run on a 0.8% gel and blotted 
onto three nitrocellulose papers as described previously. Each of the blots was hybridized 
with three different probes end labeled with 32P (Materials and Methods Part II-16, 16-1). 









Figure 8.   Analysis of the purified culture supernatant from B. subtilis 
SYerm with halo assay. 
The extracellular materials from the culture supernatant of a 28 hr Medium A culture of 
B. subtilis SYerm were isolated by HIC and RP-HPLC as previously described. The 
fractions from the RP-HPLC was tested for biological activity by halo assay against 
outgrowing B. cereus T spores. Activity was observed at fractions 12, 13, and 14 as seen 
above which belonged to anti microbial peptide sublancin. The sublancin slightly comes 
early out of the column because a different RP-HPLC column (4.6 mm x 150 mm 
ZORBAX 300 Extend C-18 column with 5 µm pore size) was used only in this 
experiment.  
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th the blots (See Table 3 for the sequence of the oligonucleotide probes). No signal was 
served in any of these blots. This was not expected since it was hard to explain the 
appearance of the cat gene without a double crossover taking place unless the colonies 
re contaminants. The limited genetic tools for L. lactis were one of the main reasons of 
ing to express nisin genes in B. subtilis. The problem in this case was most likely to be 
ated to the inefficient transformation of the plasmid into L. lactis 11454. This result 
owed that the selection approach that did not involve manipulations to L. lactis cells 
uld be a better choice. 
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Table 3.   PCR primers for upstream sacR homology region and 
hybridization probes for nisA, nisG, and nisI genes. 
Oligonucleotides SYUSRf and SYUSRr were used in the construction of pCR2.1USR. 
SYNISAh was used to detect the nisAgene, SYNISGh was used to detect nisG gene, and 
SYNISIh was used to detect nisI gene. 
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Part III.   Selection of transformants integrating the nisin gene cluster by two-step  
recombination in B. subtilis SYcat. 
Summary of the approach: 
 This strategy was modified so that genetic manipulations would not need to be 
performed with the L. lactis DNA. The strategy employed a plasmid with temperature 
sensitive origin of replication. This plasmid would be transformed and propogated in the 
recipient B. subtilis strain which would then be transformed with L. lactis DNA. 
Recombination sites would be present in the chromosome so that it would be able to 
integrate the nisin gene cluster. Then a second recombination in the cytoplasm will be 
established with the integration of the plasmid into the B. subtilis chromosome. The 
recombination site for the plasmid containing the selection gene will be present in the 
chromosome only if the first recombination with the L. lactis DNA did take place. The 
cells would then be subjected to the non-permisive temperature. Since the plasmid would 
stop replicating, the only way a cell could survive on antibiotic selection is to integrate 
the plasmid. A detailed description of the strategy was illustrated in Figure 9 and 
explained in the below section.  
 
Part III-1.   Transformation of temperature sensitive plasmid pGh9USR into B. subtilis 
SYcat. 
 Competent B. subtilis SYcat was prepared and efficiently transformed with 
pGH9USR as described in Materials and Methods Part II-13, 13-3 except the cells were 
incubated at 28 °C instead of 37°C then the cells containing the plasmid were selected at  
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28 °C by spreading on PAB-erm (5 µg/ml) plates. The permissive temperature was used 
for selection because the plasmid cannot integrate into the chromosome since there is not 
any homology between them. The strain containing the plasmid was then made 
competent and transformed with wt- L. lactis chromosomal DNA as described previously 
except the cells were incubated at 2 hr at 28 °C instead of 37 °C and at the end of this 
period cells were diluted to 500 ml with PAB. Also a control experiment was set up 
where no L. lactis chromosomal DNA was added to the competent B. subtilis SYcat cells. 
Then the incubation continued at 28°C overnight in the presence of 5 µg/ml erm to allow 
time for the 2 consecutive recombination events that were described above to take place. 
The next morning, 50 ml of the culture was again diluted with 500 ml PAB supplemented 
with 5 µg/ml erm and incubated at non-permisive temperature (37 °C), in order to get rid 
of non-transformant cells. The OD600 of the two cultures were monitored and recorded as 
seen in below. An aliquot was taken from the  
4hr  7.5 hr  18 hr
OD600 Control  0.32  0.60  1.09 
OD600 Sample  0.32  0.85  1.09 
sample after 7.5 hr and serially diluted to 10-8 and then 10-4, 10-6, 10-7 and10-8 dilutions 
were spreaded on PAB-erm (5 µg/ml) plates. The colonies from the sample plate were 
then grided on Cm containing PAB plates to see if any of the transformants were Cm 
sensitive. 1000 cells were screened, however none of the erythromycin resistant clones 
were sensitive to chloramphenicol. It was possible that after all, the recombination was 
not efficient enough to produce a double recombinant. Nisin gene cluster was a relatively 
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Figure 9.   Strategy for construction of the recombinant strain B. subtilis 
SY2erm. 
A schematic representation of the strategy to construct the recombinant strain B. subtilis 
SY2erm. Competent B. subtilis SYcat cells were prepared and pGH9USR was 
transformed as described in Materials and Methods Part II-13, 13-3 except the cells were 
incubated at 28 °C since the plasmid did not have any homology to the chromosomal 
DNA. Then the chromosomal DNA from L. lactis 11454 was isolated (Materials and 
Methods Part II-5, 5-2 and transformed into B. subtilis SYcat (Materials and Methods 
Part II-13, 13-3). First the cells were incubated at 28 °C to allow the recombination 
between two chromosomal DNA through homology at transposase and sacR and then 
with the pGh9USR through upstream sacR homology region. Then the temperature was 
raised to 37 °C to select for the transformants that had integrated plasmid into the 
chromosome. The last step shows the single crossover that could take place between the 
pGh9USR and B. subtilis SYcat forming the recombinant strain B. subtilis SY2erm. 
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order to get sufficiently efficient recombination, it will be necessary to increase the copy 







Part IV.   Using PCR to amplify the nisin gene cluster and integrate the nisin genes into 
B. subtilis 168. 
With today’s technology, robust enzymes that are claimed to be able to amplify 
DNA sequences up to 40 kb in length with high fidelity are available. By using one these 
commercially available enzymes, it would perhaps be possible to amplify nisin gene 
cluster from L. lactis 11454 genomic DNA and clone this into a plasmid and then 
transform into B. subtilis BR151. Since every transformed cell would contain a copy of 
the nisin gene cluster, the chance of recombination would be greatly enhanced. This new 
strategy was developed to increase the chance of recombination. The outline of the 
strategy was illustrated in Figure 10. The plasmid containing the cloned nisin genes 
(pCR2.1nisin) was ligated to another plasmid containing the cat gene and a single 
homology region from amyE gene of B. subtilis 168. A single homology region was 
placed to integrate the final plasmid into the chromosome of B. subtilis 168 with 
Campbell integration because single recombination tends to be more efficient than the 
double recombination. This strategy also eliminates the competition by extraneous L. 
lactis genomic DNA. 
 
Part IV-1.   PCR of nisin gene cluster and cloning into pCR2.1 vector. 
 To implement this strategy the 14 kb nisin genes were amplified from the L. lactis 
11454 chromosome (Figure 11) as described in Materials and Methods Part II-10, 10-2. 
The primers used were listed in Table 4. An aliquot of the amplified DNA was run on a 
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Figure 10.   Construction of pSY2cat and integration of nisin genes into the 
hromosome of B. subtilis BR151. 
 schematic representation for the construction of pSY2cat and the integration of nisin 
enes into the B. subtilis BR151 chromosome. The nisin gene cluster was amplified from 
. lactis 11454 chromosome as described in Materials and Methods Part-II, II-10 and 
hen cloned into pCR2.1 AT cloning vector forming plasmid pCR2.1nisin. Another 
ector, pEZamycat, was constructed by ligating the 527 bp amyL EcoRI fragment from 
CR2.1amyL into the EcoRI site of pEZcat. Then both pEZamycat and pCR2.1nisin was 
igested with XhoI and ligated to each other forming the final construct, pSY2cat. This 
onstruct was then transformed into B. subtilis BR151. The chloramphenicol resistant 
ecombinant strain was formed with the integration of the whole plasmid into the amyE 
ene of B. subtilis BR151. The new strain was named B. subtilis SY2cat. 
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the correct molecular weight and was free of non-specific products. Amplified DNA was 
directly ligated into pCR2.1 vector and then transformed into E. coli INVαF′ cells 
(Materials and Methods Part II-). It was possible to do AT cloning since the PCR enzyme 
being employed has the ability to add non-specific adenosine residue to the 3’ end of the 
amplified sequence just as Taq polymerase does. Twenty clones were analyzed with the 
XhoI digestion. Nine of the clones gave the expected band at 18 kb (vector + nisin gene 
cluster) when linearized. These clones were further analyzed with EcoRI and EcoRV 
digestions to see if the fragments matched the expected digestion pattern obtained from 
the restriction map of the nisin gene cluster (Figure 12). Also, PCR was performed to see 
if the 1.5 kb region that contains the nisA gene could be amplified from these nine 
transformants. This region was amplified from eight of the plasmid DNA. The clone 
giving the best match (pCR2.1 nisin) for the restriction enzyme digest patterns was 
chosen to clone (clone #6) into the pEZamycat. This plasmid contained a single 
homology region to the amyE gene to integrate the construct through single crossover as 
previously discussed. The plasmid pEZamycat was constructed by subcloning the amyL 
homology region from pCR2.1AL (Results Part I-1) into pEZcat. The resultant plasmid, 
pEZamycat was ligated to the linearized pCR2.1nisin. The final vector was called 
pSY2cat and transformed into B. subtilis BR151 (Figure 10). Transformants were 
selected on chloramphenicol containing plates. 8 colonies that were resistant to Cm were 
obtained. The transformants were tested with halo assay and colonies producing the 
bigger halos were further tested for sensitivity to nisin with incubating the cells in various 
concentrations of nisin. The colony producing the best result was chosen and named B. 






























Figure 11.   PCR of nisin genes from L. lactis 11454. 
The picture shows the 5 µl aliquot of the PCR product that was run on a 0.8 % agarose 
gel along with the size standard, λ DNA EcoRI digest. The conditions for amplifying the 
nisin genes from L. lactis with PCR was described in Materials and Methods Part-II, II-
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Figure 12.   Restriction enzyme analysis of the pCR2.1nisin clones. 
R amplified nisin genes were cloned into pCR2.1 and transformed into E. coli INVαF′ 
lls. The plasmid DNA was isolated from transformants (Materials and Methods Part II, 
9) and analyzed with EcoRI and EcoRV restriction enzyme digestions (Materials and 
ethods Part II, II-9) for the presence of expected band patterns. A lot of variation was 
served within the clones. Panel A shows the transformant plasmid DNAs digested with 
 EcoRI. From the restriction map of nisin genes in L. lactis11454 and the plasmid 
R2.1, the bands at 1310 bp, 1979 bp, 2917 bp, 3660 bp, 3900bp and 4078 bp were 
pected. Most of the bands were observed at clone #6 except the band at 2917 bp, and 
 bands at 3660 bp and 3900 bp probably could not be resolved on the 0.8% gel. Panel 
shows the transformant plasmid DNAs digested with EcoRV. The bands were expected 
7687 bp, 5900 bp, 2289 bp, 1319 bp and 706 bp. Clone #6 again gave the best match to 
 expected pattern. However, the band at 5900 bp was missing and the band at 7687 
s bigger than expected.  
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Part IV-2.   Testing the expression of nisin from B. subtilis SY2cat. 
 B. subtilis SY2cat was cultured in Medium A for 28 hr as described in Materials 
and Methods Part II-15 to test the expression of nisin. Nisin expression is under the 
control of a response regulator that senses the presence of extracellular nisin and switches 
on the promoter to start the transcription (Introduction Part-V). A similar requirement 
could possibly be necessary for the expression of nisin genes from B. subtilis. The 
amount needed to turn on the system was relatively small for L. lactis, however, it has 
been reported that nisin sensitivity vary significantly, even between members of the same 
species (2). Scott et. al (22) had found out that there is considerable variation in nisin 
sensitivity among S. pyogenes, S. agalactiae, S. pneumoniae, B. subtilis, and E. faecalis. 
When they had tested the nisA promoter driven expression in these organisms, they 
observed the greatest induction from the nisA promoter when nisin was added to the 
culture with a concentration just below the inhibitory level and it was 20 µg/ml for B. 
subtilis168. 
Two cultures were set up to test the nisin production from the B. subtilis SY2cat. 
One of the 5 ml overnight cultures were grown in the presence of 10 µg/ml 
choloramphenicol and the other with 20 µg/ml nisin. The next morning, these cultures 
were used to inoculate flasks containing 500 ml medium A and incubated for 28 hr. The 
culture supernatants were applied to a HIC (hydrophobic interaction column) as 
described in Materials and Methods Part-II, II-21. The eluate was then resolved on RP-
HPLC (Materials and Methods Part-II, II-22) and the fractions were tested for biological 
activity against outgrowing B. cereus T spores (Figure 13). All the fractions were also 
analyzed with MALDI-TOF MS. No differences were observed in the spectra of the 
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fractions between these two cultures (Figure 13). The activities observed at the halo 
assays were found to be related to another anti-microbial peptides subtilosin (m= 3398.9 
Da) that is naturally produced by wt-B. subtilis BR151. There were not any other 
unidentified peaks. Possible reason of not finding any nisin peak could be the errors 
introduced into one or more nisin genes, which were essential for nisin biosynthesis, 
during the PCR. Although the long PCR enzymes were claimed to be high fidelity up to 
40 kb, within the 20 clones analyzed there were a lot of variations in the length of the 
insert and the restriction digest patterns. The clone that had been integrated into the 
chromosome also lacked at least one observable band at each digestion, and since the 
resolving power of the agarose gel was not very good, each band was not always clearly 
identifiable. These size discrepancies suggest that there could be a severe fidelity 
problem during the PCR amplification of the L. lactis DNA. It was concluded that a new 
strategy should avoid the use of PCR amplification. The next section describes the 





























Figure 13.   Analysis of the purified culture supernatant from B. subtilis 
2cat with halo assay and MALDI-TOF MS. 
 subtilis SY2cat was inoculated into 5 ml PAB media in the presence of 20 µg/ml nisin 
ft plate) or 10 µg/ml Cm (right plate) and were cultured overnight. These 2 cultures 
re used to inoculate a seperate 500 ml Medium A media and incubated for 28 hr 
aterials and Methods Part II-20). The culture supernatant was analyzed by HIC and 
-HPLC as previously described. The fractions from the RP-HPLC was tested for 
logical activity by halo assay against outgrowing B. cereus T spores as previously 
scribed. Activity was observed at fractions 12-14 in the nisin added culture and 13-17 
the Cm added culture as seen in Panel A. All the fractions were analyzed with 
ALDI-TOF. There was only sublancin in fractions 12-14. Panel B shows the MALDI-
F MS spectra of fractions 16 through18 obtained from the nisin added culture. Panel C 
ows the MALDI-TOF MS spectra of fraction fractions 16 through18 obtained from the 
 added culture. Both of them gave a peak at m/z=3400 which belongs to another 
timicrobial peptide subtilosin (m=3398.9 Da). 
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A λ library of L. lactis 11454 was created by cloning the Bgl II digested genomic 
NA into Lambda GEM®-11 genomic cloning vector as described in Materials and 
ethods Part II-8. As described there, the entire nisin gene cluster is contained within a 
ingle Bgl II fragment and the Bgl II sites are located about 600 bp upstream and 
ownstream of the cluster, respectively. The plaques were hybridized with the end 
abeled probe against nisA, nisin structural gene. 11 filters, each containing 
pproximately 100 plaques were hybridized with the nisA probe (Table 3), and about 25 
f them gave positive signals. The calculated λ library base was 25,000 independent λ 
lones. λ DNA was isolated from two of the positive clones, clone #2 and clone #3, and 
igested with four different restriction enzymes. When the Southern blot of the gel was 
ybridized with a radiolabeled nisA probe, the structural gene was observed at the 
xpected molecular weight bands in both of the clones as shown in Figure 14. The clone 
2 was named λnisin and digested with Xho I to release the nisin gene cluster (16.5 kb 
ragment), which was then cloned into 2 different shuttle vectors. 
art V-1.   Cloning of nisin genes into pLPvcat and integration into the B. 
ubtiliserm∆sunA chromosome. 
The shuttle vector pLPvcat was constructed and kindly provided by Leena Paul 
62). It was used to clone fragments into the sublancin locus of B. subtilis 168. It was 
esigned to have homology regions to upstream and downstream regions of the sunA 
















































































































































































































ster with agarose gel electrophoresis and Southern blot. 
ique restriction sites (EcoR I, Sac I, Xho I) were chosen from the multipurpose cloning 
e of Lambda GEM®-11 vector to digest the clones containing the nisin gene cluster and 
n the digested DNA were run on a 0.8% agarose gel as seen above (A). The observed 
nds were compared with the expected pattern that was deduced from the sequence of 
in gene cluster. The blot of the gel (B) was hybridized with a 32P end labeled nisA 
obe to confirm the nisA gene appeared at the expected positions. Xho I and Bgl II sites 
re not present in the nisin gene cluster so the nisA gene appeared in the 16 kb 
gment. However, Sac I digested the nisin gene cluster into 4 fragments (1444,1265, 
6, 12936 bp respectively) and the nisA appeared in the 1444bp fragment as anticipated. 
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Figure 15.   Construction of pSYNcat and integration of nisin gene cluster 
nto the chromosome of B. subtiliserm∆sunA. 
 Bgl II genomic library of L. lactis 11454 was constructed in Lambda GEM®-11 cloning 
ector as described in Materials and Methods Part II-14. Plaques containing the nisin 
ene cluster was identified by hybridizing with the 32P end labeled nisA probe. The DNA 
as isolated from the positive plaques and digested with Xho I to release the nisin gene 
luster. Then the fragment was cloned into Xho I digested pLPVCat cassette vector. The 
esulting plasmid, pSYNcat, was transformed into B. subtiliserm∆sunA. The 
hloramphenicol resistant, erythromycin sensitive double recombinants were selected as 
escribed in Materials and Methods. The resulting strain was named B. subtilis SYNcat. 
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subtilis 168 chromosome. It contains cat gene as a selection marker. The nisin gene 
cluster was cloned into the Xho I site of pLPvcat as illustrated in Figure 15. The 
transformants were screened with colony hybridization using the nisA probe. Positive 
clones, containing the plasmid pSYNcat were then screened by using several restriction 
enzyme digestions. Once characterized, the plasmid was transformed into B. subtilis 
erm∆sunA and transformants were selected on chloramphenicol. B. subtilis erm∆sunA is 
a strain derived from B. subtilis 168 by replacing the sunA gene with the erm gene (62). 
To identify the single-crossover and double-crossover recombinants, transformants were 
grided on erythromycin and chloramphenicol containing plates (Materials and Methods 
Part II-19). The ones with a single crossover were resistant to both chloramphenicol and 
erythromycin. The ones with a double crossover were resistant to chloramphenicol and 
sensitive to erythromycin since the erm gene was deleted by the recombination.  
 By this criterion, one of the 14 transformants was found to be a double 
recombinant. Chromosomal DNA from 4 of the transformants was isolated and 
hybridized with the probe generated from λnisin (bacteriophage λ containing the nisin 
gene cluster) DNA by random primer extension in the presence of α-32P labeled dCTP. 
Only the clone containing the double recombinant DNA gave a positive signal (Figure 
16). This new strain that appeared to contain the nisin gene cluster integrated into the 
sublancin locus was named B. subtilis SYNcat. The ability of this strain to express nisin 
was determined as described in Materials and Methods Part II-20. The supernatant of the 
culture was purified on an HIC column (Materials and Methods Part II-21) and the 
peptides were resolved on RP-HPLC (Materials and Methods Part II-22). The fractions 
























































































Figure 16.   Analysis of pSYNcat transformants with Southern blot. 
The shuttle vector pSYNcat was transformed into B. subtilis erm∆sunA and the 
transformants integrating the nisin gene cluster was selected on chloramphenicol plates. 
The DNA was isolated from the 4 chloramphenicol resistant, erythromycin sensitive 
recombinants (double crossovers), digested with EcoR I and run on a 0.8% agarose gel. 
The gel was blotted on a nitrocellulose paper and then hybridized with a randomly 
labeled λnisin (bacteriophageλ DNA containing the nisin gene cluster) DNA with α-32P. 

















Figure 17.   Analysis of the purified culture supernatant from B. subtilis 
YNcat with halo assay and MALDI-TOF MS. 
he extracellular materials from the culture supernatant of a 28 hr Medium A culture of 
. subtilis SYNcat were isolated by HIC and RP-HPLC as previously described. The 
ractions from the RP-HPLC was tested for biological activity by halo assay against 
utgrowing B. cereus T spores as previously described. Activity was observed at 
ractions 17 and 18 as seen in Panel A. All the fractions were analyzed with MALDI-
OF. Fractions #17 and 18 produced the same spectrum. Panel B shows the MALDI-
OF MS spectra of fraction #18. 
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Part II-24). Clear zones were observed at fraction 17 and 18 where usually nisin comes 
out of the same column under the same conditions (Figure 17). MALDI-TOF MS was 
used to further analyze the all the peptide containing fractions. None of the observed 
molecular weight peaks matched the molecular weight of nisin (m/z = 3354). The activity 
observed at fraction #17 and #18 had the characteristics of nisin halo, which leaves very 
clear zones of inhibition. Also, the peptide producing the activity had the same 
chromatographic properties of nisin but had a lower molecular weight. It is therefore 
possible that this peak is a degradation product of nisin. The differences in the molecular 
weights might also result from an incompletely processed or aberrantly modified 
degradation product of nisin. 
 
Part V-2.   Cloning of nisin genes into pCR2.1 and integration into the B. subtilis SYcat 
chromosome. 
 Another shuttle vector, pSYNE was created to integrate the nisin gene cluster into 
the amy E locus of B. subtilis BR151 (Figure 18). An erythromycin resistance gene, erm, 
was introduced into the pCR2.1 cloning vector and then the nisin gene cluster was cloned 
into the Xho I site of this plasmid. Resulting plasmid was named pSYNE. Then it was 
transformed into B. subtilis SYcat that contains the transposase and sacR homology 
regions. The Campbell integrants containing the nisin gene cluster were selected on 
erythromycin containing plates. Then the presence of the nisin gene cluster was 
confirmed with hybridization of chromosomal DNA with the α-32P labeled λnisin (Figure 
19). The restriction pattern of the DNA digests did not gave the same fragmentation 
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Figure 18.   Cloning of nisin genes into pCR2.1 and integration into the B. 
ubtilis SYcat chromosome. 
 schematic representation for the construction of pSYNE and the integration of nisin 
ene cluster into the chromosome of B. subtilis SYcat was shown above. The erm gene 
as cloned into the BamH I site of pCR2.1 forming the plasmid pCR2.1erm and the Xho 
 fragment from λnisin was cloned into pCR2.1erm. The resulting plasmid, pSYNE, was 
ransformed into B. subtilis SYcat. The nisin gene cluster was integrated into the 
































































































































Figure 19.   Analysis of pSYNE transformants with Southern blot. 
The plasmid pSYNE was transformed into B. subtilis SYcat and the transformants 
containing the nisin gene cluster was selected on erythromycin containing plates. The 
DNA was isolated from four of the transformants and digested with EcoR I and Hind III 
and run on a 0.8% agarose gel. The picture shows the Southern blot of this gel. All four 
of the transformants gave a positive signal when hybridized with the randomly labeled 











Figure 20.   Analysis of the purified culture supernatant from B. subtilis 
SYNEC with halo assay and nanoESI MS. 
The extracellular materials from the culture supernatant of a 28 hr Medium A culture of 
B. subtilis SYNcat were isolated by HIC and RP-HPLC as previously described. The 
fractions from the RP-HPLC was tested for biological activity by halo assay against 
outgrowing B. cereus T spores. Activity was observed at fractions 15, 16 and 17 as seen 
in Panel A. All the fractions were analyzed with nanoESI MS. When the spectra were 
screened for nisin or nisin species, nothing was observed. Fractions 15, 16 and 17 
produced the same MALDI-TOF MS spectra. Panel B shows the nanoESI MS spectra of 
fraction #16. A triply charged peak at 929.1 and doubly charged peak at 1394.4 was seen. 
The calculated molecular weight from both of these peaks corresponds to molecular 
weight peak of sublancin (3877.8 Da). 
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The new strain was named B. subtilis SYNEC and tested for expression of the nisin gene 
cluster by culturing in medium A for 28 hr (Materials and Methods Part II-20). The  
supernatant of the culture was purified on an HIC column (Materials and Methods Part II-
21) and the peptides were resolved on RP-HPLC (Materials and Methods Part II-22). The 
fractions were tested for biological activity with the halo assay (Materials and Methods 
Part II-24). Activity was observed at fraction #15, #16, and slightly at #17 (Figure 20). 
However, these halos had ingrowth, which was the characteristic of sublancin halos. 
Sublancin is an anti-microbial peptide naturally produced by B. subtilis 168. Further 
analyis with MALDI-TOF MS spectra proved the presence of only sublancin at these 
fractions and any nisin or nisin species could not be detected in the other fractions when 
analyzed with mass spectroscopy. Sublancin was produced in large quantities in B. 
subtilis 168, which might have suppressed the peaks belonging to the nisin or nisin 
variants if present any. 
 
Part V-3.   Transfer of nisin gene cluster into B. subtilis BE1010. 
 In order to explore the possibility that the activity isolated from the culture 
supernatant of B. subtilis SYNcat consisted of nisin degradation products, the nisin gene 
cluster was transformed into B. subtilis BE1010. This was achieved by transforming the 
chromosomal DNA isolated from B. subtilis SYNEC into B. subtilis BE1010. Strain 
BE1010 is a derivative of B. subtilis 168, which lacks all the major proteases. The 
transformants were selected on chloramphenicol followed by gridding onto plates 
containing erythromycin. They retained both of the antibiotic selection markers as 
expected for these transformants. The efficiency of the recombination was very high due 
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to the extensive homologies between the two chromosomes. Assays were performed on 
several dozen of the transformants and the several clones that gave relatively large halos 
were selected for further analysis. The chromosomal DNA was isolated and presence of 
the nisin gene cluster was confirmed by hybridizing with λnisin DNA that was labeled by 
random primer extension in the presence of α-32P labeled dCTP. The new strain was 
called B. subtilis SY20N. This strain was cultured to test for nisin expression as described 
in Materials and Methods Part II-20. Also, wt-B. subtilis BE1010 was cultured the same 
way as a control. The extracellular materials from the culture supernatants were analyzed 
either by using HIC (Materials and Methods Part II-21) or non-ionic cellulose (NIC) 
column (Materials and Methods Part II-23) and the eluate was then resolved on RP-
HPLC (Materials and Methods Part II-21). The fractions were tested for biological 
activity using the halo assay (Materials and Methods Part II-23). Non-ionic cellulose 
columns were also used to analyze the culture supernatants because it was discovered by 
Amer Villaruz, a former lab member, that nisin has a strong affinity for non-ionic 
cellulose. He was able to isolate nisin from the culture supernatant of L. lactis 11454 in a 
highly pure form by using a non-ionic cellulose column (83). When the peptides from the 
culture supernatant of wt- B. subtilis BE1010 (protease deficient strain) were purified on 
NIC column and then resolved on RP-HPLC, the biological activity was observed in 
fraction #15 and #16 (Figure 21). NanoESI MS analysis of these fractions produced a 
triply charged molecular ion at m/z= 1293.6 (m= 3877.8 Da) which also correspond to the 
anti-microbial peptide sublancin (m= 3877.8 Da) (Figure 21). When the culture 










Figure 21.   Analysis of the purified culture supernatant from B. subtilis 
BE1010 with halo assay and nanoESI MS. 
The extracellular materials from the culture supernatant of a 28 hr Medium A culture of 
B. subtilis BE1010 were isolated by NIC column and RP-HPLC as previously described. 
The fractions from the RP-HPLC was tested for biological activity by halo assay against 
outgrowing B. cereus T spores as previously described. Activity was observed at 
fractions 15 and 16 as seen in Panel A. All the fractions were analyzed with nanoESI MS. 
Fractions 15 and 16 produced the same spectrum. Panel B shows the nanoESI MS spectra 
of fraction #16. A triply charged peak at m/z=1293.6 was seen. The calculated molecular 
































Figure 22.   Analysis of the purified culture supernatant from B. subtilis 
Y20N with halo assay and nanoESI MS. 
he extracellular materials from the culture supernatant of a 28 hr Medium A culture of 
. subtilis SY20N were isolated by HIC and RP-HPLC as previously described. The 
ractions from the RP-HPLC was tested for biological activity by halo assay against 
utgrowing B. cereus T spores. Activity was observed at fractions #16 through 19 as seen 
n Panel A. All the fractions were analyzed with nanoESI MS. Panel B shows the 
anoESI MS spectra of fraction #16. Fraction #16 had a triply charged peak at 
/z=1293.4. The calculated molecular weight from this peak corresponds to molecular 
eight of sublancin (3877.8 Da). Panel C shows the nanoESI MS spectra of fraction and 
18. A triply charged peak at m/z=929.1 (m=2784.3 Da) and doubly charged peak at 
/z=1392.1 (m=2782.2 Da) as seen. The calculated molecular weight from these two 

























Figure 23.   Analysis of the purified culture supernatant from B. subtilis 
BE1010 with halo assay and MALDI-TOF MS. 
The extracellular materials from the culture supernatant of a 28 hr Medium A culture of 
B. subtilis SY20N were isolated by HIC and RP-HPLC as previously described. The 
fractions from the RP-HPLC was tested for biological activity by halo assay against 
outgrowing B. cereus T spores. Activity was observed at fractions 14 through 18 as seen 
in Panel A. All the fractions were analyzed with MALDI-TOF. When the spectra were 
screened for nisin or nisin species, nothing was observed. Fractions 14, 15 and 16 
produced the same MALDI-TOF MS spectra. Panel B shows the MALDI-TOF MS 
spectra of fraction #16. A singly charged peak at m/z=3878.8. Panel C shows the 
MALDI-TOF MS spectra of fraction #18. A singly charged peak at m/z= 2784.52 was 
observed which belongs to an unknown species. 
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HPLC, the activities were observed at fractions #16 through #19 (Figure 22). When the 
fraction #16 was further analyzed with nanoESI MS, a triply charged molecular ion was 
observed at m/z=1293.4 (m=3877.2 Da) (Figure 22) which also corresponded to 
sublancin. However, when fractions #17-19 were analyzed with nanoESI MS, a triply 
charged molecular ion at m/z = 929.0 was observed which belongs to an unidentified 
species at 2782 Da. Even though this species produced clear halos that were similar to 
nisin halos, the molecular weight could not be rationalized as degradation products of 
nisin. Interestingly, the chromatographic characteristics of this peptide were the same as 
nisin. The culture supernatant from wt-B. subtilis BE1010 was also analyzed by using 
HIC and then RP-HPLC column. The activities were observed at fractions #14 through 
#18 (Figure 23) when tested with the halo assay. The MALDI- TOF MS analysis of 
fractions 14-16 produced a singly charged molecular ion at m/z=3878.8 (m=3877.8 Da) 
(Figure 23). This corresponded exactly to the molecular weight of sublancin. However, 
the MALDI-TOF MS analysis of fractions #17 and #18 produced a singly charged peak 
at m/z=2784.52 (m=2783.5 Da). This shows that the wild type protease deficient strain 
was producing the same active peptide as the recombinant strain containing the nisin 
gene cluster (SY20N). As a result, the activity isolated from B. subtilis SY20N was not 
related to any nisin degradation products. 
 
Part V-4.   Cloning of the A2 promoter sequence upstream from the nisin gene cluster in 
B. subtilis SYNcat. 
 The expression from nisin structural gene, nisA, is controlled by its own promoter 
in L. lactis. Expression from this promoter is under the control of a two-component 
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response regulatory system in which nisin, itself, is the inducer of expression. The system 
is accordingly turned on in the presence of subinhibitory levels of nisin (Introduction, 
Part I-5). It is possible that this regulatory system does not function in B. subtilis 168. If 
this is the case, cloning the constitutive A2 phage promoter upstream of nisA gene in B. 
subtilis SYNcat might restore the expression of the cluster. This promoter is known to 
function in B. subtilis 168. The construction of the cassette vector for integration of this 
promoter into the upstream of the nisin structural gene was outlined in Figure 24. The 
primers used in this part were listed in Table 4. The cassette vector was named 
pSYA2NE and transformed into B. subtilis SYNcat. 6 chloramphenicol (-) double 
recombinants were obtained out of the 400 transformants tested. These double 
recombinants are likely to have integrated the promoter into the upstream region of the 
nisin structural gene. The halo assay was performed on all of the double recombinants 
and some of the single-crossover recombinants colonies. Two of the double recombinants 
gave relatively bigger halos when compared with the host strain B. subtilis SYNcat 
suggests possible nisin production. In order to confirm the presence of promoter, PCR 
reactions were performed to amplify a 501 bp region in which the forward primer was 
originated within the promoter sequence and a 551 bp region in which the forward primer 
was originated in the upstream region of the promoter (Figure 25). The primers for this 
PCR reaction were listed in table 4. Both regions were successfully amplified from clone 
#10 by PCR, and no bands were observed in the control lanes (lanes 6-9) (Figure 25). 
Clone #10 was used in the later experiments since both regions were amplified 
successfully. Clone #10, which contains the A2 constitutive promoter, was named B. 
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Figure 24.   Construction of pSYA2NE and the integration of A2 promoter in 
ront of nisin gene cluster. 
 schematic representation for the construction of pSYA2NE and the integration of A2 
hage promoter in front of the nisA gene in the chromosome of B. subtilis SYNcat was 
hown above. The 646 bp homology region, upnisA, was amplified from the upstream 
isA region of L. lactis 11454 by PCR (see table 4 for primers) and cloned into pCR2.1 
y AT cloning. The PCR conditions were described in Materials and Methods, Part II-10, 
0-1. Several modifications were made to the indicated conditions. The annealing was 
erformed at 60 °C for 30 sec and the extension was carried out at 70 °C for 2.5 min. The 
umber of cycles was decreased to 25. The reaction volume was decreased to 50 µl while 
eeping the concentrations of components same except the final primer concentration 
as doubled to 0.5 µM. Then the upnisA fragment was cloned into the pA2trpA vector 
y using BamH I and EcoR I right after the A2 promoter. The A2promoter and the 
pnisA homology region was then amplified with PCR (see table 4 for primers) from the 
lasmid pA2upnisA. The amplified fragment was cloned into pCR2.1, making the 
lasmid pCRA2upnisA The changes described above were also made to this PCR 
eaction except the annealing temperature was 72 °C and the 0.25 µM final primer 
oncentration was maintained. The erm gene was cloned into the BamH I site of 
LPVCat to form the pLPerm. Then the plasmid pCRA2upnisA and pLPerm was both 
igested with the Xho I and Hind III and the A2upnisA fragment was ligated into the 
LPerm making the final construct pSYA2NE. This final construct was then transformed 
nto B. subtilis SYNcat. The double cross-overed strain, which integrated the erm gene 












































































































Figure 25.   Gel electrophoresis of control PCR reactions that were done to 
confirm the presence of A2 promoter in the transformants. 
The DNA was isolated from two of the double recombinants and PCR reaction was 
performed to see if the expected fragments could be amplified from the DNA of these 
transformants. Primer1 and 2, were originated from the promoter sequence and upstream 
of nisA gene, respectively (Panel B). Primer 3 and 4 were originated from the sunA gene 
and upstream of the nisA gene, respectively (Panel B). The first set of primers amplified 
the 501 bp region in clone #10 as expected but not in clone #14. The 551 bp region was 
amplified from both clone #10 and #14. No bands were observed when the wild type 
DNA was used. The PCR conditions were described in Materials and Methods Part-II, II-
10. Several modifications were made to the indicated conditions. The annealing was 
performed at 60 °C for 30 sec and the extension was carried out at 70 °C for 2.5 min. The 
number of cycles was decreased to 25. The reaction volume was decreased to 50 µl while 
keeping the same molar ratios of the components. 
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Methods Part II-20). The culture supernatant was then applied to a non-ionic cellulose 
column as described in Materials and Methods Part II-23 in order to recover any nisin. In 
parallel, nisin was isolated from supernatant of L. lactis11454 by using the non-ionic 
cellulose column. The eluates were then resolved on RP-HPLC and tested for biological 
activity with the halo assay (Materials and Methods Part II-24). The inhibition of spore 
outgrowth was observed at fractions 16, 17 and 18 of the purified peptides from the 
culture supernatants of both Lactococcus lactis 11454 (natural producer of nisin) and the 
B. subtilis SYA2NE (contains the nisin genes) (Figure 26). The halos obtained from the 
recombinant strain was bigger than the halos obtained from the natural producer even 
though the amount of starting culture was 0.5 l for B. subtilis and 1 l for L. lactis 11454. 
When these fractions were tested with MALDI-TOF MS the molecular weight peak of 
nisin (m/z = 3354) was observed in the active fractions isolated from L. lactis culture. 
However, a triply charged molecular ion peak at m/z= 929.1 (m=2784.3 Da) and a doubly 
charged peak at m/z=1392.4 (m=2782.8 Da) and a small triply charged peak at 
m/z=1855.6 (m=5563.8 Da) were observed from the culture of B. subtilis SYA2NE 
(Figure 26). When the mass of the molecular ion at 1855.6 was divided by 2, a mass 
equal that equals to 2781.9 was obtained. This argues the fact that this unidentified 
species is a dimer and each of the monomers weighs about 2782 Da. The B. subtilis 
erm∆sunA was also cultured for 28 hr at the same conditions (Materials and Methods 
Part II-20) to test the expression of the peptides from the wild type strain. The culture 
supernatant was purified on a NIC column and then eluates were resolved on RP-HPLC 
as previously described. The fractions were tested for biological activity with the halo 
assay (Materials and Methods Part II-24). The clear zones were observed at fraction #17, 
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18 and 19 (Figure 27). This was similar to the activity observed from the fractions 
obtained from B. subtilis SYA2NE culture supernatant. The fractions 17-19 were further 
analyzed with nanoESI-MS and the three fractions produced the same spectrum. Figure 
27 shows the mass spectrum of Fraction 18. The same peaks were observed in the active 
fractions of B. subtilis SYA2NE. The triply charged peak at m/z= 929.0 and 1856.2 and a 
doubly charged peak at m/z=1392.3. These peaks were also observed when the culture 
supernatants of wt-B. subtilis BE1010 were analyzed (Results Part V-3). Thus, the 
peptide producing the activity was present in the wild-type B. subtilis 168, and the 
presence of nisin gene cluster was not responsible for the production of these activities 
activity. Also, no nisin or nisin like peptide was observed when the purified peptides 
from the various recombinant strains containing the nisin gene cluster culture were 
analyzed with the mass spectroscopy.  
At this point there is strong evidence that the entire nisin gene cluster has been 
successfully transferred from the L. lactis chromosome, into B. subtilis 168 chromosome. 
Hence a major goal of the project has been achieved. However the presence of the gene 
cluster did not result in detectable nisin production. This could be attributed to lack of 
expression of the nisin genes. Alternatively, genes are expressed, but there are either no 
translation products, or the translation products do not undergo their normal post-
translational processing reactions. Introduction of a constitutive promoter, intended to 
increase mRNA synthesis, did not solve the problem. However, just because a promoter 
is introduced does not prove it is functional. So a major question is, “Are the nisin genes 


































Figure 26.   Analysis of the purified culture supernatant from B. subtilis 
YA2NE and L. lactis 11454 with halo assay and mass spectroscopy. 
he extracellular materials from the culture supernatant of B. subtilis SYA2NE and L. 
actis 11454 were isolated by NIC column and RP-HPLC (Materials and Methods Part II-
3 and 22). The fractions from the RP-HPLC was tested for biological activity by halo 
ssay against outgrowing B. cereus T spores as described previously. Activity was 
bserved at fractions #16 through 19 in both of the species as seen in Panel A. All the 
ractions were analyzed with nanoESI MS. Fractions 16 through 19 produced the same 
pectrum. Panel B shows the nanoESI MS spectra of fraction #17 of B. subtilis SYA2NE. 
raction #17 had a triply charged peak at m/z=929.1 (m=2784.3 Da) and 1855.6 
m=5563.8 Da) and a doubly charged peak at m/z=1392.4 (m=2782.8 Da).  Panel C 
hows the MALDI-TOF MS spectra of fraction and #17 of L. lactis 11454. A singly 
harged peak at m/z=3354.23. The calculated molecular weight from this peak 




Figure 27.   Analysis of the purified culture supernatant from B. subtilis 
erm∆sunA with halo assay and nanoESI MS. 
The extracellular materials from the culture supernatant of B. subtilis erm∆sunA was 
isolated by NIC column and RP-HPLC (Materials and Methods Part II-23 and 22). The 
fractions from the RP-HPLC was tested for biological activity by halo assay against 
outgrowing B. cereus T spores as described previously. Activity was observed at 
fractions #17 through 19 in both of the species as seen in Panel A. All the fractions were 
analyzed with nanoESI MS. Fractions 17 through 19 produced the same spectrum. Panel 
B shows the nanoESI MS spectra of fraction #18. Fraction #18 had a triply charged peak 
at m/z=929.0 (m=2784.0 Da) and 1856.2 (m=5565.6 Da) and a doubly charged peak at 
m/z=1392.3 (m=2782.6 Da). 
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Table 4.   PCR primers used in Results Part IV-Part V-4. 
Oligonucleotides SYNGCf and SYNGCr were used to amplify nisin gene cluster from L. 
lactis 11454 (Results Part V-1), SYNDCf and SYNISBr were used to amplify 1.5 kb 
fragment from the beginning of nisin gene cluster (Results Part V-1), SYUNISAf and 
SYUNISAr were used to in the construction of pCR2.1upnisA, SYA2UNISAf and 
SYA2UNISAr were used in the construction of pCR2.1A2upnisA, and SYT1f, SYT1r, 
SYT2f, SYT2r were used in the test PCR in Results Part VI-4 (Figure 25). 
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Part V-5.   RT-PCR of nisin genes. 
 In order to examine whether the nisin genes were being expressed, the presence of 
related mRNAs were established using RT-PCR. The Qiagen OneStep RT-PCR kit 
(Materials and Methods PartII-12) was employed for this purpose. The primers that were 
used in this section listed in Table 5. 
 RT-PCR was used to detect the mRNA from each of the nisABTCIPRK genes. To 
do so, a ~350 bp mRNA segment from each gene was amplified and the amplification 
mixtures were analyzed on 2.5 % agarose gels (Figure 28). The control lanes consisted of 
reaction in which the RT part of the reaction was omitted. The control lanes were the 
only ones that did not show the reaction products and established that the bands were 
produced by RNA and not DNA. The RT- PCR of nisA gene from B. subtilis erm∆sunA 
did not produce any bands, as the nisin gene cluster was not present in this wild type 
strain. Also, the negative control tube where no RNA was added did not produce any 
bands showing that the reaction components were not contaminated with RNA. The RT-
PCR of the nisin genes was done both with the nisin producer L. lactis 11454 and 
recombinant strain of B. subtilis containing the nisin gene cluster (SYA2NE). The 
mRNA’s for the nisABTCIPRK genes in both L. lactis 11454 and B. subtilis SYA2NE 
were shown to be present. When the bands obtained from L. lactis11454 were compared 
with the bands obtained from B. subtilis SYA2NE, they had very similar intensities. 
These results showed that the nisin genes were not only being expressed but also their 
expression levels were comparable to the natural host. However, this was not a 
“quantitative RT-PCR” experiment, so the similar intensities of the amplified bands are 
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he total RNA’s were isolated from the bacterial cultures by using the RNeasy mini kit 
Qiagen) as described in Material and Methods Part II-26, 26-1. The RT-PCR experiment 
as done by using the Qiagen OneStep RT-PCR kit (Materials and Methods Part II-26, 
6-2). The samples were run on a 2.5 % agarose gel. (Panel A) Lanes 3 and 5 are control 
anes where only the PCR part of the reaction for L. lactis 11454 and B. subtilis SYA2NE 
ere done with total RNA. Lane 6 is the RT- PCR of nisA gene from B. subtilis 
rm∆sunA. Lane7 is the negative control tube where no RNA was added. Lanes 2,8,10 
re the RT-PCR reactions of nisA, nisB and nisT from L. lactis 11454 and Lanes 4, 9, 11 
re the reactions for the same genes from B. subtilis SYA2NE. (Panel B) The RT-PCR of 
he rest of the genes was done both with the nisin producer L. lactis 11454 and 
ecombinant strain of B. subtilis containing the nisin gene cluster (SYA2NE). The + signs 
ndicates the presence of RNA and – signs indicates the absence of RNA in the reaction 
ixture of the corresponding strain. 
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Therefore the possibility remains that there was insufficient mRNA being produced to 









































Table 5.   RT-PCR primers used in Results Part V 
Oligonucleotides SYRTNISAf (57) and SYRTNISAr (57) were used to amplify 321 bp 
region from the nisA gene (Results Part V-1), SYRTNISBf and SYRTNISBr were used 
to amplify A 355 bp fragment from the nisB (Results Part V-1), SYRTNISTf and 
SYRTNISTr were used to amplify a 340 bp region from the nisT gene, SYRTNISCf and 
SYRTNISCr were used to amplify a 370 bp region from the nisC gene, SYRTNISIf and 
SYRTNISIr were used to amplify a 351 bp region from the nisI gene, SYRTNISPf and 
SYRTNISPr were used to amplify a 340 bp region from the nisP gene, SYRTNISRf and 
SYRTNISr were used to amplify a 358 bp region from the nisR gene and finally 






Part V-6.   Western blot analysis using antibodies to nisin. 
 Several fractions that show activity in the halo assay were subjected to SDS-
PAGE and Western blot analysis. Figure 29 shows the Western blot obtained using 
antibodies to nisin. There were two bands in the last lane, which contains nisin. Nisin has 
been observed to polymerize at high pH (1). The reactive nature of the dehydro residues 
is likely to be responsible for this polymerization. Nucleophilic side chains such as the 
ones present in lysine and histidine could possibly react with the electrophilic dehydro 
residues forming polymers. Up to eight and more nisin molecules has been observed to 
produce polymers when nisin was incubated at high pH (1). Nisin was also observed to 
polymerize when stored at –20°C for long periods of time(1). The lower band observed in 
this lane coresponded to the molecular weight of nisin and the upper band is possibly a 
dimer of nisin. One of the HPLC fractions from the culture supernatant of B. subtilis 
SYA2NE, the recombinant strain containing the nisin gene cluster, reacted with the nisin 
antibody. The band had the same molecular weight as nisin dimer. However, no signal 
was observed where the monomer form appeared. Corresponding fraction from the wt-B. 
subtilis culture did not react with nisin antibodies as expected. This result suggests that a 
nisin like peptide is being produced and secreted. Since the antibody was able to 
recognize this peptide, it is highly likely that it contains one or more of the modified 
residues. It is also possible that nisin was present in the medium as monomers; however, 
the antibody failed to recognize it due to the lack of appropriate 3-D structure in the 
monomer form. When this putative nisin molecule forms dimers it might be possible that 





































Figure 29.   Western blot analysis using anti-rabbit nisin antibodies. 
The peptides were isolated from the culture supernatants as described previously except 
nisin. The HPLC fractions that showed antimicrobial activity (Lanes 2-4), sublancin, and 
nisin were run on a SDS-poly acrylamide gel and blotted onto a NC-membrane 
(Materials and Methods Part II, 27-29). Lane 1 is purified sublancin, Lane 2 is Fraction 
#16 from the culture supernatant of B. subtilis SYA2NE (Figure 26), Lane 3 is Fraction 
#17 (5µl of 0.01 µg/µl) from the culture supernatant of B. subtilis SYA2NE (Figure 26). 
Lane 4 is Fraction #17 (Figure 27) from the culture supernatant of wt-B. subtilis 168. 
Lane 5 is 1 µg of nisin. 
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 The amount of the purified peptide was calculated by determining the sensitivity 








he lowest signal of nisin that could be detected with the nisin antibodies was 0.025 µg. 
he intensity of the signal obtained with 0.05 µg nisin was about the same as the signal 
btained at fraction 17. Acording to this result, concentration of the peptide in fraction 
17 was calculated to be 0.01 µg/µl. The amount of the total purified peptide in fraction 














Figure 30   Detection of the purified nisin by western blot analysis. 
Various amounts of nisin was run on a SDS-polyacrylamide gel and blotted onto a NC-
























Lantibiotics are a family of gene encoded antimicrobial peptides. They are of 
articular interest due to the presence of unusual amino acid residues that are introduced 
y post-translational processing. These residues confer novel biological and chemical 
roperties such as reactive groups that are not present in naturally occurring amino acids 
electrophilic dehydro residues) and chemical stability and protease resistance 
lanthionine residues).  
Nisin is the prototype lantibiotic and the only antibiotic of any kind that has been 
pproved by the FDA to be used as a food preservative. The natural producer of nisin, L. 
actis, has limited genetic tools available for it. Transfer of the ability to produce nisin 
nto another strain that can be readily manipulated by genetic engineering is important for 
everal reasons. Many structural analogs of nisin could be created which in turn could be 
sed for structure/function studies to elucidate the site and mode of action of this 
antibiotic. The current understanding of lantibiotic biosynthetic enzymes is largely based 
n sequence homology and genetic studies (26;41). The availability of appropriate 
utants may make it possible to biochemically characterize the biosynthetic pathway, 
hich includes novel modification enzymes. Finally, the availability of genetic tools 
ight allow us to increase the efficiency of production, which would be of great 
mportance for its industrial and pharmaceutical applications. 
Previously, it was thought that nisin could probably be expressed in B. subtilis by 
sing the subtilin biosynthetic machinery since the nisin and subtilin are similar and are 
ynthesized by homologous proteins. Various attempts have been made to express nisin 
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by using just the nisin structural gene in a subtilin producer strain, B. subtilis 6633 (31), 
(66). However, none of them has resulted in the production of nisin. Other attempts to 
express nisin, such as by attaching the nisin mature segment to the subtilin leader 
segment in L. lactis (46)and in B. subtilis 6633 (30;64) has resulted in the secretion of 
inactive forms of nisin. 
The goal of this work was to express nisin in B. subtilis 168 by transferring the 
nisin gene cluster from the natural producer into the chromosome of B. subtilis 168. A 
vector was constructed in order to introduce recombination sites from the flanking 
regions of the nisin gene cluster so that all the genes that are involved in the nisin 
biosynthesis could be integrated into B. subtilis 168 by a double recombination. The 
strain 168 has many properties that make it an attractive candidate for heterologous 
expression of nisin. These include the availability of many genetic tools, already being in 
use for industrial production of bioengineered proteins, its being a lantibiotic producer, 
and its being a gram-positive bacterium that is naturaly competent. 
The heterologous expression of lantibiotics such as nisin is more complicated than 
a typical polypeptide, since it requires the presence of not only the structural gene but 
also modification enzymes, immunity proteins, regulatory proteins, and transport 
proteins. 
The initial strategy was to transfer14 kb nisin gene cluster into B. subtilis 168 by a 
double recombination. A double recombination is a rare event and happens in fewer than 
1 in 100,000 cells. Moreover, the two chromosomes do not have any natural homologies 
and the piece of DNA to be transferred was relatively large. In order to get a recombinant 
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clone containing the complete nisin gene cluster, we needed a selection strategy that 
combined efficient recombination with an efficient selection strategy. 
Several strategies were used to enhance the chance of recombination. One 
strategy involved PCR amplification of the entire nisin gene cluster and cloning in a 
plasmid. Another strategy involved cloning the cluster in λ, and then transfering into a 
plasmid. These strategies had two advantages. First of all, a double recombination was 
not absolutely necessary for integration since the plasmid that contained the gene cluster 
was transformed in the circular form, and thus could integrate by single recombination. 
Second, these strategies eliminated the competition by extraneous L. lactis DNA because 
a copy of nisin gene cluster would be present in every cell. This enhances the chances of 
recombination. 
Competence in B. subtilis 168 is mediated by a set of proteins, which are 
responsible for binding, transport into the cell, and incorporation of the foreign DNA into 
its chromosome (77). Upon binding to DNA, one strand is stripped off and left outside 
whereas the other is drawn inside. During this process, random cuts are introduced to the 
DNA, so that what was taken inside consists of random fragments. Once the fragments 
are inside the cell, if there are sufficient regions of homology, recombination can occur. 
There is probably a limit to the amount of DNA that can be taken inside and this amount 
is correlated to the number of copies of the binding proteins. It is the saturation of these 
binding proteins by extraneous DNA that lowers the efficiency of uptake of the desired 
DNA segment.  
If all of the above factors are taken into consideration, integrating all the nisin 
genes into the B. subtilis 168 chromosome is not a simple process. On the other hand, 
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transfer of large segments of DNA is not uncommon and happens efficiently if the 
appropriate conditions are established. The transfer of subtilin producing ability from B. 
subtilis 6633 into B. subtilis 168 is an example of this. Since the two chromosomes have 
substantial homologies, the subtilin genes were easily integrated into 168 and then 
expressed without any need to do further manipulations (50). 
Therefore, by devising a selection strategy using a selection marker that can 
function in B. subtilis 168, and by increasing the chances of recombination, we were able 
to clone the nisin genes into the chromosome of B. subtilis 168. Nisin genes are likely to 
be evolved to function in a variety of hosts, as the genes are located on a 70 kb 
conjugative transposon which is a mobile genetic element. Thus once all the genes were 
integrated, nisin production had been expected. 
The standard methods for isolation of lantibiotics were used to isolate nisin from 
culture supernatants of recombinant strains of B. subtilis 168 containing the nisin gene 
cluster. Even though an antimicrobial activity was isolated that has the chromatographic 
properties that are similar to nisin, no nisin or nisin-like peptide could be detected using 
MS analysis. The antimicrobial activity was correlated with a molecular weight that was 
smaller than nisin. To test the possibility that nisin was being degraded by host proteases, 
nisin genes were transferred into a protease deficient strain of B. subtilis 168. The 
protease deficient strain produced the same active, small peptide that was produced by 
the normal strain. Moreover, this active peptide was also observed in the control culture 
of the wild type 168 strain. This proved that this antimicrobial activity was not due to the 
presence of nisin genes. However, the possibility that the nisin peptides were being 
degraded by the host enzymes still remains. At least 35 proteases have been identified in 
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the B. subtilis 168 (48) chromosome and any one of these peptides might play a role in 
the degradation of nisin. The “protease deficient” strain was deficient in just a few of 
these proteases. 
The expression from the nisin gene cluster is controlled by a two-component 
response regulator system. The presence of subinhibitory levels of nisin is essential to 
switch on this expression system in the producer strain, since nisin itself is the inducer of 
transcription of the nisin gene cluster in the natural host. The sensitivity to induction by 
nisin changes greatly from organism to organism. Studies of the nisin promoter have 
established that ng/ml levels induced transcription in L. lactis, but µg/ml levels are 
required to induce expression in B. subtilis 168. Whether it is sufficient to induce nisin 
gene expression in the inoculum culture, or it is needed in the actual culture medium is 
not clear. The latter would require growing the cells in the presence of 20 mg of nisin for 
each liter of culture just to induce expression. 
The possibility that the promoters present in the nisin gene cluster did not 
function properly in B. subtilis 168 was explored by replacing the normal promoter with 
promoters that are known to function well in B. subtilis 168. For example, a constitutive 
promoter that is known to function in B. subtilis 168 was integrated into a location 
upstream from the nisin structural gene. Despite the presence of the promoter, no nisin or 
nisin-like peptide could be detected when the purified culture supernatant was analyzed 
with mass spectrometry. In order to insure that the promoter had been integrated 
properly, the promoter region was PCR amplified and sequenced. The sequence 
confirmed the correct placement of the promoter. However, even though the promoter is 
present, it is not a guarantee that it is functioning properly. Alternatively, the genes are 
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expressed but there are either no translation products or the translation products do not 
undergo the normal post-translational processing reactions.  
The presence of the mRNA transcripts of genes in the nisin gene cluster was 
established with an RT-PCR experiment. The amplimers of the mRNAs from each of the 
nisABTCIPRK genes were detected by running the reaction mixtures on an agarose gel. 
The intensities of the RT-PCR product bands from the recombinant strain were similar to 
that of the natural host, which suggests, but does not prove that the genes are transcribed 
at comparable levels in both strains. This is because this was not a quantitative RT-PCR 
experiment, so one cannot be certain that mRNAs were expressed at similar levels. Thus 
there is still a possibility that the mRNA expression was not efficient enough to make a 
detectable translation product. However, the fact that RT-PCR products were obtained for 
all the genes in the cluster proves that all of the genes are present and are functional in 
their ability to produce transcripts. 
Even though nisin can be readily isolated from the culture supernatant of its 
natural producer, no nisin or nisin like peptide could be detected from the recombinant 
strains of B. subtilis 168 that contained nisin gene cluster by mass spectrometry analyses. 
The correct post-translational modifications of specific residues in lantibiotics have been 
shown to be prerequisite for processing and secretion of the active peptide (47). The 
leader peptide plays a critical role in the orchestration of the posttranslational 
modifications such as dehydrations of serines and threonines, formation of lanthionine 
rings, proteolytic cleavage of the leader peptide, and transport to the extracellular 
medium as a mature active peptide. If there is a problem with one or more of these 
 173
events, it may prevent the production of the active peptide. Nisin might be produced and 
secreted but not be in the natural form due to the reasons discussed above.  
Some evidence in the production of a nisin like peptide was obtained. Two 
fractions that showed antimicrobial activity in the halo assay from the culture supernatant 
of B. subtilis 168 containing the nisin gene cluster were analyzed by a western blot. The 
blot was probed with nisin antibodies and a signal that corresponded to a nisin dimer but 
not a nisin monomer, was observed in one of these active fractions. The corresponding 
HPLC fraction from the culture supernatant of the wild type B. subtilis 168 did not 
contain any signals at all. This result argues that a nisin-like peptide was produced and 
secreted but it was not a normal nisin molecule. The control lane containing the nisin had 
both monomer and dimer forms. Nisin has been shown to polymerize at high pH or when 
stored at –20 °C for prolonged periods of time (1). It is possible that the secreted product 
had various missing or incorrect posttranslational modifications that might favor the 
polymerization of the molecule or alternatively the monomer form was not recognizable 
by the antibody molecule. It is not clear at this time what kind of aberrant modification 
might induce this polymerization. But since the antibody molecule was apparently able to 
recognize a peptide argues that the peptide is a translation product of the nisin gene, and 
that it may have undergone some of the posttranslational processing events. It is also 
possible that the prepeptide was trapped in the cell wall prior to the secretion and only 
low levels of prepeptide was secreted outside the cell. If the leader peptide had not been 
cleaved off after the secretion, the molecular weight of the prepeptide would be close to 
the molecular weight of nisin dimer. Thus, the signal, which was higher than the 
molecular weight of mature nisin in the western blot could possibly correspond to the 
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molecular weight of the precursor peptide. Identifying the source of the problem 
associated with nisin production has been a challenging task. Now that the nisin gene 
cluster has been incorporated into the B. subtilis 168 chromosome, future studies of the 
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